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Near-infrared (NIR) ﬂuorescence (λmax: 700-1000 nm) has recently received 
considerable attention in bioimaging studies due to its deep penetrating ability through 
animal tissue and its significant reduction of autoﬂuorescence. Therefore, we designed 
and synthesized a set of photostable NIR cyanine dyes (named as CyNA library) 
composed of 80 molecules with structurally different amines. We later screened them and 
identified CyNA-414 as the most photostable dye. We compared CyNA-414 dye to the 
standard dye Indocyanine Green (ICG) and proved the superiority of our dye for NIR 
imaging. Next, we synthesized a succinimidyl ester derivative of CyNA-414 for 
bioconjugation (CyNE790) and compared its photophysical properties with the 
commercial standard ICG-sulpho-OSu which is the only NIR labeling dye clinically 
approved to date. A detailed evaluation of their photobleaching in buffer indicated a 15-
fold higher photostability of CyNE790 when compared to ICG. Furthermore, the 
injection of CyNE790-anti-EGFR treated SCC-15 and MCF-7 cells allowed the 
visualization of the labeled cells in mice and confirmed that the conjugation of CyNE790 
did not affect the recognition properties of the monoclonal anti-EGFR antibody. 
Furthermore, we synthesized a novel NIR fluorescent deoxyglucose analogue (CyNE 2-
DG). We examined the staining of CyNE 2-DG in cancer cells and proved its superior 
cell permeability over the NIR standard IRDye 800CW 2-DG, altogether validating its 
application for cancer cell imaging in the NIR region. 
  The applicability of fluorescent imaging is sometimes limited due to 
photobleaching, peak overlapping or low signal-to-noise ratios in complex biological 
systems. Therefore, we studied the application of cyanine dyes in an alternative imaging 
technique (i.e. Surface-enhanced Raman Scattering (SERS)) that can minimize the 
XIV 
 
limitations of fluorescence imaging. We designed the first combinatorial approach to 
discover novel and highly sensitive NIR SERS reporters. The synthesis of a NIR-SERS 
active tricarbocyanine library (CyNAMLA) and its screening led to the identification of 
CyNAMLA-381 as the most sensitive SERS reporter. scFv-conjugated CyNAMLA-381-
SERS nanotags recognizing HER-2 receptors were prepared and SERS mapping analysis 
confirmed that the nanotags were mainly localized at the cell surface of HER-2 
expressing cancer cells. We also administrated the nanotags to nude mice bearing 
xenografts generated from SKBR-3 cells, and observed that the signal of the tumor site 
perfectly resembled the SERS spectra while no signal was detected from other anatomical 
locations. These results clearly indicated that CyNAMLA-381-SERS nanotags were able 
to specifically detect tumors in vivo. In addition, we designed a derivative of cyanine dye 
(i.e. Cy3LA) as a multiplexing partner of triphenylmethine derivatives (i.e. B2LA).  In 
order to examine the multiplex differential recognition of B2LA anti-EGFR and Cy3LA 
anti-HER2 nanotags in cells, we incubated an equal amount of both nanotags in OSCC 
cells (EGFR-positive) and SKBR-3 cells (HER2-positive). The SERS measurements in 
OSCC and SKBR-3 cells fully resembled the SERS spectra of B2LA and Cy3LA and 
demonstrated the multiplex properties of B2LA and Cy3LA SERS nanotags. At last, we 
demonstrated the multiplexing capability of three different NIR Raman reporters (i.e. 
CyNAMLA-381 and the newly synthesized Cy7 LA and Cy 7.5 LA). The high sensitivity 
and tumor specificity of antibody-conjugated SERS nanotags proves their excellent 
potential as non-invasive diagnostic tools and opens up a new window for the 
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Technological advances have enabled the finding of small molecular probes 
with high selectivity to specific targets. However, the most challenging step in the 
identification of small molecule probes turns to be easy process using fluorescent 
small molecules. In this conventional strategy, targeted ligands of specific organelles 
in complex biological systems can be fluorescently labeled and hence imaged using 
fluorescence microscopy. Selective and specific images can be obtained by applying 
these small molecules as bioimaging probes in which a probe is labeled with a 
fluorescent dye. The design of ﬂuorescent probes was initially proposed by target-
oriented synthesis (TOS) where ﬂuorophores are simply used as signal amplifiers.  
When a fluorescent molecule itself undergoes a change of emission intensity 
or emission color upon recognition of targeted ligands is defined as a fluorescent 
sensor. The development of fluorescence sensors is limited in the TOS approach. 
Recently diversity-oriented synthesis (DOS) approaches have been employed to 
discover novel probes or sensors.  
 
1.1 Overview of fluorophores 
A fluorophore is a molecule with different functional groups absorbing light 
of a specific wavelength (most commonly in the UV-visible range) to reach an 
electronically excited singlet state and later emit a photon at a longer wavelength. 
Molecules that absorb energy cannot always emit fluorescence due to their loss of 
energy through non-fluorescent mechanisms (e.g. vibrational, rotational and change 
of molecular bonds) and a very limited number of scaffolds are found to be 
fluorophores. Interestingly, these few fluorescent scaffolds cover almost all colors in 
the spectra, from UV-visible to near–infrared (NIR) (Figure 1.1). Well known 





 FITC (Fluorescein isothiocyanate),
2
 TRITC (tetramethylrhodamine 
isothiocyanate), Texas Red (sulforhodamine 101 acid chloride)
3













 (Figure 1.2) 
have been employed for a range of applications in the bioorganic field.  
 
Figure 1.1. Visible spectral range of different well known fluorophores.  
 
Recently, fluorescent small molecules have received a substantial attention in 
optical bioimaging studies
10
 due to their high detection sensitivity and minimal 
technical limitations. In addition, fluorescent small molecules can be applied to the 
development of chemosensors
11
 for live cell imaging
12
 due to their good solubility, 




Figure 1.2. Representative fluorophores with emission ranging from blue to NIR. 
 
1.2 Synthetic strategies for novel fluorescent probes 
1.2.1 Diversity-oriented synthesis  
Diversity Oriented Synthesis (DOS) has recently appeared as a powerful tool 
for the preparation of molecular probes to study different biological functions. In this 
strategy, the skeleton of a small molecule is explored in a combinatorial way to obtain 
a library of molecules (Figure 1.3). Based on this approach, the field of chemical 
genomics has rapidly expanded and facilitated the discovery of new mechanisms for a 
number of biological processes. Inspired by many successful attempts, research 
groups have been racing to invent effective functional networks at a cellular level by 
applying diverse chemical libraries. In the context of bioimaging, small molecules 
that undergo changes in fluorescence upon recognition of the specific target analytes 
have drawn considerable attention to recognize different biomolecules. For example, 





are widely used as mitochondria probes.
13
 However, the design of 
fluorescent sensors for specific organelle largely relies on empirical discovery, and 
one of the most convenient ways to develop specific organelle probes bases on high-
throughput screenings: large numbers of molecules from different sources are 
screened in different organelles in order to identify the most suitable probes. The 
synthesis of a large number of molecules in high purities is challenging due to the 
difficulties in the purification steps. This limitation is particularly relevant in the 
development of novel bioimaging probes, with limited fluorophore scaffolds and 
several synthetic difficulties, and novel imaging probes are reported in a relatively 
low speed. To accelerate the development of imaging probes, Chang and co-workers 
proposed the concept of a diversity-oriented fluorescence library approach 
(DOFLA).
14 
As shown in Figure 1.3, one single molecular cassette can be modified in 
a combinatorial manner so that thousands of fluorescent small molecules covering 
UV-Vis to NIR colors can be synthesized. To date, several research groups have 









-amyloid,19 chymotrypsin,20 heparin,21 ,glutathione,22 human serum albumin 
(HSA),
23
 bovine serum albumin (BSA),
24
 site-speciﬁc labeling of proteins inside live 
cells,
25
 embryonic stem cell probe,
26
 quantitative sugar analysis,
27
 and an 
immunoglobulins
28
). These examples validate the power of DOFLA, in which the 
synthesis of fluorescent libraries and their screening towards specific analytes can 




Figure 1.3. Diversity oriented fluorescence library approach. 
 
The applicability of DOS can also be extended to optimize the photophysical 
properties of fluorescent dyes. As illustrated in Figure 1.4, the construction of a 
library of cyanine molecules to optimize their photostability properties was possible 
by modification of different “R1-9” without changing the core cassette of 
tricarbocyanine dyes.  Furthermore, highly sensitive SERS active Raman reporter 
molecules have been also found by applying this approach. 
 
Figure 1.4. Diversity at different position depending on the requirement of cyanine 
dye cassette. 
 
1.2.2 Target-Oriented Synthesis 
Target oriented ﬂuorescent probes have been designed by tagging 
ﬂuorophores to recognition moieties. The recognition moieties are designed based on 
experienced knowledge. The experimentally results may not reflect all the time as it is 
 6 
 
expected. Hence the target oriented synthesis has some limitations to develop large 
number of molecular probes. Despite the limitations several advantages make it more 
suitable for the design of fluorescence probe.  To do that, different approaches are 







1.3 Near-infrared fluorophores 
Among the different fluorophores, NIR dyes (i.e. molecules absorbing light 
in the range of 700 to 1000 nm) are more suitable for the optical imaging in vivo
31
 
while the shorter wavelength dyes ranging from blue to green are mainly used for in 
vitro cell imaging studies. Therefore, NIR light absorbing dyes have attracted much 
attention for the development of the in vivo optical imaging probes. NIR light has 
been employed in a wide range of biomedical applications due to its deep tissue 
penetration. UV-visible light often suffers from high autofluorescence and 
background limitations. On the contrary, NIR light minimizes the background 
problems and opens up a new window for the NIR light absorbing dyes. The 
advantages of imaging in the NIR region are numerous: (a) the low absorbance from 
tissue enables a deeper tissue penetration; (b) low auto-fluorescence reduces the 
fluorescence background and (c) low Raman scattering produces very high signal to 
noise ratio. Recently, the attention on tissue imaging or in vivo imaging has attracted 
the development of different NIR fluorophores. To date a very few number of 









). Among them, cyanine structures
36
 have been one of 
the most popular scaffolds amongst the various fluorescent NIR dyes for the 
development of imaging probes due to their synthetic accessibility, large molar 
extinction coefficient and broad wavelength tenability. In addition, photo-switchable 
cyanine dyes are useful for high resolution microscopy (e.g. STORM and PALM
37
) 





 and high-throughput screening (HTS).
39
 In view of these 
advantages over other fluorophores, cyanine dyes have been considered for the 
development of new NIR libraries for bioimaging purposes in this thesis.  
 
1.3.1 Cyanine dyes 
Cyanine dyes are a class of polymethine dyes which consist of an odd 
number of methine groups (CH). Konig et al. experimentally showed in 1925 that 
polymethine cyanine dyes shifted 100 nm absorbance wavelengths
40
 due to the 
presence of vinylene functional groups (Figure 1.5). This broad range of wavelengths 
covered by the cyanine dyes has been employed for a wide range of applications in 
different fields. The applicability of cyanine dyes widely ranges from photographic 
sensitizers, nonlinear optical materials,
41
 and more recently, ﬂuorescent probes for 
biomolecular labeling.
42
 Specially, one class of polymethine cyanine dyes for the 
generation of NIR compounds are tricarbocyanine and heptamethine cyanine dyes. 
 
Figure 1.5. General structure of cyanine dyes. 
 
1.3.2 Tricarbocyanine dyes 
Carbocyanine dyes are a type of cyanine dyes whose structure has two 
heterocyclic rings connected by a carbon chain alternating single and double bonds 
(e.g. =CH−CH=CH-). These dyes are also known as polymethine cyanine dyes. 
Polymethine cyanine dyes are defined as pentamethine or heptamethine depending on 
the number of carbon atoms between the two heterocycle rings. In a similar way, 
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tricarbocyanine dyes are defined in the number of chain carbons between the two 




Figure 1.6. a) General structure of heptamethine and b) tricarbocyanine dyes. 
 
 
A variety of tricarbocyanine cyanine dyes can be developed by modification 
of the side chain of the heterocyclic rings. The resulting derivatives show very similar 
spectroscopic properties due to the unaffected of  conjugation. In 1977, Reynolds 
et al. first reported a stable heptamethine pyrylium dyes bearing a reactive chloro 
functional group at the central position of the polymethine chain and two heterocyclic 
rings at the side chains.
43
 These cyanine dyes mainly absorbed light at infra-red (IR) 
regions from 1000 to 1300 nm. At the same year, Makin et al. reported a different 
heterocyclic ring at the side chain of the dyes which absorbed light in the NIR region. 
In this synthetic procedure, a condensation reaction between a heterocyclic ring 
containing an activated methyl group and an unsaturated bisaldehyde or its derivative 
was perfomed in the presence of a catalyst such as a sodium acetate.
44
 These cyanine 
dyes particularly offered a new functional group for further modification and the 
resulting compounds were more versatile in terms of spectroscopic properties, with 
absorbances ranging from 700 to 1100 nm.  
To date, the central chlorine atom in the convertible tricarbocyanine structure 
(Figure 1.7) has been modified by different nucleophiles such as thiols, alcohols, 
phenols, amines and anilines. The substitution of the chlorine at the central position 
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was first derivatized by Strekowski et al.
45
 in 1992. The authors reported the 
nucleophilic substitution with sodium methoxide, Methylamine, Sodium phenoxide, 
Sodium thiophenoxide, Thiophenol and 4-Aminothiophenol which yielded a diverse 
set of NIR dyes. This straightforward and highly efficient strategy opened up a new 
window for a broad range of chemical structures in the NIR region. To improve the 
synthetic procedure, Narayanan et al.
46
 designed a new uncatalyzed synthetic route 
for heptamethine cyanine and tricarbocyanine dyes in 1995. Though the diverse range 
of chemistry was well explored, the detailed photophysical properties (especially 
fluorescence) were not well characterized. Next in 1997, Flanagan et al. reported a 
novel NIR absorbing tricarbocyanine dye with a reactive isothiocyanate functional 
group that could be easily conjugated to primary amines.
47
 Until 2005, most of the 
NIR tricarbocyanine dyes based on the phenol and thiophenol derivatives were 
chemically unstable and displayed short Stokes shifts (~25 nm).  Bearing this in 
mind, Peng et al. reported heptamethine cyanine dyes with the formation of a C-N 
bond at the central position, which helped the intramolecular charge transfer (ICT). 
The resulting derivatives showed a hypsochromic shift of the absorbance wavelengths 
as well as longer Stokes shifts (~150 nm). These NIR fluorescent probes have better 
properties than common cyanine dyes due to their minimum overlapping
48
 of 
absorbance and emission wavelengths. Next in 2006, Lee et al. synthesized water-
soluble heptamethine cyanine dyes by Suzuki-Miyaura reacion to introduce a robust 
C-C bond at the central position of the NIR tricarbocyanine scaffold.
49
 The resulting 
dyes were more photostable when compared to aryl ether, aryl thioether, aryl amine, 






Figure 1.7. Examples of different tricarbocyanine dyes. 
 
1.4 Properties of cyanine dyes 
1.4.1 Photophysical properties of cyanine dyes 
Cyanine dyes can absorb light in the range from UV-Visible to IR and emit at 
comparatively longer wavelengths. As they are positively charged species, their 
solubility is quite good in polar solvents. Generally, cyanine dyes show low to 
moderate quantum yields, and their extinction coefficients are high with respect to 
most common dyes. The intensity (molar absorption, extinction coefficients, and 
oscillator strength) of polymethine dyes generally increases as the vinylene chain 
length is extended, and the fluorescence efficiency of NIR cyanine dyes is generally 
enhanced if dye molecules are bound to macromolecules
50
 (e.g. proteins) or 
coordinated to metal ions. Table 1.1 summarizes different cyanine dyes and their 
most representative photophysical properties.  
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Table 1.1. Spectral properties of cyanine dyes. 
Compounds Absorbance Emission Ref 
 
1072 nm (H2O) n.a 43 
 
780 nm (DMSO) n.a 51 
 
680 nm (PBS buffer)  710 nm (PBS 
buffer) 
52 
    
 
783 nm (H2O) 803 nm (H2O) 53 
 
794 nm (H2O) 
795 nm (H2O) 
798  nm (H2O) 
817 nm (H2O) 
820 nm (H2O) 
823 nm (H2O) 
53 
 

























































686 nm (H2O) 783 nm (H2O) 62 
 
786 nm (H2O) 808 nm (H2O) 62 
 
617 nm (H2O) 757 nm (H2O) 48 
 
648 nm (DMSO) n.a 63 
 




642 nm (H2O) 656 nm (H2O) 65 
 
646 nm (H2O) 670 nm (H2O) 66 
 
594 nm (H2O) 616 nm (H2O) 67 
 
1.4.2 Stability of cyanine dyes 
Cyanine dyes are generally prepared by alternating the conjugation of double 
bonds between two heterocyclic rings, one of which contains a heterocyclic ring with 
a positive charge on the nitrogen atom. Thus these cationic dyes are highly affected 
by nucleophilic solvents, and aqueous or methanolic solvents can react as 
nucleophiles under basic conditions.
68
 This low chemical stability of cyanine (e.g. 
Cy3, Cy5 and Cy7) dyes has been considered their most significant drawbacks. 
Furthermore, most of the tricabocyanine derivatives (e.g. aryl ether, aryl thioether, 
aryl amine, alkyl ether, and alkyl thioether) are unstable even in physiological 
conditions for long time. In addition to chemical stability, a major limitation of 
cyanine dyes is photobleaching or photodestruction. Upon irradiation of light to 
aqueous solutions of cyanine dyes, reactive oxygen species such as singlet oxygen 
(
1
O2), peroxide, superoxide and redox active metabolites can react with the 
fluorophores
69
 and lead to their degradation. Specially, tricarbocyanine dyes are 
known to be relatively low photostable due to their long  conjugation. Very few 
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reports about the phototability of cyanine dyes are available in the literature. For 
example, Song et al. reported in 1997 a comparative photobleaching study between 
aryl thioether and aryl amine derivatives of tricarbocyanine dyes and proved the 
superiority of amine derivatives.
62 
Though there are several example of NIR probes 
based on aryl ether, aryl thioether and aryl amines of tricarbocyanines, there is a need 
for more photostable NIR cyanine dyes for long-term in vivo experiments. To date, 
few examples of photostable cyanine dyes have been described. In 1997, Guther et al. 
first introduced cyclodextrins to enhance the chemical stability by protecting dyes 
from the collisions with reactive species. In 2004 Renikuntala et al. first reported the 
chemical modification by introducing electron-withdrawing fluorine atoms to the 
phenyl rings of cyanine dyes in order to improve the photostability of pentamethine 
cyanine dyes.
63
 In 2006 Chen et al. reported that the decomposition of tricarbocyanine 
dyes due to the incorporation of singlet oxygen (
1
O2) and introduced an electron-
withdrawing group on the nitrogen atom of the indole rings in side chain of the 
heterocycle.
70
 Toutchkine et al. introduced a small cyano group in merocyanine dyes 
and demonstrated their improved photostability of cyanine dyes.
71
 Tricarbocyanine 
dyes have not been extensively explored in terms of improving their photostability. 
Even though their applicability as NIR dyes for in vivo imaging is highly demanded.  
 
1.4.3 Surface enhanced Raman scattering (SERS) properties 
Raman active molecules can be highly sensitive when they are in close 
proximity to the roughened surface of noble metal nanoparticles or when they are 
adsorbed on metallic nanostructures. This phenomenon is known as surface-enhanced 
Raman scattering (SERS). In 1974, Fleischmann et al. described the surface effect on 
Raman active molecules, in which the Raman scattering of pyridine and its 
derivatives was significantly enhanced when adsorbed on the surface of silver 
nanoparticles.
72
 After that, the first report of SERS on silver and gold colloids was 
published in 1979 by Creighton et al.
73
 Since then, noble metal colloids have become 
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the most common material for the development of nanostructures of SERS active 
nanoparticles (NPs). SERS spectroscopy has several advantages over conventional 
fluorescence spectroscopy. For examples, SERS has a lower susceptibility to 
photobleaching and an enhanced multiplex capability due to the non-overlapping 
narrow bandwidths of the peaks. However, the reproducibility of the signal intensities 
of SERS nanotags, which are prone to aggregate formation, has been identified as the 
major drawback of SERS spectroscopy. This phenomenon is generally observed due 
to the interaction of nanotags with the environment.
74
 For example, SERS nanotags 
suspended in aqueous buffers containing chloride ions can lead to aggregation due to 
the ionic exchange on the surface of the NPs. This limitation has been recently solved 
with encapsulation strategies and incorporation of linkers. To improve the stability 
and biocompatibility of NPs, a protective layer of polyethylene glycol (PEG) has 
been used to encapsulate the noble metal nanoparticles. PEG-SH encapsulation is 
now a very well-known method to prevent gold nanoparticles from aggregation in 
buffer solutions and organic solvents.
75,76 
Encapsulation strategies have been extended 
to DNA or proteins like bovine serum albumin (BSA).
77-84 
PEG-SH protected gold 
NPs show negligible cytotoxicity and better biocompatibility when compared to free 
NPs.
85
 Moreover, this protecting layer not only enhances the stability of NPs but also 
opens up the possibility of incorporating new functional groups which can be 
conjugated to a variety of biologically relevant ligands or antibodies for targeted 
approaches.  
 
1.5 Applications of cyanine dyes 
I have discussed earlier the diversity oriented synthesis (DOS) of fluorescent 
libraries by combinatorial methods. These libraries of fluorescent small molecules are 
excellent toolboxes for the discovery of fluorescent probes. High- throughput 
screening is a key strategy in the finding of active molecules towards selected 
analytes. Inglese et al.
86
 demonstrated the efficiency of high-throughput screenings of 
 17 
 
libraries in microtiter plate assays to discover active small molecule probes. Based on 
this concept, I aim to perform high-throughput screenings to discover photostable and 
Raman-active cyanine dyes from our libraries (Figure 1.8). 
 
Figure 1.8. Representing high-throughput screening strategy in microplate readers. 
 
1.5.1 In vivo fluorescence imaging 
In vivo ﬂuorescence imaging using NIR light has a great prospective for 
molecular diagnostics and therapeutic studies. Furthermore, as NIR in vivo imaging is 
non-invasive, there is significant concern for the translation of novel optical NIR 
imaging into the clinic. The applicability of exogenous NIR-emissive contrast agents 
is highly demanded for deep-tissue ﬂuorescence imaging, and a large number of NIR 
cyanine probes have been reported to date. In 1999, Weissleder et al.
87
 applied a NIR 
fluorescent cyanine dye for in vivo imaging of tumors and successfully demonstrated 
their applicability to detect tumors of submillimeter size. Hence, these NIR 
fluorescence probes did show a very high potential to identify early stage tumors in 
vivo. The applicability of NIR tricarbocyanine probes regarding in vivo tumor 
imaging was later described for the early detection of stomach, colon, and breast 
cancer as reported by Becker et al.
88
 In 2006, Leevy et al. demonstrated the 
applicability of fluorescent molecular probes containing zinc (II) dipicolylamine (Zn-
DPA) which is able to selectively stain the surfaces of apoptotic animal cells and 






Figure 1.9. Optical images of a mouse with a S. aureus infection in the left rear thigh 
muscle. Images were acquired before (A), and immediately following (B), 
intravenous injection of probe 1 and at 6 h (C), 12 h (D), 18 h (E), and 21 h (F). 
*This picture has been copied from J. Am. Chem. Soc. 2006, 128, 16476-16477 under 
copyright permission. 
 
In 2002 Ntziachistos et al. reported in vivo imaging by Cy5.5 as NIR labeling 
dye,
90
 and recent approaches have pursued their use to study protein-DNA 
interactions.
91
 Sasaki et al. also demonstrated the applicability of NIR fluorophores as 
turn-on fluorescent sensors for the detection of nitric oxide (NO). The authors proved 
the detection of NO in cells, indicating that this NIR probe could be applicable for the 
detection of in vivo NO imaging.
57
 Kiyose et al. developed a ratiometric fluorescent 
Zn(II) probe based on tricarbocyanine structure composed of a tricarbocyanine dye 
and a Zn(II) ion chelating ligand.
89
 NIR tricarbocyanine dyes have been also applied 
to imaging bacterial infection in mice,
92
 the detection of heavy metals (e.g.Hg(II) 
56
) 






Figure 1.10. Representative examples of tricarbocyanine fluorescent probes. 
 
1.5.2 SERS imaging 
There has been a substantial interest during the last decade to apply SERS to the 







 or the investigation of sensitive biological samples.
97
. For these purposes, 
reporter molecules (i.e. Raman-active dyes) with thiol functional groups have been 
attached on the surface of silver or gold NPs with variable sizes (10–80 nm) to obtain 
SERS nanotags. As discussed earlier, the reproducibility and spectral intensity of 
these nanotags can be controlled by encapsulation and shielding from the 
environment. In the recent years, stable and biocompatible nanoparticles (NPs) have 
been used for SERS cellular imaging. Antibody-conjugated gold nanoparticles 
(AuNPs) and nanorods have been employed for the targeted imaging of specific 
cancer markers that are highly expressed on the surface of cancer cells. Hence, 
antibody-conjugated AuNPs are selectively attached to the target cancers cells and the 
higher SERS intensity from the target cancer cells enables their imaging and 
detection. In this context, antibodies that recognize the epidermal growth factor 
receptor (EGFR)
98
 over-expressed in human tumors have been conjugated to SERS 
nanotags and applied to the detection of tumors in vivo.
98
 NIR dyes (e.g. 
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diethylthiatricarbocyanine (DTTC)) have been also employed as specific Raman 
reporters for in vivo surface-enhanced resonance Raman scattering (SERRS).
99
 With 
the demonstration by Tang et al. that 60-nm AuNPs could enter human osteosarcoma 
cells (G292 line) and reside in the cytoplasm and surrounding of the nucleus,
100
 I was 
encouraged to develop novel SERS AuNPs as diagnostic tools for the detection of 
tumors in vivo or multiple cancer cells in vitro. 
 
1.6 Scope and outline of the thesis 
I have discussed earlier the synthesis of polymethine cyanine dyes and the 
different synthetic strategies for tricarbocyanine dyes. I have also highlighted the 
photophysical properties of cyanine dyes. The promising spectral properties of NIR 
dyes have attracted our interest due to their potential application for in vivo imaging 
and I have introduced the concept of DOFL for the development of new bioimaging 
probes. Hence, we aim at designing new libraries of NIR dyes with a diverse range of 
spectral properties. To date, the most common approach to synthesize a large set of 
molecules based on the tricarbocyanine structure considers the use of amines as 
nucleophiles since thioether and ether derivatives are chemically unstable. 
The aims for this thesis project are: 
1) To develop a novel strategy to improve the photostability of tricarbocyanine dyes. 
In this strategy, we introduced an electron-withdrawing group at the central 
nitrogen atom of amine tricarbocyanine dyes. The higher stability of this new set 
of molecules (CyNA) led to the design of a diversity-oriented library to identify 
the most photostable cyanine dyes. 
2)  To modify the most photostable cyanine dye from our library so that it included a 
functional group for further conjugation to small molecules or macromolecules. 
We introduced a glutaric acid linker and the functionalized dye (CyNE790) was 
applied to the conjugation of an antibody to target specific cancer cells. 
Furthermore, we proved the applicability of this protein labeling dye for in vivo 
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imaging and showed its better photophysical properties compared to the 
commercial ICG-sulpho-OSu.  
3) To apply CyNE790 to the conjugation of small metabolites, such as glucose, and 
prove its applicability in cancer cell imaging.This dye-conjugated glucose 
derivative behaved similar to glucose and the cell permeability of our new 
tricarbocyanine dye was better when compared to the reported IR800CW-2DG 
derivative.  
4) To develop the new detection tool for the identification of cancer in vivo based on 
the surface-enhanced Raman scattering (SERS) of cyanine dyes. I have applied the 
CyNA structure to design novel Raman active signature molecules and introduced 
a thiol linker motif (lipoic acid) to chemisorb an 80-member CyNAMLA library 
on gold nanoparticles (AuNPs). I have screened the full library and selected the 
most responsive compounds and compared their performance with the only 
commercially available NIR Raman reporter (i.e. DTTC).  
5) To design multiplex partners of Raman active dyes based on a different set of 
cyanine dyes, specifically Cy3LA and Cy5LA derivatives. These cyanine dyes are 
highly Raman active at 633 nm laser source, and we selected a triphenylmethene 
multiplex partner (B2LA) for the multiplex detection of cancer cells in vitro.  
6) To demonstrate the applicability of SERS multiplicity in vivo. I have designed a 
novel pair of NIR-active tricarbocyanine Raman reporters (Cy7LA and Cy7.5LA) 
to partner with our previously synthesized CyNAMLA381. We demonstrated that 
anti-EGFR antibody conjugated nanotags displayed excellent selectivity towards 
EGFR+ tumors in xenograft models and it could be applied for multiplexed 
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The field of bioimaging research has recently focused considerable attention 
on NIR dyes. Amongst several advantages, NIR light can deeply penetrate into tissues 
with lower light scattering and auto-fluorescence
 
than visible light. NIR dyes have 














 have been employed for organic NIR fluorophores. Among 
them, cyanine dyes
7
 are the most popular due to their synthetic accessibility, broad 
wavelength tunability, and large molar extinction coefficient with moderate 
ﬂuorescence quantum yields. Although a few number of NIR dyes, mainly based on 
the cyanine structure, have been reported as effective fluorescent probes for in vivo 
imaging studies,
8
 most of them are described as individual examples. The synthetic 
limitations to incorporate broad chemical diversity into NIR scaffolds have hindered 
their derivatization in a combinatorial manner, and thus restricted their range of 
applications. A rigid cyclohexenyl ring in heptamethine chain and a reactive vinylic 
chlorine atom that can be replaced by a diverse range of nucleophiles have been 
familiar for the synthesis of NIR dyes. The resulting derivatives show maximum 
absorbance wavelengths above 600 nm, which is essential to develop in NIR dyes. 
The incorporation of phenols and thiophenols
9 
has rendered tricarbocyanine 
derivatives with low chemical stability in aqueous media. In addition, the 
photodegradation of NIR cyanine dyes is significant for dyes with absorbance λmax 
longer than 700 nm.
10
 The photostabilty of the dyes diminishes significantly along 
with the increase of the -conjugation system. To overcome such limitation, amine 
and aniline building blocks have been employed, yet the low photostability of the 
resulting compounds remains as a major drawback.
11
 Therefore, libraries of NIR 
fluorophores with increased photostability would enormously expand the scope of 




To overcome the photostability and chemical diversity limitations of NIR 
dyes, first I modified the tricarbocyanine scaffold and improved its photostability and 
secondly I expanded its chemical diversity by applying a diversity-oriented 
fluorescence library approach (DOFLA). As a result, I created the first NIR library 
based on a tricarbocyanine structure (CyNA) with improved photostability. The 
CyNA scaffold was derivatized in a combinatorial manner and screened to identify 
CyNA-414 as a highly photostable NIR dye with superior ﬂuorescent properties than 
the NIR standard Indocyanine green (ICG). 
 
2.3 Results and discussion 
2.3.1 Decomposition study of tricarbocyanine dye  
A rigid cyclohexenyl ring within the heptamethine chain increases 
photostability compared to cyanine dyes with an open polymethine chain
12
 and a 
reactive vinylic chlorine atom that can be replaced by different amine derivatives 
opens a new window for the synthesis of a relatively better photostable cyanine dyes 
than aryl thioethers or aryl ethers. While amine derivatives of the tricarbocyanine 
structure (CyN) have been described as promising NIR cyanine dyes for broad 
chemical derivatization,
13
 the low photostability in aqueous media has hampered their 
biological application. Although the decomposition mechanism of some cyanine dyes 
has been studied,
14 
no systematic study regarding the photostability of tricarbocyanine 
analogues in aqueous media has been reported to date. In order to examine such 
mechanism and surmount the stability limitations of tricarbocyanine dyes, I analyzed 
the decomposition products of one amine tricarbocyanine derivative (CyN-111). 
Upon light irradiation, CyN-111 quickly underwent the incorporation of a reactive 
singlet oxygen species to render CyN-111a, which subsequently generated the non-





O2) results in the reaction with the double bonds of cyanine dyes to form an 
unstable intermediate peroxo compound (CyN-111a).  
 
 
Figure 2.1.  Reverse-phase HPLC monitoring of CyN-111 decomposition in aqueous 
media (UV detection: 500 nm). 
 
The HPLC analysis in Figure 2.1 clearly shows that a distinct retention time 
at 500 nm is shifted from the mother compound (CyN-111). As CyN-111a compound 
is highly active at 500 nm instead of 640 nm (max of CyN-111, see Table 2.1, Figure 
2.4) I selected 500 nm wavelengths for HPLC analysis. Absorbance differences 
clearly supports that conjugation in polymethine chain is highly affected due to the 
loss of conjugation. In addition, mass analysis data (Figure 2.2.) supports the 
incorporation of singlet oxygen into the main tricarbocyanine scaffold.  Eventually, 
the unstable intermediate led to the more stable CyN-111b and CyN-111c 





C-NMR and mass analysis. Moreover, I compared the IR 
spectra (Figure 2.3) of CyN-111 compound with a reaction mixture which was 







 corresponding to the ketone and aldehyde bands also confirmed the 
formation of CyN-111b and CyN-111c.  
 




Figure 2.3. IR spectra of the reaction mixture after 6 h of light irradiation. The 
carbonyl bands corresponding to CyN-111b (ketone) and CyN-111c (aldehyde) are 
easily distinguishable. 
 
2.3.2 Design and synthesis  
In view of these results, I hypothesized that the modiﬁcation of the central 
nitrogen atom with an electron-withdrawing group would suppress the stabilization of 
the iminium intermediate (Chart 2.1) that facilitates the incorporation of the reactive 
oxygen species. The removal of electron density from the amine tricarbocyanine 
structure may minimize the photoinduced decomposition and improve its 
photostability. 







To investigate this hypothesis, I modified 4 structurally diverse (including 
diﬀerent-length aliphatic, aromatic, and heterocycle-containing amines) CyN 
compounds with an electron withdrawing acetyl group to afford the corresponding 
acetylated compounds (CyNA) (Scheme 2.1). 
Scheme 2.1. Synthesis of amine tricarbocyanine derivatives. 
 
Reagents and conditions: (a) RNH2, DIEA, CH3CN, 80 

C, 10–60 min; (b) 
CH3COCl, DIEA, CH2Cl2,0 

C, 15 min. 
 
 
2.3.3 Characterization of tricarbocyanine dyes 
 
Absorbance (abs) and fluorescence maximum wavelengths (em), quantum 
yields (, and extinction coefficients ( of CyN-111, CyN-165, CyN-272, and CyN-
295 were measured in DMSO (Table 2.1). After acetylation on the central nitrogen 
atom of CyN compounds, the absorbance band was shifted approximately 160 nm 
towards the NIR region (Figure 2.4). This effect may be due to the intramolecular 
charge transfer (ICT), which is restricted in the presence of the strong electron 





Table 2.1. Characterization of CyN compounds. 





CyN-111 640 760 0.42 0.538 x 105 
CyN-165 640 762 0.37 0.352 x 10
5
 
CyN-272 635 765 0.41 0.516 x 10
5
 






Quantum yields were measured in DMSO, using IndoCyanine Green as a standard 
( : 0.13, in DMSO).1 
 
Figure 2.4. (a) Absorbance (blue) and emission (red) spectra of CyN-111 in DMSO 
(1 M); (b) absorbance (green) and emission (red) spectra of CyNA-111 in DMSO. 
 
2.3.4 Photostability measurements 
The photostability properties of CyN and CyNA structures (CyN-111, CyN-
165, CyN-272, CyN-295, and their CyNA counterparts) were evaluated by time-
course ﬂuorescence measurements in HEPES buffer, and compared to the starting 
material 1 (Figure 2.5). Interestingly, the pseudo first order rate constants (k) of the 
CyN compounds were 8 to 13-fold faster than those of the corresponding CyNA 
derivatives, indicating the significantly ameliorated photostability of the CyNA 
scaffold. The improved photostability of the CyNA scaffold validated our initial 
 37 
 
hypothesis that the incorporation of an electron withdrawing group could increase the 
photostability of the amine tricarbocyanine structure.  
 
Figure 2.5. Photostability evaluation of 1, CyN and CyNA derivatives under a xenon 
ﬂash lamp. Compounds were dissolved in HEPES buffer (10 mM, pH 7.4) containing 
1% DMSO to a 10 mM ﬁnal concentration, and ﬂuorescence measurements were 
recorded for 10 h at r.t. Values are represented as means for sequential measurements 
every 10 min and ﬁtted to a non-linear regression, one-phase exponential decay. 
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 Quantum yields 10 M DMSO solutions, standard ICG ( : 0.13, in DMSO).11[b] k 




2.3.5 Library design, characterization and photostability studies 
Since the pseudo first order rate constant (k) values of the different CyNA 
compounds indicated some dependency on the amine chemical structure (Table 2.2), I 
expanded the derivatization of the CyNA scaffold to a broad range of 80 primary 
amines (Chart 2.2) so that I could identify the compounds with the best photostability 
properties.  Compound 1 was derivatized with 80 different amines in solution phase 
chemistry, and subsequently these compounds were further modified with an acetyl 

















Chart 2.2. 80-different amine structures with different numbers according to our 




The ﬂuorescence properties of the 80-membered CyNA library were 
measured. The absorption maximum wavelengths ranged from 802 nm to 806 nm, 
emission maximum wavelength from 817 nm to 823 nm, and average quantum yields 
were around 0.10 (Table 2.3). As a primary photostability evaluation, I analyzed the 
ﬂuorescence decrease of the 80 CyNA compounds under a xenon lamp.  Figure 2.6 
clearly shows that the 80 CyNA molecules show different photostability under 
identical experimental conditions. Table 2.3 clearly indicates that the discrepancy of 
the fluorescence intensity ratio at 8 h mainly depends on different amine structures.   
 
Figure 2.6. Primary photostability evaluation: Quotients of fluorescent intensities 
(8h) vs. fluorescent intensities (0h), in a time-course fluorescence measurement using 















Table 2.3. Absorbance (abs) and fluorescence maximum wavelengths (em), quantum 
yields (, LC-MS data, condensation reaction times, and photostability primary 













CyNA-11 687.1 802 820 0.11 95.3 90 
CyNA-28 758.2 804 818 0.05 93.2 87 
CyNA-48*
4
 783.0 804 819 0.06 94.6 45 
CyNA-49 696.1 804 818 0.10 95.3 95 
CyNA-55 744.2 804 819 0.13 97.1 100 
CyNA-80 688.2 804 817 0.08 96.1 93 
CyNA-92 646.1 805 821 0.09 96.3 64 
CyNA-95 604.2 806 818 0.09 95.6 91 
CyNA-100 756.1 804 819 0.08 94.4 63 
CyNA-101 666.1 806 822 0.08 94.6 86 
CyNA-102 696.1 805 822 0.14 97.1 63 
CyNA-103 696.2 804 821 0.14 96.9 92 
CyNA-107 735.1 803 820 0.07 93.4 50 
CyNA-111 667.1 804 818 0.11 98.2 96 
CyNA-124 712.1 803 820 0.15 98.1 100 
CyNA-131 694.1 804 819 0.13 97.3 n.d 
CyNA-165 634.1 806 821 0.09 98.1 94 
CyNA-167 648.1 804 818 0.10 94.8 92 
CyNA-180 630.1 805 821 0.14 97.5 91 
CyNA-181 712.1 805 821 0.14 96.5 66 
CyNA-185 632.1 804 820 0.15 97.4 91 
CyNA-193 732.2 806 822 0.12 96.2 n.d 
CyNA-201 694.1 803 820 0.08 93.2 33 
CyNA-218 670.1 802 823 0.08 94.2 85 
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CyNA-219 672.1 804 822 0.14 96.4 65 
CyNA-220 686.1 804 823 0.12 95.3 100 
CyNA-221 687.1 803 820 0.07 93.2 86 
CyNA-230 674.2 805 822 0.09 94.3 80 
CyNA-262 712.1 803 822 0.10 95.1 81 
CyNA-266 726.1 804 823 0.08 93.5 99 
CyNA-272 673.1 804 820 0.10 93.8 98 
CyNA-274 662.1 805 820 0.12 95.6 99 
CyNA-275 694.1 804 817 0.14 96.8 62 
CyNA-277 660.1 804 817 0.11 93.7 n.d 
CyNA-282 675.1 805 819 0.09 93.5 90 
CyNA-295 590.1 806 820 0.11 96.4 100 
CyNA-319 712.1 805 820 0.06 92.1 67 
CyNA-329 731.9 806 821 0.10 94.5 99 
CyNA-335 680.1 804 821 0.06 93.2 50 
CyNA-336 742.1 804 820 0.11 94.5 85 
CyNA-341 732.1 805 822 0.10 93.7 100 
CyNA-346*
5
 724.1 804 822 0.07 92.7 69 
CyNA-351 688.1 805 818 0.10 95.8 52 
CyNA-356 742.1 804 820 0.12 96.9 83 
CyNA-358 712.0 805 819 0.14 98.2 100 
CyNA-359 711.1 805 821 0.11 95.6 85 
CyNA-364 686.0 804 821 0.05 92.1 98 
CyNA-373 618.1 805 820 0.07 93.6 76 
CyNA-374 652.1 806 821 0.14 97.3 94 
CyNA-375 670.1 804 821 0.07 93.3 98 
CyNA-381 668.0 805 821 0.14 96.5 93 
CyNA-382 658.1 804 820 0.08 93.4 85 
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CyNA-387 682.1 804 820 0.07 92.9 75 
CyNA-388 682.0 803 819 0.14 97.8 97 
CyNA-395 696.1 804 820 0.07 95.1 95 
CyNA-396 666.1 804 820 0.09 94.7 96 
CyNA-398 666.1 804 819 0.07 93.4 99 
CyNA-399 688.1 804 819 0.10 95.8 95 
CyNA-401 653.1 805 820 0.10 94.9 91 
CyNA-403 686.0 805 819 0.05 93.5 45 
CyNA-405 684.0 806 820 0.06 94.5 83 
CyNA-407 702.1 805 820 0.08 96.1 n.d. 
CyNA-414 701.2 804 819 0.13 95.9 100 
CyNA-419 632.0 804 820 0.13 97.4 91 
CyNA-427 647.0 805 821 0.14 96.7 100 
CyNA-442 632.1 806 822 0.07 94.3 54 
CyNA-443 630.0 806 821 0.09 95.6 75 
CyNA-446 642.1 804 821 0.08 94.2 85 
CyNA-477 684.1 805 819 0.09 93.7 n.d. 
CyNA-478 680.1 805 821 0.09 95.4 64 
CyNA-480 700.1 803 817 0.06 92.1 51 
CyNA-487 618.1 806 823 0.04 91.6 30 
CyNA-531 720.1 804 820 0.08 97.3 100 
CyNA-542 702.1 805 821 0.08 94.5 74 
CyNA-548 742.1 804 820 0.04 92.9 n.d. 
CyNA-565 720.1 805 821 0.09 95.3 96 
CyNA-567 716.2 805 820 0.14 98.3 100 
CyNA-572 684.1 805 818 0.05 93.2 n.d. 
CyNA-574 632.1 803 818 0.06 93.8 38 






 Quantum yields were measured in DMSO, using Cardiogreen as a standard (: 
0.13, in DMSO). 
*
2 
Purities were determined according to UV absorption at 365 nm. 
*
3
 Quotients of fluorescent intensities (8h) vs. fluorescent intensities (0h), in a time-
course fluorescence measurement using 10 M (2% DMSO) solutions in HEPES 
buffer (100 mM, pH 7.4). 
*
4 
Triacetylated derivative was isolated as the main product. 
*
5 
Diacetylated derivative was isolated as the main product. 
n.d.: non-determined value due to fluctuation of the experimental data. 
 
2.3.6 Secondary screening and comparative study with ICG 
The average intensity decrease after 8 h due to decomposition was around 
18%, and a subset with the most photostable 15 CyNA compounds were selected for 
the secondary screening under strong light irradiation for periods of 15 min (for 2 h) 
with a high intensity UV lamp (100 W, 365 nm) at 2-cm distance. Two different 
buffer conditions HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)) and 
PBS (Phosphate buffered saline) were applied to evaluate the photostability. The 
stability in PBS buffer condition was better than in HEPES under identical pH and 
1% DMSO as co-solvent (Figures 2.7 and 2.8). From the secondary screening, 
CyNA-414 and CyNA-111 showed almost similar photostability after 2 h. 
 
 
Figure 2.7. Photostability secondary screening of the CyNA library in HEPES buffer 




Figure 2.8. Photostability secondary screening of the CyNA library in PBS buffer 
(10mM, pH 7.4). 
 
Among all CyNA compounds, CyNA-414 displayed the best photostability 
and ﬂuorescence quantum yield (Table 2.2, Figure 2.7 & 2.8) and the lowest 




) hence it was selected for further examination. 
CyNA-414 exhibited outstanding properties as NIR dye and I compared it to the NIR 
standard ICG (Chart 2.3). ICG is the only NIR dye clinically approved to date,
15
 and 
has a very similar spectral proﬁle (absorption–emission: 790–810 nm) to CyNA-414. 
However, ICG shows a low quantum yield and a poor stability in aqueous media that 
have hampered its use for many bioimaging applications.
16
 





Figure 2.9. Photostability analysis of CyNA-414, ICG and CyN-414 under a high-
intensity ultraviolet lamp in PBS buﬀer (pH 7.3) containing 1% DMSO to a 10 M 
ﬁnal concentration. Values are represented as means (n = 6) for sequential 
measurements every 10 min and ﬁtted to a non-linear regression, one-phase 
exponential decay. 
 
The comparative analysis of the ﬂuorescence properties of CyNA-414 and 
ICG indicated that CyNA-414 emitted stronger NIR ﬂuorescence intensity in aqueous 
media (Figure 2.11) and exhibited a remarkably higher photostability than ICG 
(Figure 2.9). In addition, ICG has low ﬂuorescence intensities in aqueous solution and 
low ﬂuorescence quantum yields due to the extensive aggregation.17 I compared the 
spectral properties of CyNA-414 with ICG in buffer solution, and observed that 
CyNA-414 showed exactly similar absorbance spectral profile in DMSO and HEPES 
buffer solution except intensity whereas ICG showed remarkable different spectra 







Figure 2.10. Absorbance spectra: 5M solutions in PBS (pH 7.3) containing 1% 
DMSO or in pure DMSO.  
 
 




In summary, I designed a NIR ﬂuorescent scaffold (CyNA) with excellent 
photostability properties. CyNA was designed after examining the decomposition 
mechanism of amine tricarbocyanine derivatives, whose poor photostability was 
largely improved upon incorporation of an electron withdrawing acetyl group. The 
combinatorial derivatization of CyNA enabled the identiﬁcation of CyNA-414 as a 
highly ﬂuorescent NIR dye with signiﬁcantly better photostability than the NIR 
standard ICG. CyNA-414 encloses a practical prospective for NIR in vivo imaging, 
Furthermore, this set of fluorophores exhibits a significant photostability in 
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physiological conditions, and thus encloses a remarkable prospective for the 
discovery of new fluorescent bioimaging probes. 
 
2.5 Experimental details 
 Materials and Methods: 
All the chemicals (building block amines plus others) and solvents were 
purchased from Sigma Aldrich, Alfa Aesar, Fluka, MERCK or Acros, and used 
without further purification. Normal phase purifications were carried out using Merck 
Silica Gel 60 (particle size: 0.040- 0.063mm, 230-400 mesh). Analytical 
characterization was performed on a HPLC-MS (Agilent-1200 series) with a DAD 
detector and a single quadruple mass spectrometer (6130 series) with an ESI probe. 
Analytical method, unless indicated: eluents: A: H2O (0.1% HCOOH), B: ACN 
(0.1% HCOOH), gradient from 5 to 95% B in 6 min; C18 (2) Luna column (4.6 x 
50mm
2
, 5m particle size). Normal phase purifications of CyN and CyNA 
compounds were performed using column chromatography, and eluting with DCM-




C-NMR spectra were recorded 
on Bruker Avance 300 NMR and 500 NMR spectrometers, and chemical shifts are 
expressed in parts per million (ppm). High resolution mass spectrometry (HRMS) 
data was recorded on a Micromass VG 7035 (Mass Spectrometry Laboratory at 
National University of Singapore (NUS)). Photobleaching irradiation experiments 
were performed using a UVP Blak-Ray® B-100AP high intensity UV lamp (100W, 
365 nm) in Singapore Bioimaging Consortium, Agency for Science, Technology and 
Research (A*STAR), Singapore. Spectroscopic and quantum yield data were 
measured on a SpectraMax M2 spectrophotometer (Molecular Devices), and the data 





2.5.1 Synthesis of CyN and characterization 
 Synthesis of 1a: 
Scheme 2.2. Synthesis of intermediate 1a. 
 
Reagents and conditions: 1-Iodopropane, CH3CN, Reflux at 80 

C, 15h. 
To a solution of 2,3,3-trimethyl-3H-indole (2 g, 12.5 mmol, 1 eq.) in ACN, 1-
Iodopropane (10.6 mL, 62 mmol, 5 eq.) was added, and refluxed with continuous 
stirring for 15 h. The mixture was dried in high vacuum and washed by Et2O. The 
resulting solid was recrystallized in acetone to obtain 1a as a white solid (3.9 g, 95%).  
1
HNMR (300 MHz, DMSO-d6): δ =1.04 (t, 3H, J=7.2), 1.64 (s, 6H), 2.67 (s, 3H), 
1.34 (m, 2H), 4.17 (t, 2H, J=7.8 Hz), 7.63 (d, 2H), 7.82 (m, 2H). tR:  2.46 min, ESI 
m/z (C14H20N
+
) calc: 202.4; found: 202.1. 
Synthesis of 1b: 
Scheme 2.3. Synthesis of intermediate 1b 
 
Reagents and conditions: Cyclohexanone, DMF, POCl3, addition at 0 

C then 




To a chilled solution of dimethylformamide (20 mL, 273 mmol, 5.4 eq.) in 20 
mL CH2Cl2 under N2 atmosphere, 20 mL of POCl3 (17.5 ml, 115 mmol, 2.3 eq.) in 
DCM were added dropwise under an ice bath. After 30 min, cyclohexanone was 
added (5 g, 50mmol, 1 eq.), and the resulting mixture was refluxed with vigorous 
stirring for 3 h at 80 

C, poured into ice-cold water, and kept it overnight to obtain 1b 
as a yellow solid (8.0 g, 92%).  
1
H-NMR (300 MHz, CDCl3): δ = 1.57 (m, 2H), 2.35 (t, 4H, J=6.3 Hz), 2.5 (s, 1H),  
10.10 (s, 1H). tR: 4.30 min, ESI m/z (C8H9ClO2): calc: 172.0; found: 173.1. 
Synthesis of 1: 
Scheme 2.4. Synthesis of 1.  
 
Reagents and conditions: 1a (2 eq.) and 1b (1eq.) in 7:3 (butanol:benzene) refluxed 
for 12 hrs at 110 

C. 
1b (500 mg, 2.9 mmol, 1eq.) and 1a (1.91g, 5.81 mmol, 2 eq.) were dissolved 
in BuOH-benzene (7:3) under N2 atmosphere, and refluxed at 120 

C for 10 h with a 
Dean-Stark condenser. Afterwards, the solvent was evaporated, and the resulting 
green solid mixture was washed with Et2O and purified by flash chromatography 
(DCM-MeOH, 50:1) to obtain 1 as a green solid (1.8 g, 96%).  
1
HNMR (300 MHz, CDCl3) 1.06 (t, 6H, J=7.5 Hz), 1.31 (m, 4H), 1.64 (s, 12H), 
1.95 (m, 2H), 2.73 (m, 4H), 4.15 (t, 4H, J=6.9Hz), 6.23 (d, 2H, J=14.2 Hz), 7.15-7.72 
(m, 8H), 8.19 (d, 2H, J=13.8 Hz). tR: 5.64 min, ESI m/z (C36H44ClN2
+





General procedure for the synthesis of CyN-111, 165, 272, 295 
1 (100 mg, 149.5 μmol) was mixed with the corresponding amine building 
blocks (Chart 2.1, 598 mol, 4 eq.), DIEA (38.6 L, 299 mol, 2 eq.), and dissolved 
in ACN. The reaction mixture was heated at 80 

C for 20 min, quenched with 0.1 N 
HCl, concentrated under vacuum, and purified by normal-phase chromatography 
(DCM-MeOH, 98:2) to render the corresponding CyN derivatives. 
Chart 2.4. Chemical structures of CyN-111, 165, 272 and 295 
 
CyN-111 (95 mg, 85%): 
1
H-NMR (300 MHz, CDCl3)  =1.03 (t, 6H, J=7.5Hz), 1.31 
(m, 2H), 1.62 (s, 12H), 1.83 (m, 4H), 2.47 (t, 4H, J=6.3Hz), 3.38 (t, 2H, J=5.7Hz), 
3.80 (t, 2H, J=7.2Hz), 4.17 (t, 4H, J=6.2Hz), 5.63 (d, 2H, J= 12.9Hz), 6.85-7.72 (m, 
12H), 8.52 (d, 2H, J=3.9Hz).  
tR: 5.56 min, HRMS (C43H53N4
+
), calc: 625.4257; found: 625.4265. 
CyN-165 (86 mg, 80%): 
1
H-NMR (300 MHz, CDCl3): =1.05 (t, 6H, J=7.5Hz), 1.24 
(m, 2H), 1.32 (m, 2H), 1.68 (s, 12H), 1.85 (m, 4H),  2.16 (t, 2H, J=5.4 Hz), 2.47 (t, 
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4H, J=6.3 Hz), 3.44 (s, 3H), 3.71 (t, 2H, J=5.4Hz), 3.95 (t, 4H, J=6.3Hz), 5.61 (d, 2H, 
J=12.9Hz), 6.50-7.72 (m, 8H), 7.64 (d, 2H, J=12.9Hz), 7.92 (bs, 1H). 
tR: 5.66 min, HRMS (C40H54N3O
+
), calc: 592.4255; found: 592.4261. 
CyN-272 (93 mg, 83%): 
1
H-NMR (300 MHz, CDCl3): =1.08 (t, 6H, J=7.5Hz), 1.31 
(m, 2H), 1.45 (m, 4H), 1.54 (m, 2H), 1.68 (s, 12H), 1.85 (m, 4H), 2.51 (t, 4H, J=6.3 
Hz), 3.44 (t, 6H, J=7.7 Hz), 3.81 (t, 4H, J=6.9Hz), 4.21 (m, 2H), 5.65 (d, 2H, 
J=12.9Hz), 6.80-7.70 (m, 8H), 7.72 (d, 2H, J=12.9Hz).  
tR: 5.62 min, HRMS (C43H59N4
+
), calc: 631.4740; found: 631.4734. 
CyN-295 (88 mg, 87%): 
1
H-NMR (300 MHz, CDCl3): =1.05 (t, 6H, J=7.5Hz), 1.56 
(t, 3H, J= 7.0 Hz), 1.68 (s, 12H), 1.85 (m, 4H),  1.83 (m, 2H), 2.47 (t, 4H, J=6.3 Hz), 
3.79 (t, 4H, J=6.9Hz), 3.96 (m, 2H), 5.62 (d, 2H, J=12.9Hz), 6.80-7.28 (m, 8H), 7.72 
(d, 2H, J=12.5Hz).  
tR: 5.66 min, HRMS (C38H50N3
+
), calc: 548.3999; found: 548.3999. 
CyN-414 (82 mg, 70%): 
1
H-NMR (300 MHz, CDCl3): =1.03 (t, 6H, J=7.5Hz),  1.24 
(d, 3H, J=6.6 Hz), 1.32 (m, 4H), 1.36 (t, 2H, J=5.4 Hz), 1.70 (s, 12H), 1.78-1.85 (m, 
11H), 2.02-2.16 (m, 4H), 2.47 (t, 4H, J=5.4 Hz), 3.76 (t, 2H, J=6.0 Hz), 3.93 (t, 2H, 
J=6.0 Hz), 5.58 (d, 2H, J=14.1Hz), 6.83 (d, 2H, J=14.1Hz), 6.83-7.72 (m, 8H). 
tR: 5.97 min, ESI-MS (C45H63N4
+
), calc: 659.5; found: 659.4. 
 
2.5.2 Synthesis of the CyNA library and characterization 
Scheme 2.5. Synthesis of CyNA from CyN 
 





For every reaction, 1 (20 mg, 30 mol, 1 eq.) and the primary amine building 
block (Chart 2.2) (120 mol, 4 eq.) were dissolved in ACN, and N,N-
diisopropylethylamine (DIEA) (7.7 L, 60 mol, 2 eq.) was added. The reaction 
mixture was heated at 80 

C for 10-60 min, depending on the reactivity of the amine. 
The resulting blue color crude mixtures (CyN) were neutralized with 0.1 N HCl, and 
concentrated under vacuum. Resulting CyN crudes were dissolved in DCM under N2 
atmosphere, and treated with excess DIEA (96.2 L, 750 mol, 25 eq.) and acetyl 
chloride (11.7 L, 150 mol, 5 eq.) at 0 C for 15 min. The final green products were 
washed with 0.1 N HCl to remove the excess of DIEA, concentrated under vacuum, 
and purified by a normal-phase silica short column using DCM-MeOH (ranging from 
100:0 to 97:3) as the eluting solvent. The characterization of the whole library was 
performed by HPLC-MS (Table 2.3), and the compounds studied in detail were also 
characterized by 
1
H-NMR and HRMS. 
Characterization:  CyNA-111, 165, 272, 295, 414 




CyNA-111 (12 mg, 45%):  
1
H-NMR (300MHz, CDCl3): =1.05 (t, 6H, J=7.5Hz), 
1.29 (m, 2H), 1.63 (s, 6H), 1.65 (s, 6H), 1.72 (m, 4H), 1.94 (t, 4H), 2.05 (s, 3H), 3.09 
(m, 2H), 3.63 (m, 2H), 4.18 (t, 4H, J=3.9Hz), 6.07 (d, 0.3H, J=13.5Hz), 6.28 (d, 
1.7H, J=14.1Hz), 7.02-7.72 (m, 12H), 8.43 (d, 0.4H, J=14.1Hz), 8.68 (d, 1.6 H, 
J=3.3Hz).  
tR: 4.70 min, HRMS (C45H55ON4
+
), calc: 667.4370; found: 667.4350. 
CyNA-165 (10 mg, 50%):  
1
H-NMR (300 MHz, CDCl3): =1.05 (t, 6H, J=7.5Hz), 
1.76 (s, 12H), 1.87-1.92 (m, 8H),  2.58 (t, 4H, J=6.3 Hz), 3.28 (s, 3H), 3.32 (t, 2H, 
J=5.4Hz), 3.45 (t, 2H, J=6.3 Hz), 3.92 (t, 4H, J=7.5 Hz), 4.16 (s, 3H), 6.02 (d, 2H, 
J=13.1 Hz), 6.90-7.30 (m, 8H), 7.35 (d, 2H, J=4.5Hz).  
tR: 6.1 min, HRMS (C42H56N3O2
+
), calc: 634.4367; found: 634.4352. 
CyNA-272 (9 mg, 42%):  
1
H-NMR (300 MHz, CDCl3): =1.08 (t, 6H, J=7.5Hz), 
1.31 (m, 2H), 1.45 (m, 4H), 1.54 (m, 2H), 1.69 (s, 12H), 1.86 (m, 4H), 1.94 (s, 3H), 
2.51 (t, 4H, J=6.3 Hz), 3.44 (t, 6H, J=7.7Hz), 3.81 (t, 4H, J=6.9Hz), 4.21 (m, 2H), 
5.65 (d, 2H, J=12.9Hz), 6.80-7.70 (m, 8H), 7.72 (d, 2H, J=12.9Hz).  
tR: 4.24min, HRMS (C45H61N4O
+
), calc: 673.4840; found: 673.4845. 
CyNA-295 (9 mg, 48%):  
1
H-NMR (300 MHz, CDCl3): =1.05 (t, 6H, J=7.5Hz), 
1.56 (t, 3H, J=7.0 Hz), 1.68 (s, 12H), 1.83 (m, 2H),1.85 (m, 4H),  1.94 (s, 3H), 2.59 
(t, 4H, J=6.3Hz), 3.79 (t, 4H, J=6.9Hz), 3.96 (m, 2H), 6.04 (d, 2H, J=14.0Hz), 6.80-
7.28 (m, 8H), 8.14 (d, 2H, J=14.0Hz).  
tR: 4.87 min, HRMS (C40H52N3O
+
), calc: 590.4105; found: 590.4113. 
CyNA-414 (9 mg, 41%):  
1
H-NMR (300MHz, CDCl3): =1.06 (t, 6H, J=7.5Hz),  
1.24 (d, 3H, J=6.6 Hz), 1.23 (m, 2H), 1.58 (s, 6H), 1.66 (s, 6H), 1.83-2.06 (m, 6H), 
1.95 (s, 3H), 2.46-2.56 (m, 4H), 2.82 (t, 2H, J=5.4 Hz), 2.87 (t, 2H, J=5.4 Hz), 3.08 
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(t, 4H), 2.96-2.98 (m, 2H), 3.08-3.12 (m, 1H), 3.67 (t, 2H, J= 6.0Hz), 4.12 (t, 4H, 
J=7.2Hz),  6.21 (d, 1H, J=14.1Hz), 6.26 (d, 1H, J=14.1Hz), 7.11 (d, 2H, J=7.5 Hz),  
7.20 (d, 2H, J=6.9 Hz),  7.34 (m, 4H), 7.55 (d, 1H, J=14.1 Hz), 7.59 (d, 1H, 
J=14.1Hz).  
13
C-NMR (75.5MHz, CDCl3): 11.6, 11.7, 20.5, 20.6, 20.8, 20.9, 22.9, 23.7, 25.0, 
28.1, 28.2, 28.3, 28.5, 28.6, 29.6, 30.8, 46.2, 46.2, 49.2, 49.3, 102.2, 110.7, 110.8, 
122.3, 125.3, 125.4, 128.2, 128.4, 128.6, 140.9, 141.0, 142.2, 154.2, 170.4, 172.1. 
tR: 4.32 min, HRMS (C47H65N4O
+
), calc: 701.5153; found: 701.5147. 
2.5.3 Photostability measurements 
Time-course fluorescence measurements of CyN-111, 165, 272, 295 vs. CyNA-
111, 165, 272, 295 and 1 
Procedure: 10M CyN(A) solutions in 10mM HEPES buffer (pH 7.4) 
containing 1% DMSO were placed in a 96-well black plate, and fluorescence 
intensity measurements were recorded every 10 min for a total period of 10 h 
(excitation-emission: 640-750 nm for CyN derivatives, and 790-820 nm for 1 and 
CyNA derivatives). Values are fitted to a non-linear regression one-phase exponential 
decay (GraphPad Prism 5.0).  
 
CyNA library (primary and secondary screening) 
Primary screening: 10 M CyN(A) solutions in 100 mM HEPES buffer (pH 7.4) 
containing 2% DMSO were placed in a 96-well black plate, and fluorescence 
intensity measurements were recorded every 10 min for a total period of 8 h 
(excitation emission: 790-820 nm). A subset of 14 compounds selected according to 
their quotients F8h/Fo, quantum yields and maximum RFU values (Table 2.3) was 
further evaluated on the secondary screening. 
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Secondary screening: 10 M solutions in 10 mM HEPES buffer (pH 7.4) or PBS 
(pH 7.3) containing 1% DMSO were placed in a 96-well black plate, and irradiated 
for periods of 15 min (up to 2h) with a high intensity UV lamp (100W, 365 nm) at 2-
cm distance. Values are represented as means (n=2), and fitted to a non-linear 
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Fluorescence imaging techniques are widely used in biomedical research. A 
majority of these applications are based on the use of NIR labeling dyes for in vivo 
imaging. The suitability of the NIR region for in vivo imaging (e.g., deep tissue 
penetration, low auto-fluorescence background) has been extensively described.
1-3
 In 
vivo imaging typically involves the administration of NIR probes either in the form of 
fluorescent small molecules
4
 or fluorescent proteins
5
 upon covalent attachment of the 
metabolite of protein of interest to NIR labeling reagent. NIR protein labeling dyes 
must ideally retain identical fluorescent properties and good photostability profiles 
after conjugation. In addition, they must maintain the specific recognition and 
functional abilities of the protein. The increasing importance of small animal optical 
in vivo imaging has underscored the need for NIR protein labelling compounds that 
fulfil such requirements. The most common organic NIR ﬂuorophores are 
polymethine cyanine dyes. Among them, heptamethine and pentamethine cyanines 
comprising benzoxazole, benzothaizole and indolyl have been the most useful for 
fluorescent imaging as their physical properties, biodistribution, and 
pharmacokinetics have been well characterized. For example, while Indocyanine 
green (ICG) is the only NIR dye clinically approved to date, its poor photostability, 
low quantum yield in buffer solutions are major concerns for its applicability in 
biological systems. Hence, chemist have devoted lots of efforts to develop new NIR 
labeling dyes with improved ﬂuorescence quantum yields, high chemical and 
photostability, low aggregation in buffer solution and low cytotoxicity.  
3.2 Objectives 
Herein, I report the synthesis of a novel NIR labeling dye (CyNE790) based 
on the structure of CyNA-414, which is the most photostable tricarbocyanine dye 
among the 80-member library discussed in Chapter 2.  The application of CyNE790 
for protein labeling has been compared to the NIR standard ICG-sulpho-OSu. The 
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analysis of the photostability before and after bio-conjugation proved the superiority 
of CyNE 790, whose practical use as a NIR protein labeling dye was demonstrated 
with in vivo imaging studies.  
 
3.3 Results and discussion 
3.3.1 Design and synthesis 
The tricarbocyanine scaffold (1) is a synthetically accessible NIR structure, 
and shows improved fluorescent properties when compared to other heptamethine 
cyanines.
6,7
 I have discussed earlier chapter about the superior photostability of the 
amine acetylated tricarbocyanine (CyNA) structure. The electron-withdrawing acetyl 
group incorporated into CyNA significantly increased the photostability properties of 
the amine tricarbocyanine core, and a combinatorial approach was applied to identify 
CyNA-414 as a highly fluorescent and photostable NIR dye (Scheme 2.1).
8 
Whereas 
CyNA-414 exhibits good properties as a NIR dye, it lacks a reactive functional group 
that enables protein labeling. I designed the synthesis of a reactive ester CyNE790 by 
replacing the electron-withdrawing acetyl group with a glutaric acid moiety. Hence, I 
envisioned that the glutaric acid would not only provide a suitable spacer to 
incorporate a reactive succinidimyl ester group but also preserved the electron-









Scheme 3.1. Synthesis of CyNE790. 
 
Reagents and conditions: (a) 1-(3-aminopropyl)-2-pipecoline, DIEA, CH3CN, 80 
C, 40 min.; (b) acetyl chloride (for CyNA-414) or methyl 4-(chloroformyl)butyrate 
(for 2), DIEA, CH2Cl2, 0 C to r.t., 15 min.; (c) from 2, CHCl3:THF:H2O:HClconc 
(6:3:2:1), 80 °C, 12 h; (d) DCC, N-hydroxysuccinimide, anhydrous DMF. 
 
CyNE790 was prepared in a three-step synthesis with overall reasonable 
yields. Notably, the hydrolysis of the methyl ester 2 to afford the corresponding 
carboxylic acid 3 required a rigorous evaluation of the reaction conditions, since 
tricarbocyanine compounds are inherently labile under strong acid and basic 
media.
9,10
 An optimized treatment of 2 with a solution of HCl in CHCl3-THF-H2O 
(6:3:2) rendered 3, which could be isolated after normal-phase chromatography. 
CyNE790 was readily prepared from 3 by derivatization with N-hydroxysuccinimide 






3.3.2 Photophysical properties study 
The spectral characterization of CyNE790 demonstrated that the 
incorporation of the linker did not affect the maximum excitation and emission 
wavelengths or the fluorescence emission intensity of the original compound (Figure 
3.1).  
 
Figure 3.1. Absorbance and emission spectra of CyNA-414 (orange) and CyNE790 
(blue). Absorbance spectra: 5 M solutions in PBS (pH 7.3) containing 1% DMSO. 
Emission spectra: 10 M solutions in PBS (pH 7.3) containing 1% DMSO, excitation 
wavelength: 760 nm. 
 
CyNE790 showed an excellent photostability in aqueous media. 10M 
solutions in 10 mM HEPES buffer (pH 7.4) or PBS (pH 7.3) containing 1% DMSO 
were placed in a 96-well black plate, and irradiated for periods of 15 min (up to 1.5 h) 
with a high intensity UV lamp (100W, 365 nm) at 2-cm distance. Figure 3.2 clearly 
shows that the incorporation of the glutaric acid as the spacer moiety for 




Figure 3.2. Comparative photostability of CyNA-414 (orange) and CyNE790 (blue) 
under a high intensity ultraviolet lamp. Briefly, 10 M solutions in PBS (pH 7.3) 
containing 1% DMSO were irradiated for periods of 15 min (up to 75 min) with UVP 
Blak-Ray® B-100AP high intensity mercury lamp (100W, 365 nm) at 2 cm distance. 
Values are represented as means (n=4), and fitted to a non-linear regression one-
phase exponential decay (fight hand side). 
 
After confirming the spectral properties of CyNE790 as a fluorescent NIR 
labeling dye, I compared its applicability for protein conjugation with ICG-sulfo-
OSu, the commercially available succinidimyl ester of ICG.
11,12 
Whereas the 
structure of ICG has a similar spectral profile (absorption-emission: 790-810 nm) to 
CyNE790, the application of ICG in molecular imaging has been limited because its 
fluorescence is drastically quenched after protein conjugation.
13,14 
Moreover, ICG 
derivatives embody several disadvantages that hampered their use in bioimaging,
15 
such as low quantum yield, poor photostability and the formation of aggregates in 
aqueous media.
16,17 
CyNE790 exhibited superior fluorescent properties to ICG-sulfo-
OSu. In addition to its higher fluorescence quantum yield in aqueous media (Table 





Table 3.1. Photophysical properties of CyNE790 and ICG-sulfo-OSu. 












CyNE790 13% 3.3% 108,000 
ICG-sulfo-OSu 12% 0.4% 42,000 
 
[a] ICG was used as a standard in DMSO19a and in aqueous media.[19b] [b] Dyes 
were dissolved in phosphate buffered saline (PBS, pH 7.3) with 0.1% DMSO. 
On the contrary, the aggregate formation of ICG-sulfo-OSu in aqueous 
media was evidenced by the shift of the absorbance maximum values from 780 nm to 
695 nm
18 
(Figure 3.3). Interestingly, the data shows in Table 3.1 that the brightness (Ө 
x ) of CyNE 790 is 21–fold higher than ICG-sulfo-OSu.  
 
Figure 3.3. Absorbance spectra of CyNE790 (blue) and ICG-sulfo-OSu (green), 5 






Figure 3.4. Emission spectra of CyNE790 (blue) and ICG-sulfo-OSu (green), 10 
M solutions in PBS (pH 7.3) containing 1% DMSO, excitation wavelength: 760 nm 
(left hand side).  
 
3.3.3 Photostability measurements 
Photostability evaluation of CyNE790 and ICG-sulfo-OSu: 10 M solutions 
in phosphate buffered saline (PBS, pH 7.3) containing 1% DMSO were fixed in a 
glass cover slide, and irradiated with a diode laser (95 mW, 740 nm, time frame: 500 
ms, no delay). Emission was recorded with a NIR-enhanced CCD camera (Andor 
Technology) adapted to an Eclipse Ti-U microscope (objective 40×, filter cube 
750/800), and images were processed using the software NIS-Elements 3.10. The 
resulting values were represented as means (n=3), and fitted to a non-linear regression 
one-phase exponential decay (GraphPad Prism 5.0). A detailed evaluation of their 
photobleaching in buffer attested a 15-fold higher photostability of CyNE790 when 












Figure 3.5. Photostability of CyNE790 (black) and ICG-sulfo-OSu (grey) under 
laser irradiation (740 nm). Values are represented as means (n=3) for sequential 
measurements every 500 ms. Conditions: 10M (1% DMSO) solutions in PBS buffer 
(pH 7.3). Time needed to bleach 35% of the maximum fluorescence intensity for 
every compound is indicated in brackets. 
 
 
3.3.4 Antibody conjugation and characterization 
With then aim at comparing both reactive esters (CyNE790 and ICG-sulfo-
OSu) for in vivo imaging studies, we conjugated them to a monoclonal anti-EGFR 
antibody. As shown in Figure 3.6, the CyNE790-labelled antibody showed stronger 
fluorescence intensity than the ICG-labelled antibody, according to both emission 




Figure 3.6. Characterization of CyNE790 and ICG-labelled antibodies: left) 
fluorescence SDS-PAGE image; centre) SDS-PAGE image after Coomassie Blue 
staining; right) emission spectra (exc: 750 nm). 
 
Additional characterization of both antibodies indicated that the superior 
spectra properties of CyNE790 were also maintained after protein conjugation 
(Figures 3.7). Dye/protein (D/P) ratios were determined using reported procedures 
and the labeling efficiencies were similar for both dyes (Table 3.2). The dye/protein 
ration was calculated according to the following equation D/P = (790/790) / {(A280 – 
Ө x A790) / 170,000}, whereas  790 are the extinction coefficients in PBS (790 nm) 
and Ө the ratios  280/ 790. 
 
  
Figure 3.7. Absorbance and emission spectra of CyNE790-labelled (blue) and ICG-





Table 3.2. Characterization of dye conjugated antibody in buffer solution. 
Dye conjugated antibody  790 Ө D/P 
labeling 
efficiency 
ICG-labelled anti-EGFR 42,000 0.081 3.5 17.5% 
CyNE790-labelled anti-EGFR 108,000 0.037 3.6 18.0% 
 
3.3.5 In vitro and in vivo imaging 
 In addition, we (I and Dr. Marc Vendrell) proved the applicability of 
CyNE790 by detecting EGFR-expressing cells with the CyNE790-labelled anti-
EGFR. SCC-15 and MCF-7 are human cancer cell lines with respectively high and 
low expression levels of EGFR, a known target protein for tumor diagnosis and 
anticancer therapy.
20,21 
Cell imaging after incubating SCC-15 and MCF-7 cells with 
CyNE790-labelled anti-EGFR showed a brighter staining in SCC-15 cells, which 
corresponds to the higher expression level of EGFR in this cell line (Figure 3.8). 
 
Figure 3.8. Microscope images of SCC-15 (a, b) and MCF-7 cells (c,d) after 
incubation with CyNE790-anti-EGFR: a) and c) correspond to NIR-fluorescence 




The better fluorescence properties of the CyNE790-labelled antibody were 
further demonstrated by examining the NIR emission of both antibodies in mice 
(Figure 3.9a). The CyNE790-labelled antibody displayed a quantum yield of 3%, 
with a stronger fluorescence signal than the ICG-labelled antibody that enabled in 
vivo imaging with a significantly lower detection limit. Furthermore, the injection of 
CyNE790-anti-EGFR treated SCC-15 and MCF-7 cells allowed the visualization of 
SCC-15 cells in mice with much higher intensity compared to MCF-7 (Figure 3.9b), 
and confirmed that the conjugation of CyNE790 did not affect the recognition 
properties of the monoclonal anti-EGFR antibody. 
 
Figure 3.9. Fluorescence images after injection of: a) CyNE790-labelled antibody 
(left mouse), ICG-labelled antibody (right mouse) (protein amount per site: 1) 0.85 
g, 2) 0.15 g); b) CyNE790-anti-EGFR treated SCC-15 cells (left flank, left mouse) 
and CyNE790-anti-EGFR treated MCF-7 cells (left flank, right mouse). 
 
The application of CyNE790-anti-EGFR for in vivo imaging was further 
validated in xenografts prepared by injection of EGFR+ breast cancer cells MDA-
MB-231 in nude mice. Upon tumor formation (approximate tumor size: 0.3-0.5 cm), 
CyNE790-anti-EGFR was injected via tail vein, and mice were imaged in a time-
course manner. When the mice were examined 1 hr after injection the fluorescence 
was detected from whole body of all animals. The signal of compound 3 started to 
disappear earlier than antibody conjugated dye at 4 hr. The fluorescence signal from 
the tumor was clearly visible only in EGFR Ab-CyNE injected mice at 26 hr after 
 72 
 
injection. The NIR fluorescence images proved that CyNE790-anti-EGFR selectively 
stained the tumor regions while no staining was observed for CyNE790, and the 
signal of CyNE790-anti-EGFR could be detected up to 50 h after injection (Figure 
3.10). 
 
Figure 3.10. Compound 3 was injected number 1 and 3 mices which contain MDA-
MB 231 cell and CRL-2095 tumor. CyNE-EGFR-Ab was injected in number 2 and 4 
mice which contain MDA-MB 231 cell and CRL-2095 tumor. 
 
3.4 Conclusions 
In conclusion, I developed a highly fluorescent and photostable NIR protein 
labelling dye (CyNE790). CyNE790 incorporates a glutaric acid linker that enables 
protein bioconjugation and preserves the excellent photostability and NIR 
fluorescence intensity of the amine acetylated tricarbocyanine scaffold. Upon protein 
conjugation, the fluorescent properties of CyNE790 were maintained, and proved to 
be superior to the NIR standard ICG-sulfo-OSu. Furthermore, we (I, and Dr. Yun 
Seong Wook )  demonstrated the adequacy of CyNE790 for in vivo NIR imaging by 
labelling a monoclonal anti-EGFR antibody and confirming that its recognition 




3.5 Experimental details 
Materials and Methods: 
 All materials and methods have been described in earlier section 2.5. ICG-
sulfo-OSu was purchased from Dojindo Laboratories, and anti-EGFR-IgG2a (sc-120) 
was supplied by Santa Cruz Biotechnology, Inc. Photobleaching measurements were 
performed using an Eclipse Ti-U Nikon microscope (filter cube: 750/800) attached to 
Ti:sappire oscillator that operated in continuous wave mode in Singapore Bioimaging 
Consortium, Agency for Science, Technology and Research (A*STAR), Singapore, 
and the data was processed using the software NIS-Elements 3.10. In vivo images 
were taken in an IVIS spectrum imaging system (Caliper Life Sciences).  
3.5.1 Synthesis and characterization of CyNE 790 
Synthesis of 2:  
 1 (300 mg, 0.45 mmol) and 1-(3-aminopropyl)-2-pipecoline (170 mg, 0.9 
mmol) were dissolved in ACN (2 mL), and N,N-diisopropylethylamine (DIEA) (87 
L, 0.67 mmol) was added. The reaction mixture was heated at 80 C for 40 min, and 
the resulting blue color crude was neutralized with 0.1 N HCl (aq) and concentrated 
under vacuum. The crude mixture was dissolved in DCM under N2 atmosphere, and 
treated with excess DIEA (700 L, 5.39 mmol) and methyl 4-(chloroformyl) butyrate 
(110 L, 0.67 mmol) at 0 C for 15 min. The resulting green product was washed 
with 0.1 N HCl (aq) and brine, concentrated under vacuum. 2 was isolated as a green 
solid (360 mg, yield 92%) and used without further purification. 
Synthesis of 3:  
2 (360 mg, 0.41 mmol) was dissolved in 40 mL of CHCl3, and a mixture of 
THF:H2O:HClconc (3:2:1, 40 mL) was slowly added with continuous stirring at 0 C. 
After 5 min. the reaction mixture was refluxed at 80 C for 12 h, and monitored by 
HPLC-MS. After complete hydrolysis of the methyl ester, CHCl3 was added to the 
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reaction mixture, the organic layer was collected (3 × 20 mL), washed with H2O and 
purified by normal-phase chromatography using DCM-MeOH (from 100:0 to 88:12) 
as the eluting solvent. 3 was obtained as a green solid (70 mg, yield 20%). 
Characterization data for 3: 
1
H-NMR (300 MHz, CDCl3): 1.06 (t, 6H, J=7.5Hz),  
1.24 (d, 3H, J=6.6 Hz), 1.39 (m, 2H), 1.61 (s, 6H), 1.62 (s, 6H), 1.79-1.95 (m, 6H), 
2.22 (t, 2H, J=7.8 Hz), 2.33 (t, 2H, J=6.6 Hz), 2.52-2.56 (m, 4H), 2.82 (t, 2H, J=5.4 
Hz), 2.87 (t, 2H, J=5.4 Hz), 2.96-2.98 (m, 2H), 3.09-3.12 (m, 1H), 3.36 (t, 4H), 3.53 
(t, 2H, J=6.6 Hz), 3.67 (t, 2H, J=6.6 Hz), 4.06 (t, 2H, 4.2 Hz), 4.15 (t, 2H, J=4.8 Hz), 
6.15 (d, 1H, J=14.1Hz), 6.20 (d, 1H, J=14.1Hz), 7.07-7.38 (m, 8H), 7.51 (d, 1H, 
J=14.1Hz), 7.60 (d, 1H, J=14.1Hz).  
13
C-NMR (75 MHz, CDCl3): 11.6, 12.2, 19.5, 
20.4, 20.6, 20.7, 22.2, 22.9, 24.8, 28.1, 28.2, 28.3, 31.3, 32.3, 41.9, 43.9, 48.3, 49.1, 
49.3, 50.2, 51.8, 53.7, 60.4, 101.5, 101.9, 102.4, 106.2, 110.6, 110.8, 114.9, 118.8, 
122.3, 125.5, 125.6, 127.7, 128.1, 128.6, 140.6, 140.9, 141.4, 142.1, 142.2, 144.6, 
153.9, 160.9, 161.4, 171.7, 172.5, 173.6, 174.3. 
tR: 4.13 min, ESI (HRMS) m/z (C50H69N4O3
+
), calc: 773.5364; found: 773.5351. 
Synthesis of  CyNE790: 
  N,N’-dicyclohexylcarbodiimide (11 mg, 56 mol) and 3 (30 mg, 37 mol) 
were dissolved in anhydrous THF (2 mL), stirred for 10 min at r.t, and mixed with N-
hydroxysuccinimide (7 mg, 59 mol). The reaction mixture was stirred at r.t. for 12 h, 
washed with Et2O, concentrated under reduced pressure, and purified by normal-
phase chromatography using DCM-MeOH (from 100:0 to 94:6) as the eluting 
solvent. CyNE790 was isolated as a green solid (21 mg, yield 65%).  
Characterization data for CyNE790: 
1
H-NMR (300 MHz, CDCl3): 1.06 (t, 6H, 
J=7.5Hz), 1.22 (d, 3H, J=6.6 Hz), 1.39 (m, 2H), 1.61 (s, 6H), 1.62 (s, 6H), 1.79-1.95 
(m, 6H), 2.22 (t, 2H, J=7.8 Hz), 2.33 (t, 2H, J=6.6 Hz), 2.52-2.56 (m, 4H),2.64 (s, 
2H), 2.68 (s, 2H), 2.82 (t, 2H, J=5.4 Hz), 2.87 (t, 2H, J=5.4 Hz), 2.96-2.98 (m, 2H), 
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3.09-3.12 (m, 1H), 3.36 (m, 4H), 3.53 (t, 2H, J=6.6 Hz), 3.67 (t, 2H, J=6.6 Hz), 4.06 
(t, 2H, 4.2 Hz), 4.15 (t, 2H, J=4.8 Hz), 6.15 (d, 1H, J=14.1Hz), 6.20 (d, 1H, 
J=14.1Hz), 7.07-7.38 (m, 8H), 7.51 (d, 1H, J=14.1Hz), 7.60 (d, 1H, J=14.1Hz).  
13
C-NMR (75 MHz, CDCl3): 11.6, 12.3, 20.1, 20.5, 20.8, 22.9, 24.8, 25.4, 25.5, 25.7, 
28.1, 28.2, 28.3, 28.4, 29.6, 30.2, 31.6, 32.4, 33.9, 46.1, 46.2, 48.2, 49.1, 49.2, 49.3, 
101.8, 102.2, 110.6, 110.8, 110.9, 122.3, 122.4, 125.3, 125.4, 125.6, 128.0, 128.3, 
128.5, 128.7, 140.7, 140.9, 141.0, 141.1, 142.1, 142.2, 153.3, 153.9, 167.9, 168.9, 
172.0, 172.2, 172.3, 172.7, 173.6.  
tR: 4.20 min, ESI (HRMS) m/z (C54H72N5O5
+
), calc: 870.5528; found: 870.5534. 
 
3.5.2 Antibody conjugation and characterization 
Antibody conjugation:  
100 g of anti-EGFR-IgG2a were washed with PBS using a Microcon 3K 
filter (Millipore), and re-suspended in 100 L of Na2CO3-NaHCO3 buffer (pH: 9.2). 
20 eq. of CyNE790 or ICG-sulfo-OSu (typically 1.0-1.2 L of a 10 mM DMSO 
solution) were added and the whole mixture was shaken at dark for 2 h. The excess of 
dye was removed by washing with PBS (3 × 500 L) using a Microcon 3K filter 
(Millipore) (3 rounds at 14,000 rpm at 4 C for 60 min). 
3.5.3 Cell culture and cellular imaging of CyNE790-anti-EGFR in SCC-15 and 
MCF-7 cells 
SCC-15 and MCF-7 cell lines were grown as above described. Both cell lines 
were cultured in 96-well plates at 85-90% confluence and incubated with CyNE790-
anti-EGFR for 1 h at r.t (1:50 dilution of a 1 g/L antibody solution in PBS). After 
incubation, cells were washed with media (× 3) and images were taken (10× 
magnification) using an Eclipse Ti-U Nikon microscope (filter cube: 750/800) 
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attached to Ti: sappire oscillator that operated in continuous wave mode (750 nm, 120 
mW), and a NIR-enhanced CCD camera (Andor Technology). 
3.5.4 In vivo imaging 
CyNE790-labelled and ICG-labelled anti-EGFR-comparative visualization: 
Balb/c nude mice obtained from the Biological Resource Centre (Biomedical 
Sciences Institutes) were anesthetized by intraperitoneal injection of ketamine (150 
mg/kg)/xylazine (10 mg/kg) at the age of 8 weeks. CyNE790-labelled and ICG-
labelled anti-EGFR antibodies (0.15 g or 0.85 g in PBS for both antibodies) were 
injected subcutaneously in the right and left rear flanks of the mice in a volume of 
150 μL for each side. The animals were placed in an IVIS Spectrum imaging system 
(Caliper Life Sciences) immediately after antibody injection, and the fluorescence 
image was acquired using the 745 nm excitation and 820 nm emission filters.  
In vivo detection of SCC-15 cells using CyNE790-anti-EGFR: 
SCC-15 and MCF-7 cell lines were grown using RPMI media supplemented 
with 10% fetal bovine serum (FBS), 2 mM L-glutamine, and antibiotics (100 U/mL 
penicillin/ 100 g/mL streptomycin mixture) in a humidified atmosphere at 37 °C 
with 5% CO2. Every cell line cultured in one 10-cm dish at 50% confluency was 
incubated with 15g CyNE790-labelled anti-EGFR-IgG2a for 1 h at r.t. After 
incubation, cells were washed with media and PBS (× 2), scrapped and resuspended 
in 150 L PBS. CyNE790-anti-EGFR treated SCC-15 and MCF-7 cells were injected 
subcutaneously in the left rear flank of two separate mice (injection volume: 150 L). 
The animals were placed in an IVIS Spectrum imaging system (Caliper Life 
Sciences), and the fluorescence images were acquired using 745 nm excitation and 
820 nm emission filters after 15 min from the injection. All animal experiment 
procedures were performed in accordance with a protocol approved by the 




The dye solutions were injected into the tail vein of the mice in a volume of 
150μl. Immediately (1 hr) after the injection, the animals were placed in an IVIS 
Spectrum imaging system (Caliper Life Sciences), and the fluorescence image was 
acquired using the 745 nm excitation and 820 nm emission filters. More images were 
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SYNTHESIS AND CHARACTERZATION OF A CELL PERMEABLE NIR 














In biomedical applications, optical imaging has become a powerful diagnostic 
tool to monitor biological functions non-invasively, either in cell-based assays or in 
living systems. Several studies demonstrated that fluorescent imaging allows the 
identification of cancer cells and even the state of tumors in vivo.
1
 Among all the 
fluorophores, NIR-absorbing molecules have some significant advantages, hence 
considerable efforts have been driven toward the synthesis of NIR probes to monitor 
the cellular mechanism at a molecular level.  
To date, optical imaging has been highly focused on the basis of glucose 
analogues as glucose is one of the major metabolites in living systems. In 1983, Chiro 
et al. employed positron emission tomography (PET) using 
18
F-2-deoxyglucose to 




F-2-deoxyglucose has been 





deoxyglucose has been reported in the selective uptake by neurons and astrocytes by 
high-resolution micro auto radiographic imaging.
4 Thus, the applicability of glucose 
analogues for different imaging modalities has been well reported. In recent years, the 
diagnosis of mammalian cancer cells has been highly focused on the basis of glucose 
analogues as cancer cells uptake more glucose to grow the cells than the normal cells. 
Malignant cancer cells can be discriminated rate when compared to normal cells
 
due 
to their increased glycolysis, their over expression of glucose transporters (GLUTs), 
and the higher activity of hexokinases.
5,6
  These differences in metabolism have been 
applied to the identification of cancer cells by optical imaging methods that rely on 
the preparation of reporter-containing glucose analogues. A number of fluorescent 
glucose derivatives have been reported. 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-
yl)amino]-2-deoxyglucose (2-NBDG),
7
 the first fluorescent probe to monitor glucose 
uptake through GLUTs, has been widely used in cancer imaging.
8
 Limitations on the 
photophysical properties of 2-NBDG (e.g. low brightness) led to the preparation of 
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glucose analogues with improved fluorescent properties by conjugation to Cy3, 
rhodamine or two-photon dyes.
9-11
 NIR probes have recently applied to the 
preparation of fluorescent glucose analogues.
12-16
 NIR glucose derivatives have been 
prepared by conjugation of 2-deoxyglucose to penta- or heptamethine cyanine dyes 
(i.e. Cy5.5 and IRDye 800CW respectively).  Cy5.5 2-DG proved to be trapped by 
tumor cells, but its uptake is not blocked by D-glucose, questioning its delivery 
through GLUTs.
12
 On the other hand, IRDye 800CW 2-DG is uptaken in cancer cells 
and specifically blocked by excess of D-glucose,
15
 but the highly negatively charged 
chemical structure may hamper its application in cell imaging due to low cell 
membrane permeability.  
 
4.2 Objectives 
I prepared a NIR 2-deoxyglucose derivative (CyNE 2-DG) based on an 
amine acetylated tricarbocyanine structure. CyNE 2-DG showed preferential uptake 
in cancer cells and competition with excess D-glucose and its suitable cell 
permeability asserts the potential for cancer cell imaging in the NIR region. 
 
4.3 Results and discussion 
4.3.1 Design and synthesis 
I have discussed in Chapter 2 about the development of an amine acetylated 
tricarbocyanine scaffold (CyNA) with excellent photophysical properties, low 
aggregation in aqueous media and fluorescence emission in the NIR region.
17
 CyNA 
dyes have been also adapted for bioconjugation purposes after incorporation of a 
glutaric acid linker (1, Scheme 3.1 in Chapter 3) that maintains the spectral and 
photostability properties while enables the conjugation to macromolecules such as 
antibodies.
18
 The chemical structure of 3 is positively charged while many NIR 
fluorescent cyanine labeling dyes are highly negatively charged molecules. The 
minimization or absence of charges is particularly important when labeling small 
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molecules since neutral conjugates may exhibit greater permeability properties.
19 
Thus, CyNE 2-DG was prepared by coupling 2-deoxyglucosamine to the 
tricarbocyanine carboxylic acid 3 using HATU as the coupling reagent (Scheme 4.1).   
Scheme 4.1. Synthesis of CyNE 2-DG. 
 
Reagents and conditions: a) 2-D-deoxyglucosamine, HATU, DIEA, DMFanh, r.t., 30 
min. 
 
I envisaged that the conjugation of 2-deoxyglucose, a fluorescent glucose 
analogue (CyNE 2-DG) exhibited similar spectral properties to 3 with absorption and 
emission maxima around 790 and 815 nm respectively (Figure 4.1).  
 
Figure 4.1. Absorbance and fluorescence spectra of 3 (blue) and CyNE 2-DG (red) 
in phosphate buffer saline (PBS, pH 7.3) containing 1% DMSO. Excitation 
wavelength: 740 nm.  
 
4.3.2 Cellular uptake and competition assay 
 
In order to compare the uptake of CyNE 2-DG in different cells, serum-
starved cultures of breast cancer MCF7 and MDA-MB-231 cell lines and non-tumor 
human foreskin fibroblasts (HFF) were incubated at 37 

C for 20 min with 20 M 
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CyNE 2-DG, and analyzed by fluorescence microscopy. Mean NIR fluorescence 
intensity values of the different cell lines indicated that CyNE 2-DG was 
preferentially uptaken in tumor cells when compared to fibroblasts (Figure 4.2). This 





Figure 4.2. NIR fluorescence intensities in human tumor cell lines and fibroblasts 
upon incubation with 20 M CyNE 2-DG. Mean intensity values are plotted as 
average fluorescence intensities from 5 to 10 different regions and error bars as 
standard deviations.  
 
Further experiments were aimed at determining whether the uptake of CyNE 
2-DG was mediated by GLUTs. We (I and Dr. Marc Vendrell) performed 
competition experiments with increasing concentrations of D-glucose in MCF7 and 
MDA-MB-231 cells.
20,21
  As shown in Figure 4.3, the uptake of CyNE 2-DG was 
significantly reduced upon competition with D-glucose, indicating that CyNE 2-DG 
enters the cell through GLUTs. We (I and Dr. Marc Vendrell) confirmed that the 
uptake of CyNE 2-DG in MCF7 and MDA-MB-231 cells was not affected by 
competition with L-glucose (Figure 4.4) demonstrating the stereoselective interaction 




Figure 4.3. Dose-dependent inhibition of the CyNE 2-DG uptake after competition 
with D-glucose in: a) MCF7 and b) MDA-MB-231 cells. Fluorescence intensity 
values from 5 to 10 different regions were averaged and referred to the fluorescence 




Figure 4.4. CyNE 2-DG uptake after competition with L-glucose in MCF7 (left) and 
MDA-MB-231 (right) cells. Fluorescence intensity values from 5 to 10 different 
regions were averaged and referred to the fluorescence intensity measured in cells 
with no glucose competition. Error bars correspond to standard deviations.  
      
The uptake of CyNE 2-DG at different concentrations (10, 20 and 50 M) 
was evaluated in MCF7 cells (Figures 4.5). We chose 20 M as the optimum 
concentration since it showed a reasonable cell staining and a higher cell viability 
than 50 M. I performed toxicity assays of CyNE 2-DG in MCF7 cells (Figure 4.6), 
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which indicated the incubation of CyNE 2-DG (20 M) maintains a cell viability 
higher than 90% even after incubating the dye for 2 h. 
 
Figure 4.5. Fluorescence images of MCF7 cells upon incubation with CyNE 2-DG 
(left: 10 M, center: 20 M, right: 50 M) at 37 C for 20 min followed by nuclear 
staining with Hoechst. Fluorescence images were taken under the same acquisition 
conditions. NIR fluorescence is shown in red color and Hoechst staining in blue 
color. Scale bar: 100 m. 
 
Figure 4.6. Cell viability of CyNE 2-DG at different concentrations and incubation 
times in MCF7 cells. Values are referred to untreated cells (100% viability) and 
plotted as average from 3 replicates with error bars as standard deviations. 
 
 
Furthermore, I corroborated the role of 2-deoxyglucose in the cellular uptake 
by determining higher intracellular fluorescence intensities upon incubation with 








Figure 4.7. Fluorescence images of MCF7 and MDA-MB-231 cells upon incubation 
with CyNE 2-DG or 3. Cells were incubated with 20 M CyNE 2-DG or 1 at 37°C 
for 20 min followed by nuclear staining with Hoechst, and fluorescence images were 
taken under the same acquisition conditions. NIR fluorescence is shown in red color 
and Hoechst staining in blue color. Scale bar: 100 m. 
 
Altogether these results suggested that the uptake of CyNE 2-DG in tumor 
cell lines is specifically regulated by GLUTs rather than by passive penetration. I 
selected 20 min of incubation time as it has been previously reported with other 
fluorescent glucose probes.
7,10
 While 3 is slightly more fluorescent than CyNE 2-DG, 
both compounds showed a similar range of intensities in their fluorescence spectra, 
hence the differences observed in cell imaging (Figure 4.7) are basically due to their 
different uptake in MCF7 cells, proving that the glucose moiety enhances the cell 





4.3.3 Comparative cell permeability study with IRDye 800CW 2-DG 
 
After validating CyNE 2-DG as a NIR fluorescent glucose analogue, I 
compared its application for cell imaging studies to IRDye 800CW 2-DG, a tumor 
targeting NIR fluorescent agent that is uptaken by cancer cells through GLUT family 
proteins.
15
 CyNE 2-DG and IRDye 800CW 2-DG have similar fluorescence 
emission maxima (around 794 nm for IRDye 800CW 2-DG, 815 nm for CyNE 2-
DG), but the negatively charged structure of IRDye 800CW 2-DG entails a lower 
permeability that can hinder its application in cell imaging experiments. We (I and 
Dr. Marc Vendrell) compared the NIR fluorescence images of MCF7 cells upon 
incubation with CyNE 2-DG and IRDye 800CW 2-DG (both at 20 M) at 37oC for 
20 min. Images taken under the same acquisition conditions proved that the 
cytoplasmatic fluorescence intensities of the cells incubated with CyNE 2-DG were 
significantly higher than those treated with IRDye 800CW 2-DG (Figure 4.8). These 
results demonstrated the superior uptake of CyNE 2-DG in cancer cells and validated 




Figure 4.8. Brightfield and merged fluorescence images of MCF7 cells upon 
incubation with CyNE 2-DG (a and c) and IRDye 800CW 2-DG (b and d). Cells 
were incubated with 20 M CyNE 2-DG or IRDye 800CW 2-DG at 37 °C for 20 
min followed by nuclear staining with Hoechst, and fluorescence images were taken 
under the same acquisition conditions. NIR fluorescence is shown in red color and 
Hoechst staining in blue color. Scale bar: 100 m. 
 
 
In addition to that, we (I and Dr. Marc Vendrell) examined the cell retention 
of CyNE 2-DG in MCF7 cells. As shown in Figure 4.9, CyNE 2-DG was still 
detectable inside the cells after 3 h of the treatment. While these results are still 
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preliminary, they indicate that CyNE 2-DG may be phosphorylated by the 
hexokinases and retained inside the cells. 
 
Figure 4.9. Retention analysis of CyNE 2-DG in MCF7 cells upon incubation with 
20 M CyNE 2-DG at 37°C for 20 min. Brightfield and fluorescence images were 
taken under the same acquisition conditions just after treatment (a) and 3 h after 
treatment with CyNE 2-DG (b). Scale bar: 100 m. 
 
4.4 Conclusions 
In conclusion, I synthesized and characterized CyNE 2-DG as a novel NIR 
fluorescent glucose derivative. CyNE 2-DG showed a higher uptake in cancer cell 
lines than in human primary fibroblasts, and its competition with unlabeled D-glucose 
implied that its uptake into the cells may be mediated by GLUTs. CyNE 2-DG 
exhibited a brighter staining of cancer cells when compared to the commercially 
available IRDye 800CW 2-DG, which suggests its good cell permeability properties 






4.5 Experimental details 
Materials and Methods: 
 IRDye 800CW-OSu was purchased from LI-COR Biosciences. Fluorescence 
microscopy experiments were performed in a Nikon Ti microscope attached to a Cool 
LED (740 nm) excitation source in Singapore Bioimaging Consortium, Agency for 
Science, Technology and Research (A*STAR), Singapore, and images were 
processed using the software NIS-Elements 3.10. Cell viability assays were 
performed using a CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay 
(MTS) (Promega) following the manufacturer’s instructions. 
4.5.1 Synthesis of CyNE 2-DG and IRDye 800CW 2-DG 
CyNE 2-DG: 
3 (as described in earlier Chapter 3) and HATU (25 mg, 0.07 mmol) were 
dissolved in 5 mL of anhydrous DMF under N2 atmosphere and stirred at r.t. for 10 
min. 2-D-deoxyglucosamine•HCl (15 mg, 0.07 mmol) was treated with DIEA (14 L, 
0.10 mmol) and added to the reaction mixture. The reaction was stirred for another 2 
h at r.t., then the solvent was evaporated under reduced pressure and the resulting 
green solid was purified by normal-phase column chromatography (elution with 
DCM-MeOH (9:1)) to obtain CyNE 2-DG as a green solid (41 mg, yield 68%). 
IRDye 800CW 2-DG: 
2-amino-2-deoxy-D-glucose hydrochloride (Glucosamine hydrogen chloride) 
50 equivalents were solubilized in 20 mM Sodium bicarbonate buffer (pH 8.3) at 
ambient temperature
.15
 Then, aqueous solution of of IRDye 800CW NHS ester (1 
equivalent, 5 mg) was added to the reaction mixture and stirred it for 2h at room 
temperature.    The dye conjugate was puriﬁed by HPLC, monitored at 780 nm, using 
diode array detector. The column (150-mm, Luna C18 column) was equilibrated and 
eluted at 2 mL/min using a gradient with 5% acetonitrile: 100% Acetonitrile within 
23 min.  Sample was dried overnight under vacuum, with light protection.  
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tR: 7.94 min (RP-HPLC gradient from 5 to 100% B in 23 min) 
ESI (HRMS) calc. for C52H63N3O19S4
-3
: 1161.3101, found (z =2): 580.6488. 
Characterization of CyNE 2-DG: 




H-NMR spectrum of 2-D-deoxyglucosamine•HCl in D2O:  
= 3.27 (dd, 1H, J1 = 11 Hz, J2 = 3.5 Hz), 3.47(t, J = 9.5 Hz), 3.75-3.78 (m, 1H), 3.82-






H-NMR spectrum of CyNE 2-DG in MeOD: 1.04 (t, 6H, J = 7.5Hz), 
1.32 (d, 3H, J = 6.6 Hz), 1.35-1.39 (m, 5H), 1.61 (s, 4H), 1.66 (s, 4H), 1.72 (s, 4H), 
1.83-1.90 (m, 6H), 2.18 (t, 2H, J = 8.0 Hz), 2.28-2.39 (m, 2H), 2.52-2.62 (m, 4H), 
2.98 (t, 2H, J = 5.4 Hz), 3.05 (t, 2H, J = 5.4 Hz), 3.06-3.26 (m, 4H), 3.47 (t, 4H), 
3.60-3.83 (m, 6H), 4.06 (m, 2H), 4.15 (t, 2H, J = 7.5 Hz), 4.97 (d, 1H, J = 3.2 Hz), 
6.25 (d, 1H, J = 14.1 Hz), 7.24-7.58 (m, aromatic 8H), 8.29 (d, 2H, J = 10.5 Hz), 8.61 




4.5.3 Cell culture and cellular imaging 
MCF7 and MDA-MB-231 cells were purchased from American Type Culture 
Collection (ATCC) and maintained in DMEM containing 10% fetal bovine serum 
(FBS). Serum-starved cultures of different cell lines were incubated at 37 

C for 20 
min with 20 M dyes (CyNE 2-DG or IRDye 800CW 2-DG) in low-glucose DMEM 





10 min). For competition experiments with D-glucose and L-glucose, cells were 
incubated at 37 

C for 3 h with low-glucose DMEM containing 0, 10 or 50 mM 
glucose. CyNE 2-DG was then added incubated at 37 

C for 20 min, washed with 
PBS (×1) and treated with Hoechst for nuclear staining (37 

C, 10 min). Cell images 
were taken in a Nikon Ti microscope at 10× magnification with 360±20/460±25 and 
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Raman spectroscopy measures the changes in vibrational frequency due to 
polarization of the molecules under the electric field of the incident photon. It 
represents a powerful technique to obtain molecular fingerprints in liquid or gas 
states, mainly regarding information on intermolecular interactions, molecular 
structures and inherent dynamics of the molecules. However, the signal to noise ratio 
in Raman spectroscopy is usually a bottleneck for highly sensitive detection. Surface 
Enhanced Raman Spectroscopy (SERS) has recently emerged as an advanced 
spectroscopic method in which the magnitude of the Raman cross sections are highly 
influenced when Raman active molecules are placed on the surface of roughened 
noble metal surface. Eventually, this technique has become an alternative in 
bioimaging to fluorescence-based spectroscopy, as it can minimize photobleaching, 
peak overlapping, and low signal to noise ratio in complex biological systems.
1-3
 




 fold scattering enhancement through the 
electrostatic adsorption caused by the proximity of Raman-active signature molecules 
to the surface of metal nanoparticles (NPs),
4-7
  which can be modulated with 
molecular recognition motifs to render diagnostic tools for optical imaging and 
therapeutic studies.
8-12
 SERS probes have great potential for multiple functions, from 
cellular studies to in vivo tumor recognition. Gold nanoparticles (AuNPs), which 
exhibit unique electromagnetic properties, have been widely employed to prepare 
nanotags as contrast agents for diagnostic imaging applications. Furthermore, AuNPs 
are particularly used for in vivo imaging applications due to their low toxicity
4
 and 
reactive roughen surface. Although AuNP-based Raman reporters provide a robust 
platform, the preparation of ultrasensitive SERS probes is hampered by the limited 
availability, sensitivity and reproducibility of Raman intensity. Most of the commonly 
used Raman signature molecules are active in the UV-visible range (e.g. crystal 
violet, malachite green isothiocyanate, rhodamine-6G, nile blue, 2-napthalenethiol, 





This drawback is particularly important at the NIR region, where the availability of 
reporters is restricted to a few Raman-active molecules. The adequacy of the NIR 
region for in vivo studies has raised the interest in NIR SERRS (Surface Enhanced 
Resonance Raman Spectroscopy)-active molecules. NIR light can penetrate much 
deeper into tissue and pass through the skin compared to visible light, and enables the 
assessment of molecular and physiological events in tissue samples. In addition, 
many macromolecules, intrinsic tissue or organelles have low light absorption, less 
autofluorescence, and low light scattering which often come across in visible light. To 
date the cyanine derivative DTTC has been regarded as a standard in NIR SERRS 
studies,
9
 but it shows only a moderate Raman intensity that limits the preparation of 





Since little is known about the correlation between the cyanine scaffold and 
its Raman intensity, I designed a library of structurally diverse tricarbocyanines with 
the aim to discover novel NIR SERRS-active compounds that surpassed the 
sensitivity of DTTC. Based on the several advantages of NIR Raman reporters and 
AuNPs, herein I report the first combinatorial approach to discover novel and highly 
sensitive NIR SERS reporters. The synthesis and screening of an 80-member 
tricarbocyanine library and chemisorbed on AuNPs  led to the identification of 
CyNAMLA-381 as an NIR SERS reporter with 12-fold higher sensitivity than the 
standard 3,3′-diethylthiatricarbocyanine (DTTC), and we (I. Dr. Kaustabh Kumar 
Maiti and Dr. Yun Seong Wook) validated its advantages for the construction of 





5.3 Result and discussion 
5.3.1 Design and synthesis of library 
The tricarbocyanine core is an accessible NIR structure whose central 
chlorine atom can be replaced with different nucleophiles.
19
 I designed the synthesis 
of tricarbocyanine derivatives by substitution with different amines, and acetylated 
the resulting alkyl- or benzyl amino groups to obtain compounds with NIR-absorption 
properties and good chemical stability in aqueous media (CyNA).
20
 As in this 
structure does not have any linker for further modification, I designed a new amine 
linker on the side chain of tricarbocyanine scaffold by maintaining CyNA scaffold 
which is mainly responsible for good  photophysical properties and diversity. The 
modification of CyNA scaffold to CyNAM has been successfully done according to 
Scheme 5.1.  
Scheme 5.1. Synthesis of lipoic acid-containing amine acetylated tricarbocyanines 
(CyNAMLA). 
 
Reagents and conditions: a) Boc2O, DIEA, CHCl3, 60 
o
C, 4-6 h; b) R-NH2, DIEA, 
CH3CN, 60 
o
C, 20-90 min; c) CH3COCl, DIEA, CH2Cl2, 0 
o
C, 5-10 min; d) TFA-




The main concern in this synthetic route is the modification of central 
chlorine atom of 4 by amine nucleophiles, as the free amine in the side chain of 
tricarbocyanine may acts as a nucleophile. However, I have successfully overcome 
the synthetic barricade by Boc (tert-butyl carbonate) protection of amine group on the 
side chain and modified the central chlorine atom by 80 different primary amines 
including heterocyclic, alkyl and aromatic from commercial source (Chart 5.1) in a 
combinatorial manner to make an intermediate CyNAB derivative. The CyNAB 
compounds were treated with an optimized TFA-DCM (1:9) solution that overcame 
the liability of the tricarbocyanine core in acidic conditions.
22
 In order to prepare 
compounds that could be chemisorbed on AuNPs,
21
 the final coupling of CyNAM to 





















5.3.2 Characterization of CyNAMLA library 
80-member CyNAMLA compounds were characterized by HPLC-MS 
analysis. The purities of the whole library were determined by integration of the UV 
absorbance signal at 365 nm. The absorbance spectra of 10 M in DMSO solution 
was recorded in SpectraMax M2 plate reader. Table 5.1 shows the purity, 
experimental mass analysis data and absorbance values of the whole CyNAMLA 
library. 

















A2 CyNAMLA-11 890.4 91 804 2374 
A3 CyNAMLA-49 899.4 93 806 2271 
A4 CyNAMLA-55 947.4 94 805 1125 
A5 CyNAMLA-80 891.5 96 804 32082 
A6 CyNAMLA-92 849.4 95 803 23452 
A7 CyNAMLA-100 959.4 89 804 2312 
A8 CyNAMLA-101 869.4 97 803 2102 
A9 CyNAMLA-102 899.4 91 804 1602 
A10 CyNAMLA-103 899.4 92 806 6424 
A11 CyNAMLA-105 862.4 94 804 3878 
B2 CyNAMLA-107 938.4 85 805 2397 
B3 CyNAMLA-111 869.4 97 805 4021 
B4 CyNAMLA-124 915.5 91 804 2201 
B5 CyNAMLA-131 897.5 71 806 4419 
B6 CyNAMLA-164 847.6 74 803 4777 
B7 CyNAMLA-177 823.3 97 802 9396 
B8 CyNAMLA-180 833.4 91 804 8236 
B9 CyNAMLA-181 915.5 80 804 2109 
B10 CyNAMLA-184 929.4 70 803 24133 
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B11 CyNAMLA-185 835.4 71 805 4603 
C2 CyNAMLA-193 935.5 88 803 1610 
C3 CyNAMLA-201 897.5 72 804 6915 
C4 CyNAMLA-218 873.3 95 804 1922 
C5 CyNAMLA-220 873.3 97 805 6604 
C6 CyNAMLA-221 889.3 96 804 26102 
C7 CyNAMLA-230 877.5 94 804 4341 
C8 CyNAMLA-262 915.5 95 805 27810 
C9 CyNAMLA-266 929.5 75 806 3013 
C10 CyNAMLA-272 876.5 93 805 1986 
C11 CyNAMLA-274 865.5 96 806 6417 
D2 CyNAMLA-275 897.5 80 804 1408 
D3 CyNAMLA-277 863.4 94 804 2046 
D4 CyNAMLA-282 878.5 90 805 1296 
D5 CyNAMLA-295 793.5 96 804 1888 
D6 CyNAMLA-319 915.5 94 805 2850 
D7 CyNAMLA-329 933.5 75 804 4790 
D8 CyNAMLA-335 883.5 89 805 8158 
D9 CyNAMLA-336 945.5 88 805 2548 
D10 CyNAMLA-341 933.4 70 804 1071 
D11 CyNAMLA-346 927.5 87 805 2940 
E2 CyNAMLA-356 945.5 97 806 2333 
E3 CyNAMLA-358 915.5 98 804 1121 
E4 CyNAMLA-359 914.5 97 805 2068 
E5 CyNAMLA-364 889.4 96 804 3561 
E6 CyNAMLA-373 821.5 94 804 2487 
E7 CyNAMLA-374 855.5 97 803 9636 
E8 CyNAMLA-375 873.5 97 804 1976 
E9 CyNAMLA-381 885.5 98 804 38210 
E10 CyNAMLA-382 861.5 99 804 7947 
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E11 CyNAMLA-387 885.5 97 804 3910 
F2 CyNAMLA-388 885.5 96 805 1620 
F3 CyNAMLA-395 899.5 96 805 1876 
F4 CyNAMLA-396 869.5 93 806 6521 
F5 CyNAMLA-398 869.6 94 805 2629 
F6 CyNAMLA-401 856.5 91 804 2920 
F7 CyNAMLA-403 889.4 98 804 3417 
F8 CyNAMLA-405 887.4 92 805 12149 
F9 CyNAMLA-407 905.4 94 806 3000 
F10 CyNAMLA-414 904.6 88 806 5267 
F11 CyNAMLA-419 835.5 83 804 9354 
G2 CyNAMLA-427 850.4 80 805 1735 
G3 CyNAMLA-439 849.6 81 805 3589 
G4 CyNAMLA-442 835.5 75 803 1989 
G5 CyNAMLA-443 807.5 71 806 1833 
G6 CyNAMLA-446 845.5 80 804 8301 
G7 CyNAMLA-452 933.4 71 805 24271 
G8 CyNAMLA-477 887.9 97 804 9679 
G9 CyNAMLA-478 883.4 92 805 35116 
G10 CyNAMLA-480 903.5 89 805 10253 
G11 CyNAMLA-531 923.2 88 805 5272 
H2 CyNAMLA-548 945.4 70 803 10165 
H3 CyNAMLA-565 923.3 92 805 14019 
H4 CyNAMLA-567 919.5 90 802 9879 
H5 CyNAMLA-572 947.4 94 804 2718 
H6 CyNAMLA-574 835.5 93 804 1763 
H7 CyNAMLA-599 945.5 85 804 11616 
H8 CyNAMLA-611 876.5 81 804 18833 
H9 CyNAMLA-621 951.3 75 804 2050 
H10 CyNAMLA-677 903.3 83 805 2455 
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H11 CyNAMLA-686 937.4 72 806 8146 
 
*(a) ESI-MS m/z corresponding to [M
+
] values. 
*(b) Purities were determined by integration of the UV absorbance signal at 365 nm.  
*(c) SERS spectra were obtained from excitation at 785 nm with a laser power of 60 
mW.  
*(d) The main product corresponded to the double acetylated derivative. 
 
5.3.3 Measurement of SERS 
I employed 60 nm diameter AuNPs as a noble nanoparticle with roughened 
metal surface, which is an important requirement for SERS studies. CyNAMLA 
compounds proved to be remarkably NIR-active with absorbance maximum 
wavelengths around 800 nm in DMSO (Figure 5.1). Hence, I conjugated the 
CyNAMLA library to AuNPs in order to study their SERS properties.   
 
Figure 5.1. Absorbance spectra of the 6 selected CyNAMLA compounds (10 M 
concentration, pH=7.4, 20 mM PBS). 
 
CyNAMLA excitation maxima are around 790 nm (Figure 5.1), and I applied 
785 nm laser sources for the excitation of Au-nanotags. Practically, only 785 nm and 
633 nm laser sources are available in SERS microscopes, and the 785 nm source can 
generate a higher SERS signal intensity due to the resonance with the excitation 
frequency and electronic transition of NIR reporter molecules. The SERS properties 
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of CyNAMLA compounds were examined under a compact Raman scanner upon 
incubation of every compound with citrate-stabilized gold nanoparticles. This primary 
screening revealed that the SERS intensities of CyNAMLA compounds varied 
significantly throughout the library (Table 5.1, Figure 5.3), indicating that the SERS 
properties depended on the amine structure.  
 
Figure 5.2. Comparative SERS intensities of the whole CyNAMLA library. SERS 
spectra were measured in a compact Raman scanner with excitation at 785 nm and 60 
mW laser power. The intensity of the reference standard DTTC is plotted in a red 
bar. 
 
Notably, six derivatives containing mostly aromatic amines (CyNAMLA-80, 
92, 221, 262, 381 and 478, represented in Figure 5.2 as A5, A6, C6, C8, E9 and G9 
respectively) exhibited very high SERS intensities that exceeded the signal intensity 
of DTTC, and were selected for further analysis. The selected SERS active reporter 
molecules were further carried out in a Renishaw InVia Raman microscope 
(Renishaw, UK, model: HPNIR785) using an excitation wavelength of 785 nm. 
Figure 5.4 clearly indicates that the SERS signal intensity of CyNAMLA-381 




Figure 5.3. SERS intensities of the selected CyNAMLA-AuNPs. SERS spectra data 
were measured at 523 cm
-1
  for CyNAMLA and 495 cm
-1
 for DTTC in a Renishaw 
Raman microscope (excitation: 785 nm). 
 
I have studied the SERS spectra ranging from 400 cm
-1
 to 2000 cm
-1
 of 
selected best six compounds among whole library. Interestingly, all the Raman active 
molecules having a number of bands that might be assigned as follows: 523 cm
-1
 as 
(S-S), 1059 cm-1 as (CH2-S), 1124 cm
-1as (C-C), 1202 cm-1 as aromatic vibration 
of the polycyclic structure, and 1469 cm
-1
 as CH3-C) anti-symmetry stretching.
24, 25
 
Figure 5.4 indicated that the SERS spectra of all the Raman active molecules are 






Figure 5.4. SERS spectra of BSA-encapsulated nanotags that were derivatized with 
CyNAMLA-80, CyNAMLA-92, CyNAMLA-221, CyNAMLA-262, CyNAMLA-





, acquisition time: 10 s.  
 
5.3.4 Encapsulation of AuNPs and TEM characterization 
The encapsulation of SERS-active nanoparticles is a crucial step because it 
can prevent their aggregation and the desorption of Raman signature molecules from 
the NPs, and it can be used to introduce functional groups on their surface for 
bioconjugation.
26-29
 To evaluate the long-term stability of the six selected 
CyNAMLA-AuNPs, we (I and Dr. Kaustabh Kumar Maiti) modified them with 
bovine serum albumin (BSA) and glutaraldehyde so that amine-containing molecules 
(i.e. antibodies, proteins or other macromolecules) could be attached to the resulting 












Previously Qian et al. reported that the gold nanoparticles rapidly precipitate 
or aggregate under harsh conditions.
9
 AuNPs and their SERS spectra are quite stable 
after encapsulation with polyethylene glycol (PEG) due to the formation of protective 
layer on the gold colloid. Similarly, Huang et al. also reported the BSA encapsulation 
for the stability of the nanoparticles. In the present work we (I and Dr. Kaustabh 
Kumar Maiti) applied BSA encapsulation to increase the stability of SERS signal 
intensity and minimize the aggregation among the nanoparticles. In addition, the BSA 
coating layer allows efficient conjugation to tumor-targeting ligands. The increased 
size (65-70 nm) of the BSA-encapsulated CyNAMLA-AuNPs was confirmed by 
transmission electron microscopy (TEM). In addition, the plasmon spectra in Figure 
5.5 showed a minor band around 600 nm, indicating that there is no major 





Figure 5.5. Surface plasmon absorption spectra of Au-colloids containing 
CyNAMLA reporters. 
 
Similarly, dimers and trimers can be found in one of the TEM images (Figure 
5.6a), but in all samples, I observed that the predominant form of our colloids are as 
monomers (Figure 5.6b) rather than as small aggregates. 
 
 
Figure 5.6. Transmission electron microscopy (TEM) images of: (a) BSA-
encapsulated CyNAMLA-381 nanotags, (b) antibody-conjugated BSA-encapsulated 
CyNAMLA-381 nanotags. Scale bar: 20 m. 
 
5.3.5 Stability measurement of SERS nanotags 
I analyzed the stability of the SERS intensities for 1 month at highest peaks 
523 cm
-1
 and 495 cm-1, for CyNAMLA and DTTC compounds respectively. For the 
SERS measurements of CyNAMLA-gold colloid mixtures, 20 M  solutions of 
CyNAMLA compounds  in deionized water were mixed with Au  colloid  (2.6  ×  
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1010  particles/mL)  in  a  1:9  ratio  (v/v).  20 L of the reporter-Au colloid mixture 
solutions were placed on a clean glass slide with a cover slip and measured under the 
Raman microscope. The results are plotted as average intensities of 5 independent 
measurements from one single sample preparation. Remarkably, the nanotags 
exhibited consistent stable SERS intensities over time, with a low relative standard 
deviation (2 to 3%) (Figures 5.7-5.13). From the above analysis of the SERS intensity 
and signal stability, CyNAMLA-381 was chosen as the best Raman reporter in terms 
of both signal intensity and stability.  
 
 
Figure 5.7. Time-course SERS measurements of CyNAMLA-80 nanotags. 20 M  
solutions of CyNAMLA-80 compounds  in deionized water were mixed with Au  
colloid  (2.6  ×  1010  particles/mL)  in  a  1:9  ratio  (v/v).   
 
Figure 5.8. Time-course SERS measurements of CyNAMLA-92 nanotags. 20 M  
solutions of CyNAMLA-92 compounds  in deionized water were mixed with Au  





Figure 5.9. Time-course SERS measurements of CyNAMLA-221 nanotags. 20 M  
solutions of CyNAMLA-221 compounds  in deionized water were mixed with Au  
colloid  (2.6  ×  1010  particles/mL)  in  a  1:9  ratio  (v/v).   
 
 
Figure 5.10. Time-course SERS measurements of CyNAMLA-262 nanotags. 20 M  
solutions of CyNAMLA-262 compounds  in deionized water were mixed with Au  
colloid  (2.6  ×  1010  particles/mL)  in  a  1:9  ratio  (v/v).   
 
 
Figure 5.11. Time-course SERS measurements of CyNAMLA-381 nanotags. 20 M  
solutions of CyNAMLA-381 compounds  in deionized water were mixed with Au  





Figure 5.12. Time-course SERS measurements of CyNAMLA-478 nanotags. 20 M  
solutions of CyNAMLA-478 compounds  in deionized water were mixed with Au  
colloid  (2.6  ×  1010  particles/mL)  in  a  1:9  ratio  (v/v).   
 
 
Figure 5.13. Time-course SERS measurements of DTTC nanotags. 20 M  solutions 
of DTTC compounds  in deionized water were mixed with Au  colloid  (2.6  ×  1010  
particles/mL)  in  a  1:9  ratio  (v/v).   
 
5.3.6 Antibody conjugation and SERS study 
With the discovery of CyNAMLA-381 as a NIR highly sensitive SERS 
reporter molecule, we (I and Dr. Kaustabh Kumar Maiti) applied it to the preparation 
of SERS probes for cancer cell detection and discrimination. To prepare SERS 
nanotags that could selectively detect cancer cells expressing HER2 receptors, we 
conjugated CyNAMLA-381-AuNPs to two HER2-recognition motifs: a full anti-
HER2 monoclonal antibody (170 kDa) and a scFv anti-HER2 (26 kDa) antibody.
32
 
Generally, HER2 signaling pathway plays an important role in cell proliferation, and 
is upregulated in most breast cancers.
31
  Specially, ScFv anti-HER2 (MW¼ 25 kDa), 
a small antibody fragment recognizes the herceptin receptor (HER2) that is 
overexpressed in many types of human malignant tumors. Hence, Dr. Kaustabh 
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Kumar Maiti studied SDS-PAGE analysis to confirm the conjugation of ScFv anti-
HER2 to the nanotags. Figure 5.14 clearly shows the SDS-PAGE analysis of ScFv-
nanotag and the original scFv. 
 
Figure 5.14. SDS-PAGE of scFv-anti-HER2 antibody upon conjugation to SERS 
nanotags. 
 
After full characterization of the nanotags conjugated ScFv antibody, I 
examined firstly their in vitro specificity in SKBR-3 (HER2-positive) and MDA-
MB231 (HER2-negative) cancer cells. Upon incubation of SKBR-3 cells with 
antibody-conjugated CyNAMLA-381-AuNPs, strong SERS signals were observed, 
while negligible signals were detected after incubating the same NPs with MDA-







Figure 5.15. SERS spectra upon incubation with scFv-conjugated SERS nanotags in: 
a) HER-2 positive SKBR-3 cells, b) HER-2 negative MDA-MB231 cells. The 
measurements were performed with excitation at 785 nm and a laser power of 60 
mW. 
 
I also confirmed the target specificity of CyNAMLA-381-AuNPs in SKBR-3 
cells by competition assays between antibody-conjugated nanotags and free HER2-
recognition motifs: a 10 to 15-fold decrease of the SERS signals in the presence of 
the competing anti-HER2 antibodies was observed (Figure 5.16). Interestingly, the 
signal intensities obtained with scFv-conjugated nanotags were 1.5 times stronger 
than those with the full-HER2 antibody. This data suggests that scFv-conjugated 
nanotags can not only maintain the recognition properties but also improve the 
detection of full-size antibodies. Furthermore, the smaller size of scFv can 
significantly reduce the interstitial tumor pressure that impedes intratumoral 







Figure 5.16. SERS spectra upon incubation with scFv-conjugated SERS nanotags in: 
SKBR-3 cells upon competition between scFv-conjugated SERS nanotags and free 
scFv (anti-HER2). For insets contain zoom spectra. The measurements were 
performed with excitation at 785 nm and a laser power of 60 mW. 
 
5.3.7 Cell SERS mapping 
We (I and Dr. Kaustabh Kumar Maiti) performed SERS mapping 
experiments in SKBR-3 and MDA-MB231 cells (Figure 5.17).
33
 Mapping images of 
SKBR-3 cells after incubation with scFv-conjugated CyNAMLA-381-nanotags 
displayed high SERS intensities at representative frequencies of CyNAMLA-381 (i.e. 
523 cm
-1
). On the other hand, no distinguishable signals were observed in MDA-
MB231 cells under the same experimental conditions. The mapping pictures 
confirmed that the interaction between scFv anti-HER2-conjugated nanotags and 
SKBR-3 cells was mainly localized at the cell surface, which corresponds well with 
the high expression of HER2 receptors at the plasma membrane of cancer cells.
34
 
While the exact limits of the cell boundary may be difficult to determine due to the 
resolution of the bright field images, there is a good correlation in many points of the 
SERS maps and the bright field images, which confirms that the interaction between 




Figure 5.17. Bright field and SERS mapping images of cells treated with 
CyNAMLA-381-nanotags: a) SKBR-3, b) MDA-MB231 cells. All mapping images 
(523 cm
-1
) were scanned at an interval of 2 m (785 nm excitation) and the intensities 




Reflective mode dark-field images
35
 of SKBR-3 cells that were incubated with 
scFv-conjugated CyNAMLA-381-SERS nanotags also displayed a number of bright 
spots on the cell surface due to the recognition of the receptor, while the same 
experimental conditions in MDA-MB231 cells showed a negligible scattering (Figure 
5.18). The corresponding SERS spectra showed that only intense SERS signals were 
observed from the particles located on the cell surface of the HER2-postive cells 
(points 2 and 3), and no SERS signals were detected in other regions of the SKBR-3 






Figure 5.18. Dark-field reflective microscopy images (CytoViva) and SERS spectra 
from points 1-5 (indicated with arrows) in: a) SKBR-3 and b) MDA-MB231 cells.  
 
The broad spectral bump in the region of ~1300-1500 cm
-1
 may be 
characteristic of glass luminescence especially when very low Raman-active 
molecules are placed on the glass material and excited at 785 nm. 
 
5.3.8 In vivo cancer detection in xenograft mice 
Finally, in order to validate the optical detection by scFv-conjugated 
CyNAMLA-381-SERS nanotags in vivo, we (I, Dr. Kaustabh Kumar Maiti and Dr. 
Yun Seong Wook) injected them in nude mice bearing xenografts generated from 
SKBR-3 cells. After 5 h of the tail vein injection, we measured the SERS spectra of 
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the tumor site through the skin with a NIR laser beam. Whereas the signal of the 
tumor site perfectly resembled the SERS spectra of the pure nanotag, no SERS signal 
was detected from other anatomical locations (i.e. upper dorsal) (Figure 5.19).  
 
Figure 5.19. In vivo detection of HER2-positive tumors with scFv-conjugated 
CyNAMLA-381-SERS nanotags: SERS spectra of pure nanotags (blue), and SERS 
signals of the tumor location (red) and a non–tumorogenic area (black). 
 
On the contrary, we (I. Dr. Kaustabh Kumar Maiti and Dr. Yun Seong Wook) 
observed that no significant SERS signal (Figure 5.20) was detected after injecting 
the nanotags in xenograft models prepared with HER2-negative cancer cells (MDA-
MB231). 
 
Figure 5.20. In vivo imaging of MDA-MB231 (HER2-negative) tumors with scFv-
conjugated CyNAMLA-381-SERS nanotags: SERS spectra of pure nanotags (blue), 
and SERS signals of the tumor (red), and of a non-tumor area (i.e. upper dorsal) 




5.3.10 In vivo SERS imaging 
We (I, Dr. U.S. Dinish and Dr. Kaustabh Kumar Maiti) performed SERS 
mapping experiments in xenograft mice, by mapping tumor and non-tumor regions 
separately. As shown in Figure 5.21, distinctive SERS mapping images between two 
regions were distinguishable according to their SERS intensity. Mapping experiments 
in SKBR-3 xenograft models revealed much higher SERS intensities (523 cm
-1
) in the 
tumor region when compared to non-tumor areas. These results clearly indicated that 
the scFv-conjugated CyNAMLA-381-SERS nanotags were able to specifically detect 
HER2-positive tumors in vivo. The differences between white light images from 
cancer and normal tissue may be due to the fact that the focus of the light for both 
tumor and non-tumor areas may be set at different depths, since it is practically 
difficult to maintain the exact same depth for both regions in the experimental set-up. 
 
Figure 5.21. SERS mapping images (523 cm
-1
) from tumor (red square) and non-
tumor upper dorsal (black square) regions upon injection of CyNAMLA381-anti-
HER2 nanotags. All mapping images (size: 30 × 30 m2) were scanned at an interval 
of 2 m (785 nm excitation wavelength) and the intensities were normalized between 




In summary, I prepared a lipoic acid-containing NIR-active tricarbocyanine 
library (CyNAMLA), and screened the SERS properties after chemisorption in 
AuNPs. CyNAMLA compounds exhibited strong SERS intensities, and I identified 
CyNAMLA-381 as a highly sensitive NIR SERS reporter molecule with excellent 
signal stability and 12-fold higher sensitivity than the current standard DTTC. We (I, 
Dr. Kaustabh Kumar Maiti and Dr. Yun Seong Wook) further applied CyNAMLA-
381 to the preparation of ultrasensitive SERS probes for in vivo cancer imaging by 
conjugating CyNAMLA-381-AuNPs to scFv anti-HER2 antibodies. These nanotags 
displayed very good SERS intensity and selectivity towards HER2-positive cancer 
cells under both Raman and dark-field microscopes. Furthermore, we confirmed their 
in vivo application in HER2-positive and negative xenograft models. The high 
sensitivity and tumor specificity of scFv-conjugated CyNAMLA-381-SERS nanotags 
proves their excellent potential as non-invasive diagnostic tools and opens up a new 












5.5 Experimental details 
Materials and methods: 
DTTC was purchased from Sigma Aldrich. Anti-HER2 (sc-71667, Neu 
0.N.211) was supplied by Santa Cruz Biotechnology, Inc. For the preparation of scFv 
(anti-HER2) antibody the VH and VL genes of anti-HER2 antibody were amplified 
and cloned into pComb3X vector containing HA tag. The recombinant plasmid was 
transformed into E. coli BL21 DE3. Transformed E. coli were grown in SB medium 
until the OD at 600 nm reached 1.0 on a shaker at 230 rpm, followed by induction 
with 1 mM isopropyl-β-D-thiogalactopyransoside (IPTG) followed by overnight 
incubation at 30
 
C. Soluble scFv was purified via anti-HA antibody conjugated 
protein A column. Surface plasmon absorption spectra were measured on a 
SpectraMax M2 spectrophotometer (Molecular Devices), and the data analysis was 
performed using GraphPad Prism 5.0 and Origin 6. SERS measurements were carried 
out in a Renishaw InVia Raman (UK) microscope with a laser beam directed to the 
sample through 50× and 20× objective lens and a Peltier cooled CCD detector in 
Singapore Bioimaging Consortium, Agency for Science, Technology and Research 
(A*STAR), Singapore. Samples were excited with a 785 nm excitation wavelength 
laser and Stokes shifted Raman spectra were collected in the range of 400 to 2000 
cm
−1
 with 1 cm
−1
 resolution. Prior to every measurement, a calibration with a silicon 
standard (Raman peak centered at 520 cm
−1
) was performed. WiRE 3.0 software 
package was used for data acquisition. 
 
5.5.1 Synthesis and characterization of 4 and CyNAB 
 Synthesis of 1a and 4b: 
In earlier Chapter 2, I have demonstrated the synthetic procedures and 
characterization of 1a and 1b. 
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Synthesis of 4b: 
Scheme 5.3. Synthesis of 4b. 
 
Reagents and conditions: 3-bromopropylamine hydrobromide, 110 

C, 10 h. 
 
3-bromopropylamine hydrobromide (2.7 g, 12.5 mmol, 1 eq.) was added in a 
seal tube containing 2, 3, 3-trimethyl-3H-indole (2.0 mL, 12.5 mmol, 1 eq.) under N2 
atmosphere, and was gently heated up to 110 

C in an oil bath. The mixture was kept 
at 120 

C for 10 h with stirring. After the reaction was completed, the mixture was 
cooled down to r.t. to form a solid cake that was washed with Et2O and a chloroform-
Et2O (1:1) solution. The resulting solid was then dried under high vacuum to obtain 
4b as a white solid (4.3 g, yield 85%).  
1
H-NMR (300 MHz, DMSO-d6):  1.55 (s, 6H), 2.16-2.21 (m, 2H), 2.50 (s, 3H), 3.05-
3.07 (m, 2H), 4.60 (t, 2H, J = 7.5 Hz), 7.61-8.08 (m, 4H).  
tR:  2.10 min, ESI-MS m/z (C14H22BrN2
+
) calc: 217.2, found: 217.1. 
Synthesis of 4: 
Scheme 5.3. Synthesis of 4. 
 
 




Under N2 atmosphere, 1b (1.0 g, 6 mmol, 1 eq.) and 4b (2.3 g, 6 mmol, 1 eq.) 
were dissolved in 50 mL of butanol-benzene (7:3) and refluxed for 2 h in 110 

C oil 
bath. The mixture was then cooled down to r.t. followed by addition of 1a (2.0 g, 6 
mmol, 1 eq.) in butanol-benzene (7:3), and then refluxed for another 12 h at 120 

C in 
a Dean-Stark condenser. The solvent was then evaporated and the resulting green 
solid mixture was washed with Et2O and purified by normal phase chromatography 
(elution with DCM-MeOH, 95:5) to obtain 4 as a green solid (3.0 g, yield 78%).  
1
H-NMR (500 MHz, CDCl3): 1.02 (t, 3H, J = 7.5 Hz), 1.67 (s, 6H), 1.69 (s, 6H), 
1.82-1.86 (m, 2H), 1.97 (t, 2H, J = 6.6 Hz), 2.37 (t, 2H, J = 7.2 Hz), 2.55 (m, 2H), 
2.99 (t, 2H, J = 7.2 Hz),  3.57 (t, 2H, J = 6.6 Hz), 3.92 (t, 2H, J = 6.6 Hz), 4.76 (t, 
2H, J = 6.6 Hz), 5.92 (d, 1H, J = 13.5 Hz), 6.62 (d, 1H, J = 14.4 Hz), 7.00-7.72 (m, 
8H), 7.33 (d, 1H, J = 13.5 Hz), 7.41 (d, 1H,  J = 14.4 Hz).  
tR: 5.37 min, ESI (HRMS) m/z (C36H46BrClN3
+
) calc: 554.3297, found: 554.3316. 
Synthesis of CyNAB: 
4 (2.5 g, 4.5 mmol, 1 eq.) was dissolved in CHCl3, DIEA (2.9 g, 22.5 mmol, 
5 eq.) and Boc2O (1.5 g, 6.8 mmol, 1.5 eq.) were added, and the reaction mixture was 
refluxed for 4 h. The mixture was washed with H2O (2 x 100 mL) and diluted HCl 
(0.1 mL) and the combined organic layers were evaporated and purified by normal 
phase chromatography (elution with DCM-MeOH, 95:5) to obtain to obtain CyNAB 
as a green solid (3.0 g, 91%).  
1
H-NMR (300 MHz, CDCl3): 1.06 (t, 3H, J = 7.2Hz), 1.43 (s, 9H), 1.70 (s, 
12H), 1.86-1.90 (m, 2H), 1.97 (t, 2H, J = 6.6 Hz), 2.66 (t, 2H, J = 7.2 Hz), 2.81 (t, 
2H, J = 6.5 Hz), (2.76 (t, 2H, J = 7.2 Hz), 3.38 (t, 2H, J = 6.6 Hz), 4.00 (t, 2H, J = 
6.5 Hz), 4.42 (t, 2H, J = 7.0 Hz), 6.01 (d, 1H, J = 13.5 Hz), 6.46 (d, 1H, J = 14.1 
Hz), 6.46-7.35 (m, 8 H), 8.23 (d, 1H, J = 13.0 Hz), 8.39 (d, 1H, J = 15.0 Hz).  
tR:  6.51 min, ESI (HRMS) m/z (C41H53ClN3O2
+
) calc: 654.3302, found: 654.3846. 
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5.5.2 Synthesis and characterization of CyNAMLA library 
Synthesis of lipoic acid nitrophenol resin: 
Aminomethyl nitrophenol polystyrene resin was prepared according to 
reported procedures.
1
 The nitrophenol resin (2 g, 2.9 mmol, 1 eq.) was swollen in 10 
mL of DMF, and lipoic acid (2 g, 10 mmol, 3.3 eq.), N,N'-diisopropylcarbodiimide 
(1.2 mL, 12 mmol, 4 eq.) and a catalytic amount of DMAP (20 mg) were added to the 
resin, which was continuously shaken for 24 h at r.t. Subsequently, the resin was 
washed with DCM (10 × 25 mL) and dried under vacuum until use. 
General procedure for the synthesis of the CyNAMLA library:  
For all 80 compounds, CyNAB (60 mg, 92 µmol, 1 eq.) and the primary 
amine building blocks (see Table 5.1) (368 µmol, 4 eq.) were dissolved in ACN, and 
DIEA (26.8 µL, 184 µmol, 2 eq.) was added. The reaction mixture was heated at 80 

C for 0.5 – 3 h, depending on the reactivity of the amine. The resulting blue color 
crude mixture was neutralized with 0.1 M HCl, and dried under vacuum. The crude 
then dissolved in DCM and treated with excess DIEA (268 µL, 1.84 mmol, 20 eq.) 
and acetyl chloride (460 µmol, 5 eq.) at 0 

C for 10 min. The final green mixture was 
washed with 0.1 M HCl to remove excess DIEA, concentrated under vacuum, and 
purified by normal phase chromatography (elution mixture: DCM-MeOH (ranging 
from 100:0 to 95:5). Subsequently, the compounds were treated with TFA-DCM (1:9) 
at r.t overnight, washed with an aqueous NaHCO3 and dried under vacuum. A 1mol 
aliquot of all 80 compounds were dissolved in 1 mL DCM: ACN (2:1) and treated 
with an excess of lipoic acid nitrophenol resin (30 mg, 10 mol, 10 eq.) overnight at 
r.t. The resulting mixtures were purified with short silica-based columns to render 80 





General procedure for the synthesis of CyNAMLA-80, 92, 221, 262, 381 and 478: 
For every compound, CyNAB (100 mg, 0.13 mmol) was mixed with the 
corresponding amine (Chart 5.1, 0.27 mmol, 2 eq.) and DIEA (38.6 L, 0.13 mmol, 1 
eq.) in ACN. The reaction mixtures were heated at 65 

C for 40-60 min, quenched 
with 0.1 N HCl, concentrated under vacuum, and purified by normal-phase 
chromatography (elution with DCM-MeOH, 95:5). The resulting intermediates were 
treated with TFA-DCM (1:9) overnight at r.t., followed by washings with NaHCO3 
and dried under vacuum. Finally, compounds were dissolved in DCM: ACN (2:1) and 
treated with an excess of lipoic acid nitrophenol resin overnight at r.t. The resulting 
mixtures were purified with short silica-based columns (elution with DCM-MeOH, 
93:7). 
Characterization of CyNAMLA-80, 92, 221, 262, 381 and 478 
CyNAMLA-80 (12 mg, yield 10%). 
1
H-NMR (500 MHz, CDCl3):  1.07 (t, 3H, J = 
7.0 Hz), 1.25 (s, 6H), 1.56 (s, 6H), 1.71-1.75 (m, 4H), 1.83-1.92 (m, 2H), 1.94 (s, 
3H),  2.05-2.08 (m, 2H), 2.44-2.49 (m, 3H), 2.61-2.64 (m, 4H), 3.08-3.11 (m, 4H), 
3.15 (t, 2H, J = 6.5 Hz), 3.45 (t, 2H, J = 5.0Hz), 3.57-3.61 (m, 2H), 3.85 (t, 2H, J = 
7.2 Hz),  4.51 (s, 2H), 4.59 (t, 2H, J = 6.2Hz), 5.26 (d, 1H, J= 13 Hz), 5.83 (d, 1H, J = 
13.5 Hz), 6.54 (d, 1H, J = 7.5 Hz), 6.67 (d, 1H, J = 7.0 Hz), 7.13-7.98 (m, 11H).  
tR: 6.48 min, ESI (HRMS) m/z (C53H65F2N4O2S2
+
), calc: 891.4512; found: 891.4525. 
CyNAMLA-221 (15 mg, yield 11%). 
1
H-NMR (500 MHz, CDCl3): 1.06 (t, 3H, J = 
7.0 Hz), 1.44 (s, 6H), 1.51 (s, 6H), 1.68-1.71 (m, 4H), 1.83-1.87 (m, 2H), 1.90 (s, 
3H),  2.05-2.08 (m, 2H), 2.42-2.49 (m, 3H), 2.66-2.71 (m, 4H), 3.08-3.13 (m, 4H), 
3.16 (t, 2H, J = 5.0Hz), 3.45 (t, 2H, J = 5.0Hz), 3.59-3.61 (m, 2H), 3.85 (t, 2H, J = 
7.5Hz),  4.51 (t, 2H, J = 6.2Hz), 4.56 (s, 2H), 4.91 (d, 1H, J = 14.0 Hz), 5.85 (d, 1H, J 
= 13.0 Hz), 6.62 (d, 1H, J = 7.5 Hz), 6.94 (d, 1H, J = 7.0 Hz), 7.13-7.71 (m, 12H).  
tR: 6.64 min, ESI (HRMS) m/z (C53H66ClN4O2S2
+
), calc: 889.4310; found: 889.4334. 
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CyNAMLA-262 (14 mg, yield 11%). 
1
H-NMR (500 MHz, CDCl3): 1.06 (t, 3H, J = 
7.0 Hz), 1.25 (s, 6H), 1.58 (s, 6H), 1.68-1.74 (m, 4H), 1.84-1.88 (m, 2H), 1.92 (s, 
3H),  1.99-2.04 (m, 2H), 2.39-2.47 (m, 3H), 2.56-2.59 (m, 4H), 3.07-3.12 (m, 4H), 
3.38 (t, 2H, J = 6.5 Hz), 3.47 (t, 2H, J = 5.0 Hz), 3.56-3.59 (m, 2H), 3.66 (s, 3H), 3.72 
(s, 3H), 3.85 (t, 2H, J = 7.2 Hz),  4.36 (s, 2H), 4.55 (t, 2H, J = 6.2 Hz), 5.86 (d, 1H, J 
= 13.0 Hz), 5.97 (d, 1H, J = 13.5 Hz), 6.44 (d, 1H, J = 7.5 Hz), 6.58 (d, 1H, J = 7.0 
Hz), 7.14-8.03 (m, 11H).  
tR: 6.45 min, ESI (HRMS) m/z (C55H71N4O4S2
+
), calc: 915.4911; found: 891.4901. 
CyNAMLA-381 (20 mg, yield 15%). 
1
H-NMR (500 MHz, CDCl3):  1.05 (t, 3H, J = 
7.5 Hz), 1.53 (s, 6H), 1.59 (s, 6H), 1.67-1.74 (m, 4H), 1.83-1.87 (m, 2H), 1.88 (s, 
3H),  2.02-2.08 (m, 2H), 2.39-2.46 (m, 3H), 2.69-2.71 (m, 4H), 3.06-3.11 (m, 4H), 
3.12 (t, 2H, J = 5.0 Hz), 3.46 (t, 2H, J = 5.0 Hz), 3.64 (s, 3H), 3.59-3.61 (m, 2H), 3.84 
(t, 2H, J = 7.5 Hz),  4.59 (t, 2H, J = 6.2Hz), 4.35 (s, 2H), 5.01 (d, 1H, J = 14.0 Hz), 
5.87 (d, 1H, J = 14.5 Hz), 6.69 (d, 1H, J = 9.0 Hz), 6.78 (d, 1H, J = 9.0 Hz), 7.13-
8.01 (m, 12H).  
tR: 6.50 min, ESI (HRMS) m/z (C54H69N4O3S2
+
), calc: 885.4806; found: 885.4796. 
CyNAMLA-478 (18 mg, yield 13%). 
1
H-NMR (500 MHz, CDCl3): 1.07 (t, 3H, J 
=7.5 Hz), 1.59 (s, 6H), 1.65 (s, 6H), 1.70-1.76 (m, 4H), 1.86-1.89 (m, 2H), 1.95 (s, 
3H),  2.1-2.13 (m, 2H), 2.24 (s, 3H), 2.42-2.45 (m, 3H), 2.50-2.54 (m, 4H), 2.70 (t, 
2H, J = 7.5 Hz), 3.08-3.11 (m, 4H), 3.11 (t, 2H, J = 6.5 Hz), 3.46 (t, 2H, J = 6.5 Hz), 
3.57-3.59 (m, 2H), 3.89 (t, 2H,  J = 7.5 Hz),  4.42 (t, 2H, J = 7.5 Hz), 4.57 (t, 2H, J = 
6.5 Hz), 5.89 (d, 1H, J = 13.5 Hz), 5.94 (d, 1H, J= 13.5 Hz), 6.42 (d, 1H, J = 14.0 
Hz), 6.66 (d, 1H, J = 15.0 Hz), 7.13-8.01 (m, 12H).  
tR: 6.74 min, ESI (HRMS) m/z (C55H71N4O2S2
+





5.5.3 Procedures for SERS measurements  
The spectral measurements were carried out in a Renishaw InVia Raman 
microscope (Renishaw, UK, model: HPNIR785) using an excitation wavelength of 
785 nm. In brief, the laser system is coupled to a Leica microscope so that the laser 
beam is directed to the sample through a 50× or 20× objective lens and a Peltier 
cooled CCD detector is used to collect the Raman signals. The WiRE 3.0 software 
package provided with the Raman system was employed for instrument control and 
data acquisition. Stokes shifted Raman spectra were collected in the range of 400 to 
2000 cm
−1
 with a resolution of about 1 cm
−1
. The maximum laser power at the sample 
was measured to be 60 mW and the exposure time was set at 10 s throughout the 
measurements. The shutter of the laser was immediately closed after each 
measurement to minimize any possible photodamage on the sample under a 
prolonged illumination. Baseline correction of the measured spectra was performed to 
remove the broad background and fluorescence band. Prior to each measurement, the 
instrument was calibrated with a silicon standard whose Raman peak is centered at 
520 cm
−1
. For the SERS measurements of CyNAMLA-gold colloid mixtures, 20 μM 
solutions of CyNAMLA compounds in de-ionized water were mixed with Au colloid 
(2.6 × 10
10
 particles/mL) in a 1:9 ratio (v/v). 20 μL of the reporter-Au colloid mixture 
solutions were placed on a clean glass slide with a cover slip and measured under the 
Raman microscope. The results are plotted as average intensities of 5 independent 
measurements from one single sample preparation. 
 
5.5.4 BSA encapsulation of CyNAMLA-AuNPs and stability studies 
 CyNAMLA compounds (20 μM solutions in deionized water) were mixed 
with Au colloid (2.6 × 10
10
 particles/mL) in a 1:9 ratio (v/v). After 10 min incubation, 
colloids were treated with BSA (0.5% in deionized water) mixed with 25% 
glutaraldehyde (15:1) and reacted at r.t. for 4 h followed by centrifugation (8000 rpm, 
5 min). Glutaraldehyde was used to form a cross-linked organic encapsulation layer 
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around the gold and stabilize the particles, preventing the distortion of the reporter 
molecules. In order to remove the excess of glutaraldehyde, pellets were resuspended 
in 10 mM glycine with 10 mM sodium citrate (pH = 7.8) at r.t. Finally, the 
encapsulated Au colloids were washed 3 times by centrifugation (8000 rpm, 5 min), 
resuspended in 1 mM sodium citrate, and stored at 4 
o
C. For bioconjugation and long 
time storage we resuspended the encapsulated gold colloid in PBS. 
 The SERS signals of BSA-encapsulated nanotags that were derivatized with 
CyNAMLA-80, CyNAMLA-92, CyNAMLA-221, CyNAMLA-262, CyNAMLA-
381, CyNAMLA-478 and DTTC were measured for one month. SERS spectra were 
obtained upon excitation with a 785 nm laser (60 mW power), and the SERS 
intensities of the highest Raman peaks (i.e. 523 cm
-1
 for CyNAMLA compounds and 
495 cm
-1
 for DTTC), are plotted as means ± standard deviation of 5 independent 
measurements taken from the same sample at different time points. 
5.5.5 Procedures for Antibody conjugation and TEM characterization  
Antibody conjugation: 
The carboxylic acids groups of BSA were activated with N-(3-
(dimethylamino)-propyl)-N’-ethylcarbodiimide (EDC) (125 nmol) and N-
hydroxysuccinimide (NHS) (125 nmol). After 30 min incubation, excess of EDC and 
NHS was removed by 3 rounds of centrifugation (8000 rpm, 10 min), and 
resuspended in PBS using Amicon Ultra 3K centrifuge microcons (Milipore). The 
activated particles were then reacted with mouse monoclonal anti-HER2 or scFv anti-
HER2 at 25
 C for 2 h and then overnight at 4 C. Non-specific binding chemicals 
and antibodies were removed by centrifugation (8000 rpm, 10 min) and the final 





TEM images were taken in a Jeol JEM-1010 Transmission Electron 
Microscope. Acceleration voltage was 40 ~ 100KV and stability was 2 ppm min
-1
. 
The magnification range of the instrument covers from 50 to 600,000× with a 
resolution of 0.3000 nm. Images of these BSA encapsulated nanotags were taken at a 
250,000× magnification.  
5.5.6 SERS experiments in cells 
Human cancer cell lines (MDA-MB231 and SKBR-3) were grown in RPMI 
1640 medium supplemented with 10% (v/v) fetal bovine serum (FBS) and antibiotics 
(100 U mL
-1
 penicillin/100 g mL-1 streptomycin mixture) at 37 C in a humidified 
atmosphere with 5% CO2. HER2 positive (SKBR-3) and negative (MDA-MB231) 
cells were grown as indicated above in 12-well plates, incubated with scFv-
conjugated SERS nanotags (450 pM) in the absence or presence of pre-incubated free 
scFv anti-HER2 (10-fold excess, aprox. 4 nM) for 1 h at 37 

C, washed with cold 
PBS (× 3), gently scrapped and resuspended in PBS to a cell density of 1 × 10
6
 
cells/mL for SERS measurements.  
5.5.7 SERS mapping in SKBR-3 and MDA-MB231 cells 
SERS mapping experiments were performed in a Renishaw InVia Raman 
microscope system with a laser beam directed to the sample through a 20× objective 
lens, and a Peltier cooled CCD detector. Cells were plated in a 8-well glass slide at a 
density of 10
6
 cells/mL, and after incubation with antibody-conjugated 
CyNAMLA381-nanotags (450 pM) for 4 h at 25 C rinsed with PBS (×3) and media 
(×2, 15 min incubation per wash). Samples were excited with a 785 nm excitation 
wavelength with a laser focal spot of 2 m and 30 mW power and mapping 
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measurements at 523 cm
-1
 were carried out as raster scans in 2 m steps over the 
specified area (aprox. 30 x 30 m2) with 1 s as the integration time per step. 
5.5.8 Dark-field microscopy experiments 
Approximately 50,000 cells (SKBR-3 or MDA-MB231) were plated in a 8-
well chamber slide (Lab-Tek II, Nunc, USA) and incubated overnight at 37 C, 5% 
CO2. After 24 h, the medium was removed and scFv-conjugated SERS nanotags (450 
pM) in serum-free medium were added to the cells. The cells were incubated for 1 h 
at 37 C, and fixed with 4% paraformaldehyde for 15 min. The cells were then rinsed 
twice with PBS, and subsequently mounted with Vectasheild fluorescent mounting 
medium. Cells were visualized using an enhanced dark field (EDF) illumination 
system (CytoViva) attached to a Nikon Eclipse 80i microscope. The system consisted 
of a CytoViva 150 dark-field condenser that was in place of the original condenser of 
the microscope and attached via a fiber optic light guide to a Solarc 24 W metal 
halide light source. Images were taken under a 60× oil objective lens with an iris. A 
drop of the NP-reacted cell suspension was added to poly-L-lysine-coated microscope 
slides, and samples were viewed as wet mounts, using type A immersion oil. 
5.5.9 SERS experiments in xenograft mice 
Balb/c nude mice from the Biological Resource Centre (Biomedical Sciences 
Institute) were anesthetized by intraperitoneal injection of ketamine (150 
mg/kg)/xylazine (10 mg/kg) at the age of 4-6 weeks, and SKBR-3 or MDA-MB231 
cells were injected subcutaneously into the rear flank (5 x 10
6
 cells per site in a 
volume of 150L). When the tumors grew to a size around 0.2 cm in diameter, scFv-
conjugated SERS nanotags (450 pM, 100 L) were injected into the tail vein of the 
mice. After 5 h, mice were anesthetized by intraperitoneal injection of ketamine and 
xylazine mixture solution and in vivo SERS measurements were performed using a 
Renishaw InVia Raman microscope with 785 nm laser excitation and 60 mW laser 
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power. The integration time was set as 30 s and the laser was coupled to the sample 
through a 20× objective lens with a beam spot of aprox. 2 m. The animal experiment 
procedures were performed in accordance with a protocol approved by the 
Institutional Animal Care and Use Committee (IACUC). 
5.5.10 SERS mapping experiments in xenograft mice 
SERS mapping experiments were performed in a Renishaw InVia Raman 
microscope system with a laser beam directed to the sample through 20× objective 
lens and a Peltier cooled CCD detector in SKBR-3 xenograft mice prepared as above 
mentioned. Specified skin areas (aprox. 30 x 30 m2) were excited with a 785 nm 
excitation wavelength with a laser focal spot of 2 m and 30 mW power, and 
mapping measurements at 523 cm
-1
 were carried out as raster scans in 2 m steps 
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MULTIPLEX CANCER CELL DETECTION BY SERS NANOTAGS WITH 











In the last few years SERS spectroscopy has captured attention as a 
promising analytical tool due to the capacity to provide molecular information with 
high sensitivity. SERS employs Raman active signature molecules and noble metal 
nanoparticles (e.g AuNPs or AgNPs).
1–4
 Generally, higher sensitivity can be achieved 
through an additional resonance enhancement, termed surface-enhanced resonant 
Raman scattering (SERRS) when the excitation occurs in resonance with electronic 
transitions in the signature molecules. The basic requirements for SERRS are that 
Raman active dyes must be adsorbed onto a roughened noble metal surface to provide 
the surface enhancement of the scattered light and also must absorb light in a suitable 
wavelength, in resonance with the applied excitation frequency of the light. As a 
result, sharp distinguishable fingerprints (e.g. vibrational spectrum of signature 
molecules) with enhanced signal intensities, narrow band widths and multiplexing 
properties can be detected.
5,6
 To date, single imaging agents (e.g fluorescent probes) 
are unlikely to provide enough information to accurately monitor a specific disease 
process. While challenging, the simultaneous detection of multiple targets may 
facilitate the development of more precise diagnostic tools. The multiplexing 
potential of SERS nanotags relies on the narrow spectrum band widths of the 
vibrational Raman spectra of the reporter molecules, and allows the simultaneous 
recognition of closely related targets. Although the concurrent detection of defined 
multiple targets can facilitate the development of accurate diagnostic probes, the 
identification of multiplex reporter pairs that are compatible under the same 
experimental conditions is difficult. Our group recently reported the excellent 
properties of triphenylmethines as Raman signature molecules,
7
 and demonstrated the 
improved stability of their SERS signal upon chemisorption on AuNPs using a lipoic 
acid (LA) linker. A triphenylmethine derivative (B2LA, Figure 6.3) was identified as 





 In order to study the multiplexing capabilities of B2LA SERS nanotags, we 
(Dr. Kaustabh Kumar Maiti and I) evaluated their compatibility with different 
Raman-active chemical compounds. As I discussed on the ultrasensitive NIR Raman 
reporters based on the cyanine structure (CyNAMLA) in Chapter 5, we (Dr. 
Kaustabh Kumar Maiti and I) aimed at finding multiplex partners of the B2LA 
Raman reporter. The main discrepancy between triphenylphosphine and NIR cyanine 
derivatives is their difference in the optimum laser source. Triphenylphosphine 
derivatives are highly active under the 633 nm laser, whereas NIR cyanine reporters 
are highly active under the 785 nm laser. 
6.2 Objectives 
Herein SERS nanotags have been prepared to accomplish the multiplex 
detection of different cancer cell lines. I evaluated the adequacy of lipoic acid-
containing cyanine derivatives (Cy3LA and Cy5LA) to function as multiplex 
partners with a triphenylmethine Raman reporter (B2LA) under a single excitation 
wavelength (e.g. 633 nm laser). B2LA and cyanine SERS nanotags have been then 
applied for the detection of different cancer cells using different antibodies. 
Specifically, the multiplex antibody-conjugated SERS nanotags (e.g. anti-EGFR and 
anti-HER2) that recognize different types of cancer cells (i.e. OSCC and SKBR-3 
respectively) have been applied to detect both cell lines using a single excitation 
wavelength. A few multiplex peaks have been identified from both pairs 
Cy3LA/B2LA and Cy5LA/B2LA. 
6.3 Result and Discussion 
6.3.1 Design and Synthesis 
I focused on the synthesis of cyanine dyes which are well-known dyes with 
absorption properties in the red/far-red region of the visible range.
9–12
 It is obvious 
that positively charged Raman reporters are attracted to the surface of the negatively 
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charged citrate buffered nanoparticles. Therefore we demonstrated the synthesis of 
Cy3LA and Cy5LA SERS nanotags based on positive charge species. A range of 
positively charged species have been investigated including Cy3LA, Cy5LA, and 
B2LA motifs to examine their multiplex capabilities.  
To adapt Cy3 and Cy5 structures to chemisorption, I designed the synthesis 
of lipoic acid linker (Cy3LA and Cy5LA, respectively) so that they could be attached 
on AuNPs using thiol-based chemistry (Scheme 6.1). Starting from 2,3,3-
trimethylindoline, I prepared the intermediates 1a and 4b using reported 
procedures.
14-16
 Afterwards, 1a was condensed to the commercially available bis-
phenylimines X and Y in acidic conditions, followed by the subsequent addition of 5, 
the Boc-protected derivative of 4b. As a result, the Boc-derivatives of Cy3 and Cy5 
(6 and 7, respectively) were obtained with overall yields slightly over 50%. 
Deprotection of 6 and 7 with an optimized TFA-DCM (1:9) solution afforded the 
corresponding free amine compounds, which were treated with a lipoic acid-
containing activated ester resin
17












Scheme 6.1. Synthesis of lipoic acid cyanine derivatives. 
 
Reagents and conditions: (a) 1-iodopropane, CH3CN, 80 C, 15 h; (b) 3-
bromopropylamine hydrobromide, 120 C, 10 h; (c) di-tert-butyl dicarbonate, DIEA, 
CHCl3, reflux, 4 h; (d) AcOH, acetic anhydride, pyridine, 110 C; (e) TFA-DCM 
(1:9), r.t., 16 h; (f) lipoic acid activated ester resin, CH2Cl2, r.t., 16 h. 
 
6.3.2 Preparation of SERS nanotags and encapsulation 
We (Dr. Kaustabh Kumar Maiti and I) employed AuNPs as a roughened 
noble metal surface due to their low toxicity and adaptability to bioconjugation. 
Cy3LA, Cy5LA and B2LA were used as Raman reporters which proved to be 
suitable for SERRS due to their maximum absorbance wavelengths around 500-600 
nm. Notably, their surface plasmon absorbance spectra remained similar (i.e. maxima 





Figure 6.1.  Surface plasmon absorption spectra of Au-colloids and B2LA, Cy3LA 
and Cy5LA-nanotags. 
 
The chemisorption of Raman reporters is a critical step to ensure the stability 
and reproducibility of SERS nanotags over time.
8-13
 To date different research groups 
have developed different methods to stabilize the SERS signal intensity. I described 
the BSA encapsulation in Chapter 5 to stabilize the SERS signal intensity. I followed 
different strategy which was described by Qian et al. in which AuNPs are stabilized 
by encapsulation with polyethyleneglycol (PEG) due to the formation of a protective 
layer on the gold colloid (Scheme 6.2).  
 
Scheme 6.2. Synthesis of stable SERS nanotags encapsulated with PEG-SH and 
conjugated to antibodies. 
 
 
Nanotags derivatized with B2LA and Cy3LA were encapsulated with a 
mixture of thiol polyethyleneglycol (PEG-SH) and carboxylic acid-containing PEG-
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SH that allowed the covalent linkage to the free amine groups of antibodies.
3
 
Furthermore, we (I and Dr. Kaustabh Kumar Maiti) confirmed that the SERS signal 
intensities of both nanotags were stable for several days (Figure 6.2). 
 
Figure 6.2. Evaluation of the stability of the SERS signals for B2LA anti-EGFR and 
Cy3LA anti-HER2 nanotags. Values are represented as means ± SD (n=3). 
 
6.3.3 Measurement of SERS 
 After chemisorbing B2LA, Cy3LA and Cy5LA on AuNPs, we (I and Dr. 
Kaustabh Kumar Maiti) analyzed their SERS spectra under the 633 nm laser and 
evaluated their multiplexing compatibility. Notably, a number of peaks could be used 
to uniquely identify the three different nanotags: 1617, 1374, 1366, 918 and 440 cm
-1
 
for B2LA-AuNPs, 1589, 1383 and 613 cm
-1
 for Cy3LA-AuNPs and 1596, 1501, 
1404 and 1353 cm
-1
 for Cy5LA-AuNPs (Figure 6.3). Whereas the discrimination 
between Cy3LA and Cy5LA-derivatized nanotags may require further optimization, 
it was apparent that the combination of triphenylmethine and cyanine Raman 
reporters could be used as a basis for the construction of multiplex SERS nanotags, 
and we (Dr. Kaustabh Kumar Maiti and I) explored their application for the detection 





Figure 6.3. Normalized SERS spectra of B2LA, Cy3LA and Cy5LA after 
chemisorption on AuNPs. Spectra were measured in a Raman microscope (633 nm 
laser excitation, 6.2 mW laser power, acquisition time: 10s) and plotted as average 
intensities (n=3). The most distinctive peaks from every reporter are highlighted in 
yellow.  
 
6.3.4 Antibody conjugation and Characterization 
After encapsulation, we (Dr. Kaustabh Kumar Maiti and I) conjugated 
monoclonal antibodies against two different epidermal growth factor receptors 
(EGFR (Erb-B1) and HER2 (Erb-B2)) to render B2LA anti-EGFR and Cy3LA anti-
HER2 nanotags. EGFR is over-expressed in diverse cancer cells (e.g. OSCC), and 
HER2 is a well-known breast cancer marker with a high expression in SKBR-3 
cells.
18
 The antibody conjugation was verified by the appearance of protein 
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absorption peaks at 280 nm, and the size of the fully functionalized nanotags was 
determined by transmission electron microscopy (TEM) (Figure 6.4).  
 
Figure 6.4. Transmission Electron Microscopy (TEM) images of nanotags 
derivatized with: (a) B2LA, (b) Cy3LA 
 
6.3.5 Cell SERS studies 
In order to examine the multiplex differential recognition of B2LA anti-
EGFR and Cy3LA anti-HER2 nanotags in cells, we (Dr. Kaustabh Kumar Maiti and 
I) incubated an equal amount of both nanotags in OSCC cells (EGFR-positive and 
HER2-negative) and SKBR-3 cells (HER2-positive and EGFR-negative). After 
washings with PBS, the SERS measurement in OSCC cells fully resembled the SERS 
spectra of B2LA (Figure 6.5a) whereas the SERS signal of SKBR-3 cells coincided 
with the spectra of Cy3LA (Figure 6.5b). Moreover, as negative controls, we did not 
observe significant SERS signals in OSCC or SKBR-3 cells after incubation with 




Figure 6.5. (a) SERS spectra of OSCC cells after incubation with antibody-free 
B2LA-nanotags (left) or anti-EGFR B2LA-nanotags (right); (b) SERS spectra of 
SKBR-3 cells after incubation with antibody-free Cy3LA-nanotags (left) or anti-





Figure 6.6. Multiplex SERS spectra upon incubation of both B2LA anti-EGFR and 
Cy3LA anti-HER2 nanotags with: (a) OSCC cells, (b) SKBR-3 cells, (c) co-cultured 
cells. Spectra were measured with a Raman microscope (633 nm excitation 
wavelength, 6.2 mW laser power, acquisition time: 10s) and plotted as average 
intensities (n=3). 
 
Altogether, these results clearly indicated that: 1) B2LA anti-EGFR and 
Cy3LA anti-HER2 nanotags specifically recognized OSCC and SKBR-3 cells with 
non-overlapping SERS peaks, 2) the SERS signals derived from any possible non-
specific binding of the two nanotags were negligible. Finally, we demonstrated that 
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B2LA and Cy3LA-nanotags could be used as a multiplex platform by recognizing 
both OSCC and SKBR-3 cells after they were co-cultured in the same wells. Upon 
incubation with an equal proportion of both B2LA and Cy3LA-nanotags, the SERS 
signals of the co-cultured cells showed clearly separable peaks from the two reporter 
molecules: 1615, 1363, 917 and 437 cm
-1
 for B2LA anti-EGFR, and 1585, 1465, 
1380, 1268, 1118, 931, 612 and 556 cm
-1
 for Cy3LA- anti-HER2 (Figure 6.6). With 
this data, we (Dr. Kaustabh Kumar Maiti and I) attested that B2LA and Cy3LA are 
fully compatible Raman reporters for the preparation of multiplex SERS nanotags.  
 
6.3.6 Cell SERS mapping  
To confirm the recognition properties of B2LA anti-EGFR and Cy3LA anti-
HER2 nanotags and analyze their localization in OSCC and SKBR-3 cells, we 
performed SERS mapping experiments in both cell lines.  
 
 
Figure 6.7. Bright field and SERS mapping images of: (a) B2LA anti-EGFR 
nanotag-treated OSCC cells (1615 cm
-1
), (b) Cy3LA anti-HER2 nanotag-treated 
SKBR-3 cells (1468 cm
-1
). All mapping images (size: 30 × 30 m2) were scanned at 
an interval of 2 m (633 nm excitation wavelength).  
As shown in Figure 6.7, images of nanotag-treated OSCC cells and SKBR-3 





 respectively) in the cell surface region. Non-treated OSCC and SKBR-
3 cells showed negligible SERS signals at both frequencies (Figure 6.8). These 
mapping pictures confirmed that the interaction between B2LA anti-EGFR and 
Cy3LA anti-HER2 nanotags and their respective receptors was mainly localized at 
the cell surface, which corresponds well with the high expression of EGFR and HER2 





Figure 6.8. Bright field and SERS mapping images of: (a) non-treated OSCC cells 
(1615 cm
-1
), (b) non-treated SKBR-3 cells (1468 cm
-1
). All mapping images (size: 30 
× 30 m2) were scanned at an interval of 2 m (633 nm excitation wavelength) and 
the intensities were normalized between the lowest (0) and the highest color (1). 
 
6.4 Conclusions 
In summary, I developed a novel multiplex SERS platform for cancer cell 
detection based on the combination of triphenylmethine and cyanine Raman 
reporters. The SERS compatibility under a single excitation wavelength between a 
selected triphenylmethine and different lipoic acid-containing cyanine reporters was 
examined. Nanotags derivatized with a selected pair (B2LA and Cy3LA) were 
 150 
 
derivatized with anti-EGFR and anti-HER2 antibodies, and proved to specifically 
recognize the respective cancer cells (e.g. OSCC and SKBR-3) with non-overlapping 
SERS peaks. After confirming the performance of these nanotags in co-culture 
conditions and determining their localization by SERS mapping experiments, we (Dr. 
Kaustabh Kumar Maiti and I) demonstrated that B2LA and Cy3LA are fully 
compatible Raman reporters for the preparation of multiplex SERS nanotags and can 























6.5 Experimental details 
Materials and Methods: As described earlier Chapter 2 and 5. 
6.5.1 Synthesis and characterization of Cy3LA and Cy5LA 
Intermediate 1a, 4b have been synthesized according previously described in Chapter 
2 and Chapter 5. 
Synthesis of 5: 
4b (0.38 g, 1 mmol, 1 eq.) and di-tert-butyl dicarbonate (0.55 g, 2.5 mmol, 
2.5 eq.) were added to a mixture of dry CHC13 (30 mL) and DIEA (0.88 mL, 5 mmol, 
5 eq.). The reaction mixture was gently heated to reflux temperature and stirred for 4 
h. After that, the organic layer was extracted with Et2O, dried over anhydrous 
Na2SO4, and concentrated under reduced pressure. Purification of the crude residue 
on a silica gel column (elution with CH2C12-MeOH 50:l) rendered 5 as a light brown 
liquid (1.26 g, yield 60%).  
1
H-NMR (300 MHz, CDCl3): 1.33 (s, 9H), 1.44 (s, 6H), 1.84-1.87 (m, 2H), 2.27(s, 
3H), 3.42 (t, 2H, J = 6.5 Hz), 3.55 (t, 2H, J = 7.0 Hz), 6.52-7.12 (m, 4H). tR: 5.21 
min, ESI-MS m/z (C19H29N2O2
+
) calc: 317.2, found: 317.1. 
Synthesis of 6: 
N,N-diphenylformamidin hydrochloride X, (0.39 g, 2 mmol, 1 eq.) was 
condensed with 1a (0.66 g, 2 mmol, 1 eq.) in a solution of ACOH:Ac2O (1:1) at 110 
C for 20 min, and cooled down to r.t. Then 5 (1.2 g, 3 mmol, 1.5 eq.) and pyridine 
were added to the mixture and stirred under reflux. After 1 h, the reaction mixture 
was poured into water and NaHCO3 was slowly added with stirring until complete 
neutralization was reached. After diluting with CH2Cl2 the organic layer was washed, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification 
of the crude residue on a silica gel column (elution with CH2C12-MeOH 50:2) 
rendered 6 as a blue solid (0.57 g, yield 50%).  
ESI-MS m/z (C33H44N3O2
+
) calc: 528.35, found: 528.2. 
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Synthesis of 7: 
Malonaldehyde bis(phenylimine) hydrochloride Y, (0.52 g, 2 mmol, 1 eq.) 
was condensed with 1a (0.66 g, 2 mmol, 1 eq.) in a solution of ACOH:Ac2O (1:1) at 
110 C for 20 min, and cooled down to r.t. Then 5 (1.2 g, 3 mmol, 1.5 eq.) and 
pyridine were added to the mixture and stirred under reflux. After 1 h, the reaction 
mixture was poured into water and NaHCO3 was slowly added with stirring until 
complete neutralization was reached. After diluting with CH2Cl2 the organic layer 
was washed, dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification of the crude residue on a silica gel column (elution with CH2C12-MeOH 
50:2) rendered 7 as a blue solid (0.66 g, yield 54%).  
ESI-MS m/z (C36H48N3O2
+
) calc: 554.4, found: 554.2. 
Synthesis of Cy3LA and Cy5LA: 
For the preparation of Cy3LA, 6 (0.10 g, 0.19 mmol) was treated with a 
solution of TFA-DCM (1:9) at r.t. overnight, washed with a solution of NaHCO3, and 
the organic layer was dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. The resulting solid was dissolved in a solution of CH2Cl2-CH3CN (9:1), 
added to the lipoic acid nitrophenol resin and shaken for 16 h at r.t. After the reaction, 
the resulting filtrates were combined and dried under pressure to render Cy3LA as a 
blue solid (92 mg, yield 85%). The same procedure was used starting from 7 to obtain 
Cy5LA (95 mg, yield 78%). 
Cy3LA: 
1
H-NMR (500 MHz, CDCl3): 1.08 (t, 3H, J = 7.0 Hz), 1.69-1.72 (m, 4H), 
1.84 (s, 6H), 1.85 (s, 6H), 1.87-1.91 (m, 4H), 2.40-2.44 (m, 2H), 3.08-3.10 (m, 2H), 
3.14-3.17 (m, 2H), 3.48-3.52 (m, 2H), 3.58-3.62 (m, 2H), 4.17 (t, 2H, J = 7.5 Hz), 
4.25 (t, 2H, J = 7.5 Hz), 5.29 (s, 3H), 7.06-8.42 (m, 8H), 8.39 (bs, 1H).   
13
C-NMR (126 MHz, CDCl3): 11.25, 20.97, 25.59, 26.45, 28.08, 28.12 (2C), 
28.87(2C), 29.62, 30.85, 34.58, 35.83, 36.45, 40.08, 42.91, 45.89, 53.34, 56.53, 
104.43, 110.98, 121.92, 121.99, 125.14, 125.26, 128.75, 128.96, 140.49, 140.55, 
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141.77, 150.89, 173.62, 173.80, 174.43. tR:  3.98 min, ESI-HRMS m/z (C37H50N3O 
S2
+
) calc: 616.3390, found: 616.3388 
Cy5LA:  
1
H-NMR (500 MHz, CDCl3): 1.09 (t, 3H, J = 7.0 Hz), 1.59-1.62 (m, 4H), 
1.69 (s, 6H), 1.72 (s, 6H), 1.84-1.95 (m, 4H), 2.45-2.49 (m, 3H), 3.08-3.10 (m, 2H), 
3.14-3.17 (m, 2H), 3.48-3.52 (m, 2H), 3.58-3.62 (m, 2H), 3.94 (t, 2H, J = 7.5 Hz), 
4.40 (t, 2H, J = 7.5 Hz), 6.17 (d, 2H, J = 7.2 Hz), 6.98 (d, 1H, J = 8.0 Hz),  7.06-8.42 
(m, 8H), 8.61 (bs, 1H).   
13
C-NMR (126 MHz, CDCl3): 11.43, 20.69, 25.67, 26.78, 28.04, 28.28, 28.89(2C), 
28.92 (2C), 30.37, 34.63, 36.12, 36.59, 38.40, 38.76, 43.58, 45.49, 48.83, 49.40, 
56.62, 102.74, 106.02, 110.11, 111.44, 122.02, 122.94, 124.55, 125.59, 127.84, 
128.97, 140.67, 141.61, 141.82, 142.43, 151.90, 153.85, 171.22, 173.68, 174.47. tR:  
4.07 min, ESI-HRMS m/z (C39H52N3O S2
+
) calc: 642.3546, found: 642.3555. 
6.5.2 Nanotags labeling and antibody conjugation 
The reporter molecules (B2LA and Cy3LA, 10 µM) were incubated with 
citrate-stabilized Au-colloid for 10 min before the heterofunctional linker HS-PEG-
CO2H (10 µM) was added to both solutions (volume: 2.6 mL). After shaking for 15 
min, the Au-colloid was exposed to excess PEG-SH (1.8 mL, 10 µM) to maximize 
the surface coverage and stabilize the PEG and the chemisorbed reporter molecule. 
After 4 h, free PEG-SH was removed incubation by 3 rounds of centrifugation (4000 
rpm, 15 min), and the colloid was re-suspended in PBS for bioconjugation. The 
carboxylic acids groups were activated with N-(3-(dimethylamino)-propyl)-N’-
ethylcarbodiimide (EDC) (125 nmol) and N-hydroxysuccinimide (NHS) (125 nmol). 
After 30 min incubation, excess of EDC and NHS was removed by 3 rounds of 
centrifugation (8000 rpm, 10 min), and re-suspended in PBS using Amicon Ultra 3K 
centrifuge filters (Milipore). The activated particles were then reacted with two 
different antibodies at 25 C for 2 h and then overnight at 4 C: for B2LA nanotags, a 
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mouse monoclonal anti-EGFR IgG2a (12 nM); for Cy3LA nanotags, a mouse 
monoclonal anti-HER2. Further non-specific binding chemicals and antibodies were 
removed by centrifugation (8000 rpm, 10 min) and the final nanotags were re-
suspended in PBS and stored at 4
 C.  
 
6.5.3 Thiolated PEG encapsulation 
Freshly prepared reporter solutions at different concentrations (e.g. 5 to 30 
µM) were mixed with Au colloid in a 1:9 ratio (v/v) to optimize the reporter 
concentration. Maximum SERS intensities and minimum colloidal aggregation were 
obtained at 10 µM concentration of reporter. After 10 min incubation, a 100 μM 
solution of thiolated PEG (PEG-SH, M.W, PEG: 5 kDa) was added in 10 to 20-fold 
excess and incubated overnight incubation. Excess of PEG-SH was removed by 3 
rounds of centrifugation (5000 rpm for 6 min) and re-suspension in water. 
 
6.5.4 SERS measurements of B2LA, Cy3LA and Cy5LA-gold colloid  
20 μM solutions of B2LA, Cy3LA and Cy5LA in deionized water were 
mixed with Au colloid (2.6 × 10
10
 particles/mL) in a 1:9 ratio (v/v). 20 μL of the 
reporter-Au colloid mixture solutions were placed on a glass slide with cover slip, and 
their Raman spectra (range: 400 to 2000 cm
−1
, resolution: 1 cm
−1
, acquisition time: 10 
s) were measured in a Renishaw InVia Raman microscope under excitation with a 
633 nm excitation wavelength laser (6.2 mW power). The results are plotted as 








6.5.5 Measurement of SERS spectra and SERS mapping in OSCC, SKBR-3 cells 
and co-cultured cells 
Cell culture: 
OSCC and SKBR-3 cells were grown in RPMI1640 medium supplemented with 10% 
(v/v) fetal bovine serum (FBS) and antibiotics (100 U mL
-1
 penicillin/100 g mL-1 
streptomycin) in a humidified atmosphere at 37 C with 5% (v/v) CO2. 
Approximately 5 × 10
5
 cells per well were seeded on 12-well culture plates the day 
before SERS measurements. 
Measurement of SERS spectra: 
OSCC, SKBR-3 and co-cultures cells were grown as mentioned above in 12-
well culture plates. For co-culture experiments, an equal amount (aprox. 5×10
5
 cells) 
of OSCC and SKBR-3 cells were plated in the same well 24 h before the 
measurements. Antibody-conjugated B2LA and Cy3LA-nanotags (450 pM) were 
incubated with OSCC, SKBR-3 or co-cultured cells for 1 h at 25 C. Afterwards, the 
cells were washed with cold PBS (×3), gently scrapped and re-suspended in PBS 
(every well of a 12 well-plate containing approximately 5×10
5
 cells was re-suspended 
in 100 L PBS). Raman experiments were performed in a Renishaw InVia Raman 
microscope with a laser beam directed to the sample through 20× objective lens and a 
Peltier cooled CCD detector. Samples were excited with a 633 nm excitation 





 resolution. Acquisition time for all spectra was 10 s.  
 
SERS mapping Experiments: 
For SERS mapping experiments, cells were plated in a 8-well glass slide at a 
density of 10
6
 cells/mL, and after incubation with antibody-conjugated B2LA and 
Cy3LA-nanotags (450 pM) for 1 h at 25 C, cells were rinsed with cold PBS (×3) and 
subsequently placed on a cover slip with mounting media. Raman experiments were 
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performed in a Renishaw InVia Raman microscope with a laser beam directed to the 
sample through 20× objective lens and a Peltier cooled CCD detector. Samples were 
excited with a 633 nm excitation wavelength and a laser power of 6.2 mW, and 
measurements were carried out as raster scans in 2 m steps over OSCC and SKBR-3 
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MULTIPLEX TARGETED IN VIVO CANCER DETECTION USING 













SERS offers high spectral sensitivity as well as a multiplexing capability that 
makes it a promising tool for many bio-analytical applications. The multiplexing 
capability of SERS nanotags exists due to narrow bandwidths of the Raman spectra of 
the reporter molecules and provides the opportunity for the simultaneous recognition 
of closely related targets.
1-3
 The recent high demand for a sensitive and simultaneous 
detection of multiple targets in vivo has led the researchers to use nanoaparticle (NPs) 
based on SERS technique.
4-10
 In most cases, such sensing modality is realized by 
anchoring strong Raman active molecule (reporter molecule, RM) on to the surface of 
metal NPs, which can be further conjugated with molecular recognition motifs to 
render specific targeting.
11-20
 Such nanoprobes are termed as SERS nanotags and its 
sensitivity inherently depends on the Raman reporter molecules. SERS nanotags have 
shown significant advantages over conventional fluorescence-based NPs such as 
quantum dots. 
12, 21-22
 Quantum dots have shown great potential as ex vivo multiplex 
imaging probes but they possess several limitations such as i) limited availability at 
NIR region,
1,22 
ii) stability and photobleaching
22,23





 The use of gold NPs (AuNP) in SERS nanotags provides the 
advantage of low toxicity among others.  
Previously, highly Raman active molecules such as crystal violet (CV) and 
malachite green isothiocyanate (MGITC), rhodamine-6G, Nile blue, 2-
napthalenethiol, TRITC (tetramethylrhodamine-5-isothiocyanate) and polymethine 
cyanine core molecules such as Cy3, Cy5 and DTTC (3,3
’
-diethyl-
thiatricarbocyanine) have been used as reporters for the development of SERS 
nanotags.
12,25-28
  However, one of the limitations of the SERS nanotags for in vivo 
applications is the limited availability of sensitive reporter molecules, that are 
strongly active at NIR regions. To address this problem, previously in Chapter 5 I 
demonstrated that CyNAMLA-381 among 80-member tricarbocyanine library 
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showed a 12-fold higher sensitive compared to the standard DTTC.
29
 SERS-nanotags 
constructed with CyNAMLA-381 have been successfully demonstrated for 
ultrasensitive detection of tumors in vivo.
  
One of the key advantages of SERS is its multiplexing potential, which is yet 
to be fully explored mainly due to the limited number of available ultrasensitive RMs. 
In vitro multiplexing in cell lines using SERS nanotags constructed with commercial 
RMs has been also recently studied.
30
 Based on this approach, I also proved in 
Chapter 6 that the polymethine cyanine dyes (Cy3LA, Cy5LA) can be a multiplex 
partner to the triphenylmethine core (B2LA). In addition, the applicability of 
polymethine cyanine dyes as a multiplex partner in cancerous cells clearly indicates 
the potential to identify the various tumors in vivo. 
 
7.2 Objectives 
 In this chapter, I synthesized a highly Raman active NIR Raman reporter-set 
(Cy7LA and Cy7.5LA) as a Raman multiplex partner compatible with CyNAMLA-
381 which was selected as a most sensitive RMs in Chapter 5. For the demonstration 
of the in vivo multiplexing capability, we (Dr. Kaustabh Kumar Maiti, Dr. U.S. 
Dinish and I) injected an equal amount of bio conjugated nanotags (CyNAMLA-381, 
Cy7LA and Cy7.5LA) through the tail vein of a mouse bearing tumor xenograft for 
the demonstration of targeted multiplex sensing of cancer in mouse model. Moreover, 
we also reported the kinetic of the SERS probes over several days, demonstrating the 
possibility of in vivo pharmacokinetic study. 
7.3 Results and Discussion 
7.3.1 Design and synthesis of NIR Raman reporters  
I applied a lipoic acid (LA) linker strategy to NIR dyes Cy7 and Cy7.5 to 
form two new RMs (Cy7LA and Cy7.5LA) that could be chemisorbed onto Au-NPs 
for SERS studies.
31-32
 I first prepared the scaffold 9 and 10 with an aminopropyl 
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linker (Scheme 7.1). The Boc-protected aminopropyl group of 9 and 10 was 
synthesized by established synthetic protocol followed by treatment with an 
optimized trifluoroacetic acid (TFA)-dichloromethane (DCM) (1:9) solution.
33
 The 
amine intermediates then reacted with activated ester resin of lipoic acid to yield 
target compounds Cy7LA and Cy7.5LA with an average purity of 90%. 
 
Scheme 7.1. Synthesis of lipoic acid-containing amine acetylated tricarbocyanines 




Reagents and conditions: (a) 1-iodopropane, CH3CN, 80 C, 12 h; (b) 3-
Bromopropylamine hydrobromide, 120C, 12 h; (c) Di-tert-butyl dicarbonate, DIEA, 
CHCl3, reflux, 4 h; (d) AcOH, Acetic anhydride, pyridine, 110 C; (e) TFA-DCM 





7.3.2 SERS measurement of NIR Raman reporters 
UV-Vis absorption studies (Figure 7.1) confirms that these compounds are 
ideally suitable for NIR excitation. The maximum absorption wavelengths of these 
compounds are found to be at 795, 745 and 780 nm cm
-1
 for CyNAMLA-381, 
Cy7LA and Cy7.5LA respectively.  
 
Figure 7.1. UV-Vis absorption of Cy 7LA, Cy 7.5LA and CyNAMLA-381(10 M) 
in PBS buffer (pH 7.3) with 1% DMSO. 
 
 
Figure 7.2. Surface plasmon absorption spectra of Cy 7LA, Cy 7.5LA and 




  SERS properties of RMs were studied with 785 nm laser excitation after 
anchoring them onto citrate-stabilized 60 nm AuNPs. The plasmon resonance spectra 
of Au colloid and Au-Cy7LA, Au-Cy7.5LA and Au-CyNAMLA-381 conjugate are 
shown in Figure 7.2. The clean spectra confirm that no aggregation occured in the 
colloidal nanotags. Among the tested candidate dyes, Cy7LA and Cy7.5LA showed 
strong SERS signal in NIR range comparable to CyNAMLA-381 (Figure 7.3). SERS 
spectra of other two compounds are in the Figure 7.4 
 
Figure 7.3.  Normalized SERS spectra of CyNAMLA 381 after chemisorption on 
AuNPs. Spectra were measured in a Raman microscope (785 nm laser excitation, 
acquisition time: 10s) and plotted as average intensities (n=3). 
 
 
Figure 7.4. Normalized SERS spectra of Cy7 LA and Cy7.5LA after chemisorption 
on AuNPs. Spectra were measured in a Raman microscope (785 nm laser excitation, 





Figure 7.5. Normalized SERS spectra of CyNAMLA-381, Cy7LA and Cy7.5LA 
after chemisorption on AuNPs. Spectra were measured using a Raman microscope 
(785 nm laser excitation, 30 mW laser power, acquisition time: 10s) and plotted as 
average intensities (n=3). The most distinctive peaks from each reporter are 
highlighted in yellow.  
 
  As shown in Figure 7.5, the SERS signals exhibited characteristic Raman 
peaks for every RM that that could be monitored in a multiplex mode (503 cm
-1
 for 
Cy7LA;  586 cm
-1
 for Cy7.5LA and 523, 614 cm
-1
 for CyNAMLA-381). The 
relative SERS enhancement of the three nanotags was calculated from the highest 
intensity Raman peak for each nanotags, 523 cm
−1 








Cy7.5LA. It was found that Cy7LA-nanotag showed about 
1.5 times higher intensity than CyNAMLA-381 nanotag while intensity of Cy7.5LA 
nanotag was about 0.76 times lower than CyNAMLA-381 nanotag (Figure 7.3 & 
Figure 7.4).  
 
7.3.2 Signal stability of SERS nanotags  
These NPs-RM complexes were further encapsulated using bovine serum 
albumin (BSA) and glutaraldehyde as a cross-linking agent. Such encapsulation can 
help in preventing the aggregation and desorption of RMs from the NPs, and provided 
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the functional groups on their surface for further bioconjugation.
26, 34-37
 The excess 
glutaraldehyde was removed by treatment owith glycine treatment. The long-term 
stability of SERS-signals of CyNAMLA-381, Cy7LA and Cy7.5LA-AuNPs was 
studied for a period of one month. SERS intensities of the highest Raman peaks (i.e. 
523 cm
-1
 for CyNAMLA-381, 503 cm
-1
 for Cy7LA and 949 cm
-1
 for Cy7.5LA) 
obtained from 5 independent measurements taken from the same sample at different 
time and used to monitor the stability of these nanotags. Remarkably, these nanotags 
did not show any significant aggregation and exhibited stable SERS intensities over 
time, with a very low relative standard deviation of ~5% as shown in Figure 7.6. As 
evident from Figure 7.7, transmission electron microscopy (TEM) revealed that the 
size of these nanotags was around 65 nm. The observed 5 nm increment in size is 
attributed to the BSA layer encapsulation.   
 
 
Figure 7.6.  Time course SERS measurement of three nanotags. SERS intensities of 
the highest Raman peaks (i.e. 523 cm
-1
 for CyNAMLA-381, 503 cm
-1
 for Cy7LA 
and 949  cm
-1
 for Cy7.5LA), are plotted as means ± standard deviation of 5 





Figure 7.7. Transmission electron microscopy (TEM) images of: a) BSA-
encapsulated CyNAMLA-381 nanotag, b) BSA-encapsulated Cy7LA nanotag, c) 
BSA-encapsulated Cy7.5LA nanotag;   Scale bar: 50 nm. 
 
7.3.4 SERS multiplex detection in liver and tumor site 
To demonstration of the multiplexing capability in vivo, we (Dr. Kaustabh 
Kumar Maiti and Dr. U.S. Dinish and I) injected three BSA encapsulated nanotags 
(CyNAMLA-381, Cy7LA and Cy7.5LA) in equal amount through the tail vein of 
xenografts mouse model. SERS measurements were performed 5 h after the injection 
by focusing the laser beam on the desired anatomical region (e.g. liver) through the 
skin. The measured spectra displayed a combination of the three individual spectrums 
from three nanotags and clearly revealed the distinct Raman shift corresponding to 
each RMs as shown in Figure 7.8.  The Raman shift at 503 cm
-1
 was originated from 
Cy7LA while 523 cm
-1
 and 586 cm
-1
 were contribution of CyNAMLA-381 and 
Cy7.5LA respectively.  
After the successful demonstration of the multiplex detection in liver, we 
focused on targeted sensing using a xenograft tumor model from OSCC cells (oral 
squamous cell carcinoma) with a high expression of EGFR and low expression of Her 
2 receptor. We (Dr. Kaustabh Kumar Maiti and I) prepared two SERS nanotag probes 
using Cy7LA and Cy7.5LA as reporter and conjugated with monoclonal anti-EGFR 
antibody while a third nanotag used CyNAMLA-381 as a reporter and was 
conjugated to an anti-Her 2 antibody as negative control. We (Dr. Kaustabh Kumar 
Maiti and Dr. U.S. Dinish and I) measured the SERS spectra from the tumor site 5 h 
after injection of equal amount of all three nanotags. The measured SERS spectra 
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resembled a clear combination of Cy7LA and Cy7.5LA peaks, with no observation 
of the characteristic peak at 523 cm
-1
 from CyNAMLA-381 (Figure 7.9). This data 
clearly indicated the selective accumulation of the two anti-EGFR antibody 
conjugated SERS nanotags (Cy7LA and Cy7.5LA) in the tumor. Furthermore, we 
measured the SERS signal from the liver site and found that the spectra contained the 
characteristic peaks from all three nanotags. Moreover, no SERS signal was detected 
from other anatomical regions (e.g. upper dorsal region).  
 
Figure 7.8. Multiplex SERS detection from liver site. Peaks at 503 cm
-1 
corresponds 
to Cy7LA (red shade); 523 cm
-1 
corresponds to CyNAMLA-381 (green shade); 586 
cm
-1 
corresponds to Cy7.5LA (blue shade). SERS spectra obtained with 785 nm laser 





Figure 7.9. In vivo multiplex detection in xenograft tumor: A:- SERS spectra from 
tumor site (peaks obtained at 503 and 586 cm
-1
 from two EGFR positive nanotags, 
Cy7LA and Cy7.5LA); B:- SERS spectra from liver site (peaks obtained at 503, 523 
and 586 cm
-1
 from two EGFR nanotag Cy7LA, Cy7.5LA and anti-HER2 nanotag 
CyNAMLA-381); C:- SERS spectra from dorsal region. SERS spectra were obtained 
at 785 nm laser excitation at 30 mW power and integration time 20 s. Scale bar: 2000 
cps. 
 
We also repeated the experiment with another combination of antibodies with 
Cy7LA and CyNAMLA-381 nanotags conjugated to anti-EGFR antibody and 
Cy7.5LA nanotag conjugated to anti-Her2 antibody. The SERS measurements from 
tumor site revealed the presence of Cy7LA and CyNAMLA-381 nanotags only and 





Figure 7.10. In vivo multiplex detection of xenograft tumor: A:- SERS spectra from 
tumor site (peaks obtained at 503 and 523 cm
-1
 from two EGFR positive nanotag 
Cy7LA and CyNAMLA-381); B:- SERS spectra from liver site (peaks obtained at 
503, 523 and 586 cm
-1
 from two anti-EGFR nanotag Cy7LA, CyNAMLA-381 and 
anti-HER2 nanotag Cy7.5LA); C. SERS spectra from dorsal region. SERS spectra 
were obtained at 785 nm laser excitation at 30 mW power and integration time 20 s. 
Scale bar: 2000 cps. 
 
7.3.5 In vivo SERS mapping experiment 
The previous experiments confirmed that the specificity of the prepared 
nanotags. The selective targeting was totally independent of the RMs, and simply 
relied on the recognition of receptors by the antibodies conjugated to the nanotags. 
SERS mapping can reveal the localization and distribution of every functionalized 
nanotag.
 30, 38-39
 Hence, we performed mapping experiment at tumor and liver sites 
(area: 600 x 400 µm
2
) using the above combination of nanotags (CyNAMLA-381 & 
Cy7LA as anti-EGFR and Cy7.5LA as anti-HER2). We confirmed the selective 
targeting of anti-EGFR nanotags in the tumor (Figure 7.11a and 7.11b, right column) 
and concurrent passive localization of all three nanotags in liver (Figure 7.11a, b, c, 
left column). The SERS mapping results confirms that the two anti-EGFR nanotags 
were distributed more or less uniformly throughout the tumor area and confirmed the 
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absence of any non-specific binding of the anti-HER2 nanotags in the tumor location 
(Figure 7.11c right column). 
 
 
Figure 7.11. Multiplex SERS mapping images:  Left column from liver site and right 
column form tumor site. (a:- mapping corresponding to peak 523 cm
-1 
for 
CyNAMLA-381; b:- mapping corresponding to peak 503 cm
-1 
for Cy7LA and c:- 
mapping for the peak at 586 cm
-1 
for Cy7.5LA ). Intensities were normalized.  
 
7.3.6 Determination of detection limit  
The determination of limit of detection (LOD) provides an understanding 
about the sensitivity of the constructed nanotag.
40
 To measure the LOD, we chose 
Cy7LA-nanotag as a representative candidate and we examined its concentration 
dependent in vitro SERS measurement of anti-EGFR conjugated nanotag in a 
suspension OSCC cells. We obsereved tha the intensity of the Raman peaks increased 





Figure 7.12. Normalized SERS spectra of EFGR-labeled Cy7LA-nanotag at different 
concentrations, 430, 215, 108, 54 and 27 pM. 
 
7.3.7 Time-course distribution of SERS nanotags 
We also studied the time-course distribution of these SERS nanotags in tumor 
and liver, taking advantage of the long-term stability and multiplexing capabilities. 
We monitored the SERS intensity for a period of 8 days at tumor sites after injection 
of CyNAMLA-381 and Cy7LA anti-EGFR nanotags as and anti-HER2 Cy7.5LA 
nanotags. We could observe that SERS intensity from 503 and 523 cm
-1
 peaks in 
tumor site increased up to 24 h and then remained more or less stable for 8 days, 
which indicates that the nanotags are highly specific and stable over a period of time 
(Figure 7.13). On the other hand, SERS intensities from all three nanotags showed a 
gradual decrease after 48 h in liver site and then sharp fall to merginal level in 8 days. 
Our observation suggests that these nanoparticles might have been excreted through 
the fecal pathway, which agrees with the report on the excretion of BSA encapsulated 
Au-NPs.
41-42
 Also, RES (reticuloendothelial system) of the body can also function to 
phagocytose these nanoparticles types of  nanoparticles, which is later moved into 
liver and generally excreted as feces with bile.
42
 The relatively easy clearance of our 
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nanotags from the liver and their excellent sensitivity, stability and tumor specificity 
validates their potential as a promising in vivo theragnostic probes. 
 
Figure 7.13. Kinetics study of nanotags in tumor and liver site with normalized 
intensity of 503 cm
-1
 for Cy7LA, 523 cm
-1
 for CyNAMLA-381 and 586 cm
-1
 for 
Cy7.5LA nanotags. Spectra were measured and plotted as average intensities (n=3) 
with error bar denoting relative standard deviation. 
 
7.4 Conclusions 
In summary, we report two new lipoic acid-containing NIR active 
tricarbocyanine Raman reporters (Cy7LA and Cy7.5LA) as multiplex partner of our 
previously discovered CyNAMLA-381 for in vivo multiplex targeted imaging. We 
have successfully demonstrated the selective in vivo multiplex targeted detection and 
this study may help to design sensitive nanoprobes for the simultaneous detection of 
multiple diseases. Furthermore, we studied the time-course distribution and 
localization of these nanotags in tumor and liver over a period of 8 days. The SERS 
intensity from targeted nanotags in tumor was stable for relatively long-term while 
their intensity in the liver decrease stipply after 2 days, which indicates the possible 
excretion via fecal pathway. This study will accelerate the design of biocompatible 




7.5 Experimental details 
Materials and methods: As described earlier Chapter 2 and 5. 
7.5.1 Synthesis of Cy7LA and Cy 7.5LA 
Synthesis of 8a. 
Scheme 7.2 Synthesis of 8a. 
 
                                                               
1-Iodopropane (4 g, 24 mmol, 5 eq) was added to the solution of 1,1,2-
trimethyl-1H-benz[e]indole  (1 g, 4.8 mmol, 1 eq) in ACN  and refluxed for 15 hour. 
The reaction mixture was cooled down to r.t and concentrated under reduced pressure 
to get solid residue which was washed by ether for several time and recrystalized 
from methanol solution. tR: 2.62 min, ESI m/z (C18H22N
+
) calc: 252.2; found: 252.1. 
1
H-NMR (300 MHz, DMSO-d6): 1.02 (t, 3H, J= 7.2 Hz), 1.76 (s, 6H), 1.90-1.97 (m, 
2H), 2.95 (s, 3H), 4.57 (t, 2H, J=7.8 Hz), 7.70-8.20 (m, 6H). (6.1 g, yield 85%) 
Synthesis of 8b: 
Scheme 7.3. Synthesis of 8b 
 
Reagents and conditions: 3-Bromopropylaminehydrogenbromide, 1,2-
dichlorobenzene, 110 





3-Bromopropylaminehydrogenbromide (1.1 g, 4.7 mmol) was added slowly 
to a stirred solution of 1,1,2-trimethyl-1H-benz[e]indole  (1 g, 4.7 mmol) in 1,2-
dichlorobenzene at 110 C. The reaction mixture was stirred for overnight at 110 C 
after complete addition.  The solution was decanted and washed with ether solution to 
obtain a solid compound. The solid was recrystallized in methanol to give 1 g (53%) 
as a white solid. tR: 2.34 min ESI m/z (C18H24BrN2
+
) calc: 267.2; found: 267.1. 
1
H-
NMR (300 MHz, DMSO-d6): 1.34 (s, 6H), 1.74-1.77 (m, 2H), 2.92 (s, 3H), 4.47 (t, 
2H, J=7.8 Hz), 7.70-8.20 (m, 6H). (1 g, yield 50%). 
Synthesis of 8c: 
Scheme 7.4. Synthesis of 8c 
 
Reagents and conditions: Boc2O, DIEA, CHCl3, 60 

C, 4 h.  
 
The solid crude 8b (0.5 g, 1.1 mmol) was dissolved in CHCl3 in presence of 
N,N’-Diethylisopropylamine (0.8 ml, 4.5 mmol) and the reaction mixture was 
refluxed for 4 h after addition of Di-tert-butyl dicarbonate (0.36 g, 1.65 mmol).  After 
that the reaction mixture was washed with 0.1 N HCl (5 x 100mL), water (5 x 100 
mL) and dried over Na2SO4. The organic solution was removed under reduced 
pressure to obtain an oily reddish color compound. Purification of the crude residue 
on a silica gel column (elution with CH2C12-MeOH 50:3) rendered 8c as a light 
brown liquid (0.25 g, yield 48%) tR: 4.25 min ESI m/z (C23H31N2O2
+
) calc: 367.3; 
found: 367.4. 
1
H-NMR (300 MHz, CDCl3): 1.43 (s, 9H), 1.64 (s, 6H), 1.86-1.96 (m, 
2H), 3.20 (s, 3H), 3.45 (t, 2H, J = 6 Hz), 4.36 (t, 2H, J = 5.4 Hz), 6.94-7.51 (m, 6H). 
(350 mg, yield  62%) 
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Synthesis of 9: 
Scheme 7.5. Synthesis of 9. 
 
 
Reagent and conditions: a) AcOH, Ac2O, 110 

C, 25 min. b) pyridine, 110 

C, 1 h. 
 
N-[5-(phenylamino)-2,4-pentadienylidene]anilinemonohydrochloride (0.28 g, 
1 mmol, 1 eq.) was condensed with 1a (0.32 g, 2 mmol, 1 eq.) in a solution of 
ACOH:Ac2O (1:1) at 100 C for 25 min, and cooled down to r.t. Then 5 (0.39 g, 1 
mmol, 1.0 eq.) and pyridine were added to the mixture and stirred under reflux. After 
1 h, the reaction mixture was cooled down to r. t. and neutralized by NaHCO3 
saturated solution  and  washed with 0.1 (N) HCl solutions (3 × 100 mL), followed by 
aqueous solution (5 × 100 mL) and dried over anhydrous Na2SO4 and concentrated 
under reduced pressure. Purification of the crude residue on a silica gel column 
(elution with CH2C12-MeOH 50:2) rendered 9 as a green solid (0.35 g, yield 55%). 
tR: 6.24 min ESI m/z (C38H50N3O2
+
) calc: 580.4; found: 580.5. 
Synthesis of 10: 
Scheme 7.6. Synthesis of 10. 
 
Reagent and conditions: a) AcOH, Ac2O, 110 

C, 20 min. b) pyridine, 110 





N-[5-(phenylamino)-2,4-pentadienylidene]anilinemonohydrochloride (0.2 g, 
0.7 mmol, 1 eq.) was condensed with  8a  (0.27 g, 0.7 mmol, 1 eq) in a solution of 
ACOH:Ac2O (1:1) at 110 C for 20 min, and cooled down to r.t. Then 8c (0.35 g, 0.7 
mmol, 1 eq) and pyridine were added to the mixture and stirred under reflux. After 1 
h, the reaction mixture was poured into water and NaHCO3 was slowly added with 
stirring until complete neutralization was reached. After diluting with CH2Cl2 the 
organic layer was washed, dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. Purification of the crude residue on a silica gel column (elution 
with CH2C12-MeOH 50:2) rendered 10 as a green solid (0.4 g, yield 54%). tR: 6.72 
min ESI m/z (C46H54N3O2
+
) calc: 680.4; found: 680.4. 
Synthesis of Cy7LA: 
 
9 (0.1 g, 0.15 mmol) was treated with a solution of TFA-DCM (1:9) at r.t. 
overnight, neutralized with a solution of NaHCO3, and the organic layer was dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. The resulting solid 
that was dissolved in a solution of CH2Cl2-CH3CN (9:1) added to the lipoic acid 
activated nitrophenol resin and shaken for 24 h at r.t. After the reaction, the resulting 
filtrates were combined and dried under pressure, followed the purification by DCM: 
MeOH (50:2) as eluting solvent to render Cy7LA as a slight green solid (82 mg, yield 
72%).  
1H-NMR (500 MHz, CDCl3): 1.05 (t, 3H, J = 7.5Hz), 1.25-1.34 (m, 4H), 1.37-1.47 
(m, 2H), 1.63 (s, 6H), 1.65 (s, 6H), 1.80-1.85 (m, 4H), 2.09-2.14 (m, 2H), 2.42 (t, 2H, 
J = 8 Hz), 3.05-3.17 (m, 2H), 3.45 (d, 2H, J = 4.5 Hz), 3.57 (t, 1H, J = 7 Hz), 3.83 (t, 
2H, J = 7 Hz), 4.35 (t, 2H, J = 7.3 Hz), 5.92 (d, 1H, J = 13.5 Hz), 6.50 (t, 1H, J = 12.5 
Hz), 6.82 (d, 1H, J= 7.2 Hz), 6.93 (d, 2H, J = 7.5 Hz), 7.13 (t, 2H, J = 7.5 Hz), 7.30-
7.33 (m, 4H), 7.40 (t, 1H, J = 7.5 Hz), 7.52 (t, 1H, J = 4.5 Hz), 7.71 (d, 2H, J = 3.5 
Hz)  
tR:  6.42 min, ESI (HRMS) m/z (C41H54N3OS2
+




Synthesis of Cy7.5LA: 
The same procedure was followed starting from 10 to obtain Cy7.5LA (75 
mg, yield 71%). 
1H-NMR (500 MHz, CDCl3): 1.08 (t, 3H, J = 7.5Hz), 1.43-1.47 (m, 3H), 1.63-1.78 
(m, 5H), 1.91 (s, 6H), 1.97 (s, 6H), 2.18-2.19 (m, 2H), 2.37-2.45 (m, 2H), 2.51 (t, 2H, 
J = 7.5 Hz), 3.06-3.14 (m, 2H), 3.51 (d, 2H, J = 4.5 Hz), 3.56 (t, 1H, J = 7 Hz), 3.95 
(t, 2H, J = 7.5 Hz), 4.15-4.21 (m, 1H), 4.52 (t, 1H, J = 7.5 Hz), 5.93 (d, 1H, J = 13.5 
Hz), 6.53 (t, 1H, J = 12 Hz), 6.92 (d, 2H, J = 7.5 Hz), 7.25 (m, 1H), 7.40-7.59 (m, 
6H), 7.86-7.95 (m, 6H), 8.05 (d, 2H, J = 8.5 Hz). tR:  6.81 min, ESI (HRMS) m/z 
(C49H58N3OS2
+
) calc: 768.4016, found:  768.4049  
 
7.5.2 In vivo SERS multiplexing 
Balb/c nude mice from the Biological Resource Centre (Biomedical Sciences 
Institute, A*STAR) were anesthetized by intraperitoneal injection of ketamine (150 
mg/kg)/xylazine (10 mg/kg) at the age of 4-6 weeks, and OSCC cells (5 x 10
6
 cells 
per site in a volume of 150L) were injected subcutaneously into the rear flank. 
When the tumors grew to a size around ~ 0.2 cm in diameter, anti-EGFR antibody-
conjugated SERS nanotags for targeted (positive control) and anti-HER2 antibody–
conjugated nanotag for non-targeted (negative control) (430 pM, 100 L) were 
injected into the tail vein of the mice. After 5 h, mice were anesthetized by 
intraperitoneal injection of ketamine and xylazine mixture solution and in vivo SERS 
measurements were performed from tumor site and non-tumorogenic area i.e. liver 
and dorsal region using Raman microscope with specified area using 30mW, 785 nm 
laser excitation. The integration time was set as 20 s and the laser was coupled to the 
sample through a 20X objective lens with a beam spot of aprox. 3 m.  The animal 
experiment procedures were performed in accordance with a protocol approved by 
the Institutional Animal Care and Use Committee (IACUC). 
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7.5.3 SERS mapping 
SERS mapping experiments were performed in a Renishaw InVia Raman 
microscope system with a laser beam directed to the sample through a 20X objective 
lens. Antibody conjugated nanotag (CyNAMLA-381-nanotag, Cy7LA-nanotag and 
Cy7.5LA-nanotag) with equal concentration (450 pM) were injected through tail-
vein. SERS-mapping in tumor and non-tumor area was conducted by selecting small 
area. Laser excitation at 785 nm wavelength (focal spot of 3 m) and 30 mW power 
was used. Mapping measurements at 523 cm
-1
 for CyNAMLA-381, 503 cm
-1
 for 
Cy7LA and 586 cm
-1
 for Cy7.5LA were carried out as raster scans in 40 m steps 
over the specified area (aprox. 600 x 400 m2) with 1 s integration time. 
7.5.4 Limit of detection (LOD) study 
To find out the limit of detection (LOD) of the best SERS-nanotag Cy7LA, a 
variable concentration dependent SERS study of the gold NPs has been carried. Anti-
EGFR antibody-congugated nanotag (Cy7LA-reporter) with NPs concentration 430 
pM, 215 pM, 108 pM, 54 pM and 27 pM were incubated with OSCC cells  for 2 
hours at 37 C, and then washed with cold PBS (× 3), gently scrapped and 
resuspended in PBS to a cell density of 1 × 10
6
 cells/mL for SERS measurements. As 
shown in Figure 7.13, the normalized SERS spectra for the EGFR-labelled Cy7LA-
nanotag with five different concentrations were obtained. Raman peak 503 cm
-1
 for 
Cy7LA was used for quantitative evaluation. The expected intensity of Raman peak 
increases continuiously with increasing concentration of the targeted NPs. Based on 
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NIR ﬂuorescence (λmax: 700-1000 nm) has received substantial attention in 
various chemical and biological studies. Despite the several advantages of NIR 
tricarbocyanine dyes, the photodegradation is a serious problem for the NIR cyanine 
dyes having absorbance λmax longer than 700 nm. First, we examined the mechanism 
of photodecomposition for the amine derivative of tricarbocyanine dye in aqueous 
media. We hypothesized that the lone pair electron of nitrogen atom cloud enriched 
the  electron system which eventually reacts with singlet oxygen in presence of 
light. As a result, derivatives of tricarbocyanine are not suitable for long time imaging 
study. To overcome this limitation, we developed a photostable NIR cyanine dye in 
which amine group of CyN was acetylated and thus the photoactivating lone pair 
electron was removed. Since the photostability depended on different amine 
structures, we designed a CyNA library composed of 80 structurally different amines 
and screened them to identify the best photostable dye. We found CyNA-414 as the 
most photostable dye with moderate quantum yield and good emission properties 
(820 nm), and compared to a commercially available standard NIR dye (e.g. 
Indocyanine green (ICG)). 
Although the new photostable CyNA-414 exhibited  good properties as a 
NIR dye it lacked a reactive functional group to enable its use in protein labeling or 
small molecules. Hence, we adapted this molecule for bioconjugation processes by 
introducing a suitable spacer. The replacement of this spacer not only maintained 
good photophysical properties but also enabled bioconjugation. NIR protein-labeling 
dyes must ideally retain highly fluorescent emission and good photostability profiles 
once conjugated to the protein of interest, and must maintain the specific recognition 
and functional abilities of the protein. Therefore, we synthesized succinimidyl ester 
(CyNE 790) and compared its photophysical properties to the standard ICG-sulpho-
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OSu. A detailed evaluation of their photobleaching in buffer showed a 15-fold higher 
photostability of CyNE 790 compared to ICG-sulfo-OSu. Furthermore, the injection 
of CyNE 790-anti-EGFR treated SCC-15 and MCF-7 cells allowed the visualization 
of SCC-15 cells in mice and confirmed that the conjugation of CyNE 790 did not 
affect the recognition properties of the monoclonal anti-EGFR antibody. 
Due to the excellent photophysical properties of CyNE 790 we prepared 
glucose derivatives of CyNE 790 for cancer cell imaging in NIR region. It is known 
that malignant cancer cells show an increased glycolysis rate when compared to 
normal cells due to the over expression of glucose transporters (GLUTs) and the 
higher activity of hexokinases. These differences in metabolism have been applied to 
the identification of cancer cells and tumors by optical imaging methods that rely on 
the preparation of reporter-containing glucose analogues. Hence, we synthesized a 
new probe CyNE-2DG which is a novel NIR fluorescent deoxyglucose analogue. We 
validated the staining of cancer cells by this fluorescent deoxyglucose analogue and 
proved its superior cell-permeability of CyNE 2-DG over the NIR standard IRDye 
800CW 2-DG, which supports its application for cancer cell imaging in the NIR 
region.  
In addition to the application of NIR fluorophores to fluorescent imaging, we 
also explored an alternative imaging techniques such as Surface-enhanced Raman 
Scattering (SERS) that can minimize the limitations of fluorescence imaging. SERS 
probes are based on the 10
14–1016 fold scattering enhancement caused by the 
proximity of Raman-active signature molecules to the surface of metal NPs which can 
be modulated with molecular recognition motifs to render diagnostic tools for optical 
imaging and therapeutic studies. However, the preparation of ultrasensitive SERS 
probes is hampered by the limited availability, sensitivity, and reproducibility of 
Raman-active compounds at NIR region. Thus, we aimed to develop novel signature 
molecules that are active in NIR region. For such purpose, we designed the first 
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combinatorial approach to discover novel and highly sensitive NIR SERS reporters. 
The synthesis of a lipoic acid-containing 80-member NIR-SERS active 
tricarbocyanine library (CyNAMLA) and the screening of this library led to the 
identification of best NIR SERS reporter. To prepare SERS nanotags that could 
selectively detect cancer cells expressing HER2 receptors in vivo, we conjugated 
CyNAMLA-381-AuNPs to a scFv anti-HER2 antibody. We injected the scFv-
conjugated CyNAMLA-381-SERS nanotags in nude mice bearing xenografts 
generated from SKBR-3 cells. Whereas the signal of the tumor site perfectly 
resembled the SERS spectra of the pure nanotags, no SERS signal was detected from 
other anatomical locations. These results clearly indicate that the scFv-conjugated 
CyNAMLA-381-SERS nanotags were able to specifically detect HER2-positive 
tumors in vivo.  
In addition to the applicability of SERS nanotags for in vivo cancer, we aimed 
to apply multiplexing Raman reporters for the cancer in vitro cellular assay. The 
concurrent detection of deﬁned multiple targets can facilitate the development of 
accurate diagnostic probes. We designed derivative of cyanine dye such as Cy3LA 
and Cy5LA as good multiplexing of the previously reported B2LA compound.  In 
order to examine the multiplex differential recognition of B2LA anti-EGFR and 
Cy3LA anti-HER2 nanotags in cells, we incubated an equal amount of both nanotags 
in OSCC cells (EGFR-positive and HER2-negative) and SKBR-3 cells (HER2-
positive and EGFR-negative). After washings with PBS, the SERS measurement in 
OSCC cells fully resembled the SERS spectrum of B2LA whereas the SERS signal of 
SKBR-3 cells matched with the spectrum of Cy3LA. Thus, we demonstrated here 
that B2LA and Cy3LA-nanotags could be used as a multiplex platform by 
recognizing both OSCC and SKBR-3 cells after they were co-cultured.  
Finally, we have synthesized of NIR-active Raman reporters which can be 
applicable for the multiple detection of cancer cell in vivo. We demonstrated the 
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multiplexing capability of three different Raman reporters (i.e. CyNAMLA-381 and 
newly synthesized highly sensitive Cy7 LA and Cy7.5 LA), and their high sensitivity 
and tumor specificity of antibody-conjugated SERS nanotags showed their excellent 
potential as non-invasive diagnostic tools. For the first time, we successfully 
demonstrated the selective in vivo multiplex targeted detection with full multiplexing 
capability and this study may help to design novel SERS nanoprobes for the 
simultaneous detection of multiple disorders.  
8.2 Future prospective 
8.2.1 Design of a cell tracker NIR fluorescence imaging agent 
We have discussed about the application of NIR cyanine dyes in fluorescent. 
CyNE 790 dye can be further modified for the development of NIR cell-tracker dyes. 
According to Scheme 8.1, CyNE 790 can be functionalized by means of an amine 
linker that can be further modified depending on the biological application. For 
instance, a chlorobenzyl functional group could be introduced to covalently bind 
macromolecules under physiological conditions. There are some examples based of 
this strategy in other fluorescent scaffolds
1-3
. Maleimide derivative may also have a 
good potential to attach covalently to thiol motifs. Figure 8.1 shows that the covalent 
attachment to thiols derivatives can be used to label the cells, which could be 







Figure 8.1. Design of NIR cell-tracker NIR fluorescent dyes. 
 




Reagents and conditions: a) CyNE 790 dissolved in Sodium bicarbonate buffer (pH 
8.3) with cosolvant (2% DMSO) and ethylenediamine; b) 4-(chloromethyl)benzoyl 
chloride, DIEA, 0 





8.2.2 SERRS for ultrasensitive detection of multiple targets 
Surface-enhanced Raman scattering (SERS) is an ultrasensitive technique 
that can detect chemicals at a trace level. In fact, SERS has been reported for the 
detection of single molecules, macromolecules. Another attractive feature of SERS is 
its ability to accurately detect multiple analytes in parallel way due to the 
multiplexing capability. Generally, NPs of the noble metals Ag and Au are employed 
as SERS substrates. A variety of factors such as size, aggregation and geometry of the 
NPs affect the maximum absorbance wavelength of the roughened metal surface. 
Most often, 20 to 80 nm NPs (Au or Ag) are described as SERS substrate but the size 
and the nature of these NPs determines their plasmon spectra. For example, the 
absorbance maxima of Au and Ag full spheres in water are 430 nm and 525 nm 
respectively. Their plasmon bands can be red shifted to NIR region when Au/Ag 
nanoshells with an outer diameter of 55 nm. In Au/Ag nanoshells, the shell thickness 
can be decreased with an increasing gold content, and as a result the plasmon band 
exhibits red shifted to NIR region when Au/Ag nanoshells with an outer diameter of 
55 nm are used. In Au/Ag nanoshells, the shell thickness can be decreased with an 
increasing gold content, and as a result the Plasmon band exhibits a red shift to reach 
max around 600–700 nm (Figure 8.2). In addition, recently Halas and co-workers 
reported that the absorption peak of spherical gold nanoshells can be modified within 
the spectral range from 600 to 1200 nm whereas it is not easy to tune the plasmon 
spectra of spherical Au (or Ag) NPs.  
NIR light absorbing nanoshells would be very attractive for the surface-
enhanced resonance Raman scattering (SERRS). The basic requirements for SERRS 
are that either Raman-active dyes or SERS substrate (noble metals) must absorb light 
in a suitable wavelength, in resonance with the applied excitation frequency of the 
light. The resulting outcome is a signal of higher intensity than conventional SERS.  
Previously, we proved the applicability of SERRS effect using NIR Raman-active 
dyes, which are electronically excited under a 785 nm laser. However, we employed 
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gold colloid (60 nm, with 534 nm plasmon band) for SERS substarte which did not 
match with the excited light at 785 nm. We may consider Au/Ag nanoshells 
absorbing light at around 700 nm as SERS substrate in order to obtain a stronger 
SERRS effect by combining both NIR-active Raman reporters and NIR-active SERS 
substartes. As a result, sharp distinguishable fingerprints with enhanced signal 
intensities, narrow bandwidths and multiplexing properties could be used to prepare 
novel highly sensitive multiple detection probes.  
 
Figure 8.2. Schematic diagram for the preparation of Au/Ag nanoshells from Ag 
nanospheres. The plasmon spectra show a clear dependence on the size of the gold 
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